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Abstract 
Measurement error in explanatory variables and unmeasured confounding can lead to biased 
estimates of exposure-outcome associations in observational epidemiological studies. In this 
thesis, simulation studies show that the effects of residual and unmeasured confounding on the 
estimated exposure-outcome association can be complex, especially when the confounders are 
correlated. Unmeasured confounding is a greater problem when the confounders are 
uncorrelated. In addition, classical measurement error in the exposure variable attenuates the 
estimated association towards the null. 
Two methods for correcting for measurement error in explanatory variables, regression 
calibration and simulation-extrapolation, are investigated via simulation study. The regression 
calibration method performs well when there are no unmeasured confounders, removing all of 
the bias due to measurement error in the explanatory variables. The simulation-extrapolation 
method reduces bias but does not remove it completely. 
A sensitivity analysis is used to investigate residual confounding by triglycerides and forced 
expiratory volume in one second (FEVi), and exposure measurement error in C-reactive protein 
(CRP) on the association between CRP and coronary heart disease in the British Women's Heart 
and Health Study. Allowing for measurement error in FEVI has little impact on the estimated 
exposure-outcome association. Allowing for measurement error in triglycerides slightly 
attenuates the estimated association, while allowing for measurement error in CRP moves the 
estimated association away from the null value. 
Non-compliance in randomised controlled trials can result in an intention-to-treat analysis that 
estimates the effectiveness of treatment, but not its efficacy. Data from the Nambour Trial are 
used to investigate the effect of sunscreen use on time to basal cell carcinoma accounting for 
compliance. A rank preserving structural failure time model is used for the analysis, as it 
allows failure time outcomes and complex compliance data. The compliance analysis moves 
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1.1. Causal effects in epidemiology 
The aim of epidemiologic analysis is often to estimate the causal effect of an exposure on an 
outcome of interest. The problems with using observational studies for causal inference are 
well known. 1,2 Selection bias, recall bias, loss to follow-up and reverse causation are some of 
the problems that can lead to biased estimates of associations between exposure and outcome in 
observational studies. Confounding is caused by variables associated with both outcome and 
exposure, and not on the causal pathway between exposure and outcome. Controlling for 
variables with these properties may remove bias, but they must all be measured perfectly, and 
their association with the exposure of interest perfectly characterised. There are also variables 
for which control does not remove bias even though they have all three properties of 
confounders. 3 While it is recognized that, under certain conditions, non-differential 
measurement error in the exposure leads to a bias towards the null, 4 the effects of measurement 
error in confounders, which leads to residual confounding, are not well understood. 
Consider, for example, the effect of antioxidant vitamin intake on cancer, cardiovascular 
disease, and mortality. Observational studies have shown protective effects, 5-7 while in contrast 
randomised trials have shown no effect on outcomes. s. 9 It has been suggested that the disparity 
in results is likely to be due to confounding by behavioural and social factors acting across the 
life coursejO, 11 For example, factors related to childhood social class may be important 
confounders for the association between antioxidant vitamin intake and disease outcome. To 
fully capture the life course effect of such confounders, all related factors must be measured 
perfectly. Failure to do so, either due to unmeasured confounders or residual confounding, will 
result in biased estimates of the causal exposure effect. There are, of course, other possible 
explanations for this disparity in results. Observational studies estimate the effect of dietary 
exposure on disease outcomes, whereas randomised trials change exposure in the intervention 
group. This change is often by supplementation, and can result in exposure to the nutrient of 
interest much higher than would ever be seen in an observational study. In some situations, 
however, the exposure in the observational studies is precisely the same as the treatment in the 
randomised controlled trials (RCTs). For example, two widely cited papers in 1993 
demonstrated substantially lower coronary heart disease (CHD) risk amongst people using 
vitamin E supplements, that were apparently robust to confounding. 6,7 Furthermore, there was 
no trend towards increasing protection by vitamin E supplements when taken for more than 
two years. The exposure in these observational studies is precisely the same exposure as that 
tested in RCTs of vitamin E supplementation that have run for up to six years. In these RCTS 
there is robust evidence of no material effect on CHD risk. 12 
Some authors debate whether residual and unmeasured confounding can cause large exposure- 
outcome effect estimates. Morabia13 asserted that strong associations are unlikely to be 
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completely attributable to confounding because strong confounders are likely to be detected in 
the study population, or recognized in the literature as strong confounders and therefore 
measured and controlled for in the analysis. More recently, Khaw, Day, Bingham et al. 14 
advanced similar arguments with respect to whether residual confounding could explain 
observed associations between plasma ascorbic acid and mortality. Much of the literature 
describing the effects of residual confounding on exposure effect estimates assumes that there is 
a single confounder of the exposure-outcome association. In these cases, the assertions made by 
Morabia13 may generally (but not always) apply. 
When measurement error in explanatory variables exists, statistical methods have been 
proposed to correct exposure effect estimates for the bias caused by measurement error. These 
methods involve using external or internal validation studies, replicate measures or 
transportation to estimate the measurement error parameters, such as the error variance for 
continuous variables or the sensitivity and specificity for binary variables. Sensitivity analysis 
methods can be used in situations in which the measurement error or misclassification 
parameters cannot be estimated from available data, by using a range of plausible values for the 
measurement error parameters to show the possible impact of measurement error on estimated 
exposure effects. 
It may also be difficult to estimate causal treatment effects from RCrs. The primary method of 
analysis in RCrs is by intention-to-treat M. In an ITT analysis, participants are analysed 
based on their randomly allocated treatment. An ITT analysis estimates the effectiveness of 
treatment, i. e. the effect of a treatment policy. Another estimate of interest is the efficacy of 
treatment, i. e. the effect of receiving treatment. If participants do not comply with their 
allocated treatment, the ITT analysis does not estimate of the efficacy of treatment. The ITT 
estimate is instead a combination of the effect of treatment among compliers, and the lack of 
effect among non-compliers. As-treated and per-protocol analyses generally produce biased 
efficacy estimates. As-treated analyses, in which the randomisation is ignored and participants 
analysed based on treatment actually received, are subject to the same problems as 
observational analyses. Per-protocol analyses, in which subjects are censored at the first time 
they depart from their randon-dsed treatment, may be subject to selection bias. Statistical 
methods have been developed to analyse data from RCTs with non-compliance that respect the 
randon-tisation and provide an estimate of treatment efficacy. These analysis methods are 
preferable to as-treated or per-protocol analyses when an estimate of treatment efficacy is 
required. 
Aims 
This thesis is divided into three distinct parts. In Part A, the effects of residual and unmeasured 
confounding and exposure measurement error on exposure effect estimates are considered. 
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Simulation studies demonstrate the effects of such errors on exposure-outcome ORs estimated 
from logistic regression models. In Part B, some of the results obtained from the simulated 
datasets of Part A are corrected for measurement error using two methods, regression 
calibration and simulation-extrapolation. A sensitivity analysis is performed using data from 
the British Womeres Heart and Health Study, and the effect of residual confounding and 
exposure measurement error on the estimated association between C-reactive protein (CRP) 
and CHD is investigated. Part C considers methods for analysis of data from RCrs when 
participants depart from their randon-dy allocated treatment and demonstrates the use of one 
particular model, a rank preserving structural failure time model, in an RCr investigating the 
effect of sunscreen use on basal cell carcinoma (BCC), where data on sunscreen used are 
available. 
The aims of this thesis are as follows: 
1. TO review the literature on the bias in the causal exposure effect estimate caused by 
exposure measurement error and misclassification in observational epidemiological 
studies (Chapter 2). 
2. To review the literature on the bias in the causal exposure effect estimate caused by 
residual confounding in observational epidemiological studies (Chapter 2). 
3. To review the literature on the bias in the causal exposure effect estimate caused by 
unmeasured confounding in observational epidemiological studies (Chapter 2). 
4. To investigate the impact of residual and unmeasured confounding in logistic regression 
analyses with either two or four confounders using a simulation study (Chapter 3). 
5. To investigate the impact of exposure measurement error, in addition to residual and 
unmeasured confounding, in logistic regression analyses with either two or four 
confounders using a simulation study (Chapter 3). 
6. To review the literature on methods available to correct for measurement error in 
observational studies in cases where the amount of measurement error is known or can 
be estimated (Chapter 4). 
7. To review the literature on sensitivity analysis methods in epiden-dology (Chapter 4). 
8. To use simulation studies to investigate two methods for correcting for measurement 
error, regression calibration and simulation-extrapolation, using datasets described in 
Chapter 3 (Chapter 5). 
9. To review the literature on the association between CRP and CHD (Chapter 6). 
10. To investigate the impact of residual confounding and exposure measurement error on 
the association between CRP and CHD using data from the British Women's Heart and 
Health Study (Chapter 7). 
11. To review the literature on methods available to estimate treatment efficacy in RCTs with 
departures from randomly allocated treatment (Chapter 8). 
12. To review the literature on the association between sunlight and BCC (Chapter 9). 
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13. To use rank preserving structural failure time models to estimate treatment efficacy, 
allowing for departures from randomly allocated treatment, in an RCT of the effect of 
sunscreen use on time to first BCC using data from the Nambour Skin Cancer and Actinic 
Eye Disease Trial (Chapter 10). 
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Chapter 2. 
Background literature: The effects of measurement error and 
misclassification in explanatory variables and unmeasured 
confounding in epidemiological studies 
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Introduction 
In this chapter, literature describing the effects of measurement errors in exposure or 
confounding variables, or omission of confounders on estimated exposure effects is described. 
This is motivated by an investigation of the impact of unmeasured confounding, caused by 
omitting confounders from a regression analysis, residual confounding, caused by 
measurement error in confounders, and exposure measurement error on estimated exposure 
effects from logistic regression models, which is presented in Chapter 3. First, types of 
measurement error and measurement error models are described. This is followed by a review 
of the literature describing the effects of measurement errors in exposure variables on exposure 
effect estimates. The next section describes the effect of measurement errors in confounding 
variables on exposure effect estimates. The final section of this chapter describes the effect of 
unmeasured confounding on estimated exposure-outcome effects. 
2.2. Types of measurement error and measurement error 
models 
Twoughout this chapter, X will denote a variable measured without error. This will be referred 
to as the true value of the variable. In the context of epidemiological studies, and measurement 
error in an exposure or confounder, the true value is defined to be the value that is causally 
related to the outcome of interest. For example, the long-term average of blood pressure may 
be causally related to risk of coronary heart disease, but it is difficult to measure. A single blood 
pressure measurement is unlikely to capture the long-term average accurately, due to natural 
fluctuations in blood pressure, calibration error in the measuring instrument, or a persons 
anxiety level. This single measurement can be regarded as a measurement of the long-term 
average blood pressure which is subject to measurement error. Throughout this chapter, 
measurements that are subject to error will be denoted by Z. The effects of measurement errors 
depend on the type of measurement error, and how it is related to the true value of interest- 
Types of measurement errors and measurement error models are described below. 
Random and systematic measurement error 
Random and systematic measurement errors are affected by the value of the variable of interest, 
and not by other variables that may be related. For continuous variables, random errors can be 
thought of as adding noise to the measurement of a variable. They do not influence the data in 
any particular direction. More specifically, the expected value of the error is zero when the 
error is random. 
Systematic errors, on the other hand, will bias the measurement of a variable in a specific 
direction (i. e. the expectation will be non-zero). Systematic errors can occur, for example, if 
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laboratory measurements become more variable the closer to the lower limit of detection the 
measurement lies. 
2.2.2. Differential and non-differential error 
Differential measurement error occurs when the measurement error depends on the value of 
another variable. For example, the measured value of the variable may depend on the outcome. 
This form of measurement error can occur in, for example, case-control studies in the form of 
recall bias. A case may be more likely to remember and report past exposures than a control, 
which leads to error in the exposure that is differential with respect to the outcome. 
2.2.3. Additive and multiplicative measurement error 
Measurement errors can act either additively or multiplicatively on the true value of the 
variable being measured. If X denotes the true value of the variable, Z denotes the 
mismeasured variable, and c is the error, then additive measurement error takes the following 
form: 
Z=X+c, 
while multiplicative measurement error takes the form: 
Equation 2.1: Z=Xe- 
Throughout this chapter, and the remainder of the thesis, measurement error will be assumed 
to be additive. It is useful to note that, by taking logarithms of Equation 2.1, the measurement 
error structure becomes additive: 
InZ=InX+Inc, 
and therefore all characteristics of additive measurement error apply to multiplicative error on 
a log scale. 
2.2.4. Classical and Berkson measurement error models 
In the classical measurement error model, the error is assumed to be independent of the true 
value of the variable. Therefore, if the measurement error is additive, the model for classical 
measurement error is: 
Z=X+c, 
and Var(Z)=Var(X)+Var(c). A classical measurement error model is appropriate if there is a 
true level of exposure but it cannot be precisely measured, for example a personýs exposure to 
air pollution. 
In the Berkson measurement error model, measurement error is assumed to be independent of 
the measured values of the variable, and the true value is centred around a proxy measurement. 
Assuming measurement error is again additive, the Berkson model is: 
X=Z+c, 
and Var(X)=Var(Z)+Var(E). The Berkson measurement error model is appropriate if the dose of 
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an exposure can be controlled, but the true level of exposure X (e. g. the amount of drug 
absorbed into the bloodstream) varies randon-dy around the fixed dose Z. 
2.3. The impact of measurement error in exposure 
In this section, the effects of measurement error or misclassification in the exposure variable are 
discussed. Literature on the effects of measurement error or n-dsclassification of confounders is 
described in Section 2.4. Methods for correcting for measurement error or misclassification will 
be considered in Chapter 4. 
Binary exposure 
Early interest in the effects of exposure measurement error focused on 2X2 tables. Bross15 
showed in this setting that non-differential misclassification results in an underestimation of the 
difference in proportions of cases between two populations (an important correction to the 
results in this paper is provided by NeweII16). It was also shown that misclassification reduces 
power to detect effects. This could be viewed effectively as a loss of study subjects. A similar 
idea was advanced by Phillips and Davey Sn-dth, 17 who showed that, in some situations, it may 
be better to recruit fewer people to a study and use study resources to obtain repeated 
measurements on those subjects than to recruit more people and measure exposures only once. 
Greenland'8 showed that non-differential misclassification of a binary exposure variable in the 
presence of covariates results in attenuation of the observed exposure effect estimate. 
Considering odds ratios (ORs) in strata defined by values of a binary confounder, non- 
differential misclassification of the exposure may introduce heterogeneity into the stratum- 
specific ORs when in truth they are homogeneous, or hide heterogeneity if it truly exists. 
The effects of non-differential and random misclassification of a binary exposure variable on 
estimates of relative risk in the 2x2 table setting was considered by Flegal, Brownie and Haas. 19 
A formula was provided that related the observed relative risk to the sensitivity and specificity 
of the n-dsclassified exposure, the prevalence of exposure, and the true relative risk. This 
showed that: 
1. If the true relative risk equals one, then the observed relative risk equals one and there 
is no bias, regardless of the sensitivity, specificity or prevalence of exposure. 
2. If the sum of the sensitivity and specificity equals one, the observed relative risk will be 
one regardless of the true relative risk. 
3. If the sum of the sensitivity and specificity is less than one, the observed relative risk 
will show an effect in the opposite direction to the true relative risk. 
4. If the sum of sensitivity and specificity is greater than one, the observed relative risk 
will underestimate the true relative risk. 
5. If the sensitivity is perfect (i. e. equal to one), the observed relative risk increases as the 
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prevalence increases. 
6. If the specificity is equal to one, the observed relative risk decreases as the prevalence 
increases. 
7. When both sensitivity and specificity are imperfect, the relationship of the observed 
relative risk with prevalence of exposure is not monotonic. 
8. When comparisons of observed relative risks are made between groups, such as those 
defined by levels of a confounder, the differences in the prevalence of exposure in the 
groups can cause heterogeneity between the observed relative risks when there is none 
in the true relative risk, or mask true heterogeneity. 
9. Spurious trends with other variables can also be caused or masked if the prevalence of 
exposure increases as the third variable increases. 
Marshall and Hastrup20 considered misclassification. in a binary exposure and confounder 
where the errors were uncorrelated. They demonstrated, through simulation studies, that 
increasing the misclassification in the exposure biases the estimated OR towards the null if the 
confounder misclassification is held fixed. Additionally, if there is no misclassification in the 
confounder, and no true association between exposure and outcome, n-tisclassification of the 
exposure does not introduce any bias into the estimated exposure-outcome OR. 
Davidov, Faraggi and Reiser2l considered misclassification of a binary exposure in a logistic 
regression setting. Exact and first order approximations of the effect of misclassification were 
provided. In the general setting, where n-dsclassification may be differential, the bias was 
shown to depend on the sensitivity and specificity of the misclassification, and the odds of 
exposure for the two different levels of outcome. 
The effects of non-differential misclassification of binary exposure variables have been well 
discussed in the literature, but often appear to be misunderstood. It is often stated that the 
exposure effect estimate is biased towards the null when the misclassification is non- 
differential. In fact, this is not a sufficient condition to guarantee a bias toward the null. The 
rule in reality applies to the average effect of non-differential measurement error in repeated 
studies that vary only randomly from each other. Therefore, in a single study, the bias due to 
non-differential udsclassification of an exposure can be either towards or away from the null. 
This has been demonstrated in simulation studies by Jurek, Greenland, Maldonado et al. 4 and 
Sorahan and Gilthorpe. 22 
2.3.2. Polytomous exposure 
Non-differential misclassification of a polytomous exposure was considered by Fung and 
Howe. 23 Using simulation studies, they showed that non-differential misclassification of 
exposure results in a bias towards the null value. In addition, exposure misclassification 
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influences the p-value of a test and results in a loss of power. 
Dosemeci, Wacholder and Lubin24 investigated the effect of non-differential misclassification of 
polytomous exposures. In contrast to the results of Fung and Howep they found that 
n-tisclassification could bias the exposure effect estimate towards or away from the null value, 
and that in some situations the bias could act to reverse the direction of the estimated effect. 
Gilbert25 suggested that, although the misclassification was non-differential, it was also 
systematic, and that the reversal of trend was due to the systematic n-tisclassification. This 
proposition was investigated by Weinberg, Umbach and Greenland. 26 They found that a 
change in direction of the exposure effect estimate could occur if systematic exposure 
misclassification was present. Furthermore, even if systematic exposure n-tisclassification 
occurs, if the error can be assumed to be monotonically increasing with the value of the true 
exposure, a reversal in trend cannot occur. 
Dose-response trends are often considered in epidemiological studies with polytomous 
exposures. Brenner27 considered the effect of non-differential n-dsclassification of a three-level 
polytomous exposure on the estimated dose-response relationship. Misclassification. between 
adjacent groups only was considered. Misclassification of the exposure can suggest a trend 
where there in reality is none. If all levels of the exposure are misclassified (e. g. from low to 
medium and vice versa, and from medium to high and vice versa), the effects of each 
n-dsclassification may cancel each other out partially or completely. In situations with a non- 
monotonic dose-response relationship, misclassification may result in under- or over-estimation 
of the relationship. In the situation of a monotonic non-linear dose-response relationship, 
misclassification leads to an attenuation of the estimated trend. P-values are often provided 
when the trend is assessed. Brenner27 additionally showed that non-differential exposure 
misclassification can either increase or decrease the true p-value from a Mantel extension test 
for trend. An increased p-value is more likely when the true dose-response relationship is 
monotonic, and a decreased p-value more likely when the true dose-response trend is non- 
monotonic. 
Wacholder, Dosemeci and Lubin28 showed that collapsing a categorical variable into fewer 
categories can result in differential misclassification, even if the original variable is non- 
differentially misclassified. This could occur if, for example, people are categorised as never 
smokers, ex-smokers, and current smoker subject to non-differential misclassification. In an 
analysis comparing ever-smokers with never-smokers, the two categories may be subject to 
differential misclassification. This can occur if the categories that are collapsed have different 
risks of disease and different probabilities of misclassification. If differential misclassification 
does arise from collapsing categories, exposure effect estimates may be larger than the true 
value, or suggest an effect in the opposite direction. 
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A common practice in epidemiology is to categorise continuous variables. If the continuous 
variable is subject to non-differential measurement error, the categorical variable that arises 
from this process may be differentially n-dsclassified. 29 For example, subjects may be more 
likely to be misclassified the closer to the cutpoint their true exposure value lies. If a higher 
level of exposure leads to an increased probability of disease then differential misclassification 
of the exposure variable can occur. In their simulation studies, Flegal, Keyl and Nieto29 showed 
that the bias due to differential misclassification arising from categorising a continuous variable 
may be smaller than if the error was non-differential. Gustafson and LOO also showed that the 
differential misclassification that may arise by dichotomising a continuous variable can result in 
a smaller bias in the effect estimate than the bias caused by the non-differentially n-dsmeasured 
continuous variable. Whether this reduction in bias occurs depends on the underlying 
relationship between the outcome and continuous exposure. It was also suggested that if 
dichoton-dsing a continuous variable improves model fit, then the bias due to the resulting 
misclassification will be worse than if the continuous variable was used in the regression. 
2.3.3. Continuous exposure 
The idea of considering the effects of measurement errors in exposures was first introduced by 
Spearman in 1904,31 who noted that errors in continuous variables would attenuate the 
correlation between the variables. 
Measurement error in a normally distributed exposure was considered by Armstrong, 
Whittemore and Howe. 32 Assuming a discrin-dnant analysis model and a case-control setting, 
formulae were provided for the bias in the estimated logistic regression coefficients. The 
formulae account for both random and differential measurement errors. If there is no 
confounding and no differential error, the exposure effect estimate is attenuated towards the 
null by a factor of 22 +a 2), where 0,2 is the variance of the true exposure, and 2 is the t7; 1(a. XXa; 
variance of the measurement error. If a confounder is included in the model and measured 
without error, the attenuation due to measurement error in the exposure is increased. This 
increased attenuation also occurs when an additional explanatory variable that is not a 
confounder is unnecessarily included in the analysis. 
The attenuation factor defined in the previous paragraph is the same as the attenuation in a 
linear regression when the exposure is measured with error. This effect can be easily 
demonstrated. The univariable linear regression equation is 
Y=PX+F-. 
Suppose that 0=2- A scatter plot of Y against X will have a slope of 2, as shown in Figure 2.1. 
Now suppose that X is measured with error. Figure 2.1 shows that the scatter plot of Y against 
the mismeasured X has a greater horizontal spread, which results in a regression slope with 
smaller gradient. 
15 
Literature: Effects of measurement error and unmeasured confounding 
Armstrong33 discussed the effect of measurement error in normally distributed exposures, 
assuming a classical measurement error model with non-differential and random measurement 
error. The same attenuation factor of 22 +a 2) as found by Armstrong, Whittemore and C; 
AT. 
X 
HoWe32 was found for exponential models, or cohorts in which the time to event is observed. 
The effect of Berkson type measurement error was also considered, and resulted in no 
attenuation of the relative risk estimate. There was, however, an increase in the standard error 
of the estimate. These results apply to case-control studies in which cases and controls are 
matched by age, or cohort studies in which the time to the outcome event is observed. If the 
time to event is not observed, the results described here do not apply. However, if the risk of 
disease is small, the effects of measurement error will be close to that described above. 
Attenuation of the exposure-outcome relationship, and a lack of attenuation in the Berkson 
measurement error model, have also been demonstrated by Clayton and GiU34 in the context of 
linear regression with a normally distributed exposure. 
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The effect of measurement error correlated with the true value of an explanatory variable was 
considered by Wacholder. 35 Assuming a univariate linear regression model, this type of 
measurement error in the exposure can result in inflation, attenuation or a reversal of direction 
of the true exposure effect estimate. If the error variance is less than the variance of the true 
variable, and there is a negative correlation between the error and the true variable, 
exaggeration of the true effect can occur. Reversal of effects can occur if the error variance is 
greater than the variance of the true variable, and the correlation between the error and the true 
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variable is negative. The correlation between exposure and error can lead to a Berkson 
measurement error model, in which the error is uncorrelated with the exposure as measured. 
This situation results in no bias in the estimated exposure effect when using the measured 
exposure as opposed to the true exposure. 
In a simulation study with continuous exposure and single confounder, Marshall and Hastrup20 
also showed that, if the errors in the exposure and confounder are uncorrelated, measurement 
error in the exposure attenuates the estimated exposure effect towards the null for both linear 
and logistic regressions. This effect occurs regardless of the bias induced by measurement error 
in the confounder. It was additionally demonstrated that, if the exposure has no true 
association with the outcome and there is no measurement error in the confounder, exposure 
measurement error does not induce any bias in the estimated exposure-outcome association. 
Marshall, Hastrup and Ross36 showed that bias in the exposure effect estimate can be in either 
direction if the error in exposure is correlated with the error in confounder in both linear and 
logistic regressions, depending on the correlation between the errors and the amount of error in 
the confounder. 
Kipnis, Freedman, Brown et al. 37 provided a formula for the effects of measurement error in a 
continuous exposure for linear regression analyses. This formula showed that, under the 
classical measurement error assumptions of errors uncorrelated with the true variable or each 
other, measurement error in the exposure leads to an attenuation towards the null of the true 
exposure-outcome association. The formula also allowed for the classical measurement error 
assumptions to be relaxed. In these situations, error in the exposure can lead to an observed 
association in the opposite direction to the true exposure-outcome association, or a larger 
observed association than the true association. 
2.3.4. Summary 
The effects of exposure measurement error on estimated exposure effects are summarised 
below. 
If the measurement error in a continuous exposure is non-differential and random the 
exposure effect estimate is attenuated towards the null when compared with the true 
effect. 
If there is no true association between exposure and outcome, non-differential and 
random exposure measurement error has no effect on the observed exposure effect 
estimate. 
For non-differential and random misclassification of a binary exposure, the observed 
relative risk equals one if the sum of the sensitivity and specificity of misclassification 
equals one. 
For non-differential and random misclassification of a binary exposure, the observed 
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relative risk is in the opposite direction to the true relative risk if the sum of the 
sensitivity and specificity of misclassification is less than one. 
For non-differential and random misclassification of a binary exposure, the observed 
exposure effect is an underestimate of the true exposure effect if the sum of the sensitivity 
and specificity of n-tisclassification is greater than one. 
Systematic exposure measurement error may bias the observed effect estimate towards or 
away from the null value, or result in an observed effect in the opposite direction to the 
true effect. 
0 Non-differential and random exposure measurement error causes a loss of power to 
detect effects. 
0 Non-differential measurement error may introduce or conceal heterogeneity in stratum 
specific exposure effect estimates. 
0 When trend is being assessed, exposure measurement error can suggest a trend where 
there is none. 
Exposure measurement error may result in underestimation or overestimation of a dose- 
response relationship when the true relationship is non-monotonic. 
0 Exposure measurement error causes underestimation of dose-response relationships if 
the true relationship is monotonic. 
0 The p-value for trend may be overestimated or underestimated when exposure is 
measured with error. 
The bias induced by collapsing a categorical or continuous variable subject to non- 
differential measurement error into fewer categories may be smaller than the bias caused 
by the original variable. 
Including perfectly measured confounders or unnecessary additional variables in a 
regression model increases the attenuation caused by exposure measurement error. 
Berkson error in the exposure results in no attenuation of the observed exposure effect 
estimate, but increases the standard error of the effect estimate. 
If the exposure measurement error is correlated with the true exposure variable, the 
observed exposure effect estimate may be inflated, attenuated or reversed in comparison 
with the true effect. 
If errors in variables are correlated, exposure measurement error may bias effect 
estimates in either direction. 
2.4. The impact of measurement error in confounders 
In this section, the literature describing the impact of measurement error or misclassification in 
confounders is discussed. 
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2.4.1. Binary confounders 
It is well documented that measurement error in confounders reduces the ability to control for 
confounding in the analysis. For example, Greenland'8 illustrated the effect of confounder 
misclassification in the simple setting of dichotomous outcome, exposure and single 
confounder. Non-differential misclassification of a binary confounder resulted in an OR 
intermediate between the crude OR and the true OR. The estimated OR could be biased either 
towards or away from the null value when a binary confounder was misclassified. Considering 
ORs in strata defined by values of the confounder, it was shown that non-differential 
misclassification may introduce heterogeneity into the stratum-specific ORs when in truth they 
are homogeneous, or hide heterogeneity if it truly exists. Walker and Lanes38 provided a 
method to assess whether observed heterogeneity in stratum specific ORs is caused by either 
non-differential or differential misclassification of a confounder. 
The effect of dichotomising a continuous confounder was demonstrated by Becher. 39 By 
simulating a case-control study with a continuous exposure and a binary confounder obtained 
by dichotomising the true continuous confounder at various cutpoints, it was demonstrated 
that the bias in the estimated exposure effect increases with increasing correlation between 
exposure and confounder, and is minin-tised when the cutpoint is at the overall mean of the 
continuous confounder when cases and controls are combined. The bias in the estimated 
exposure effect was also shown to reduce for an increasing number of categories created from 
the true continuous variable. 
An expression for the bias caused by misclassification of a binary confounder on the exposure 
effect estimate in logistic regression with binary explanatory variables was provided by 
Davidov, Faraggi and Reiser. 21 An exact formula for the bias in the exposure-outcome log OR 
was provided, and a Taylor series expansion provided a first order approximation that 
depended on the sensitivity of the misclassification, but not the specificity: 
Bias= (40, -40OX1-00)+(410 -41, Xl-01) 
In this formula, 4ij is the retrospective odds of the confounder, when the outcome equals i and 
the exposure equals j, and Oi is the sensitivity of the confounder misclassification given the 
outcome equals L This suggests that, if 00 and 01 both equal one, there is no bias in the 
estimated exposure effect. The direction of the bias in the exposure effect estimate is dependent 
on 40, -400 and 410 -411. The bias can therefore act to increase or decrease the estimated 
exposure effect. The results cannot be extended to the case with continuous covariates, as 
closed form expressions do not exist in this situation for logistic regression models. 
2.4.2. Polytomous confounders 
Using simulation studies, Fung and Howe23 demonstrated the effects of misclassification of a 
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polytomous confounder on exposure-outcome relative risk estimates. An exposure and single 
confounder, each with four categories, were simulated and subjected to non-differential 
misclassification. They showed that the bias caused by confounder misclassification may be 
either towards or away from the null value. The exposure effect estimate was biased away from 
the null when the association between the confounder and exposure was in the same direction 
as the association between the confounder and outcome. The exposure effect estimate was 
biased towards the null when the association between the confounder and exposure was in a 
different direction to the association between the confounder and outcome. Confounder 
misclassification also influences the estimated power of the Mantel trend test. When the 
association between the confounder and exposure is in the same direction as the association 
between the confounder and outcome, confounder misclassification increases the estimated 
power, while if the associations are in opposite directions the estimated power decreases. 
As stated above, Greenland'S18 results suggested that, for non-differential misclassification of a 
binary confounder, the adjusted OR is intermediate between the crude OR and the true OR. 
Brenner4O showed that this relationship does not necessarily exist for non-differential 
misclassification of polytomous confounders. Estimated associations can be biased away from 
the true value in the opposite direction to the crude value, or the estimated association can be 
further from the true value than the crude value. The misclassification probabilities used to 
demonstrate these effects resulted in systematic n-dsclassification of the confounder, as the 
misclassification probabilities were not the same between all categories of the polytomous 
confounder. 
2.4.3. Continuous confounders 
The effects of measurement error in continuous confounders were demonstrated by 
Armstrong33 in the context of a continuous exposure and a single confounder. A classical 
measurement error model was assumed, in which the explanatory variables were drawn from a 
multivariate normal distribution with normally distributed errors that were uncorrelated with 
either the true covariate values or other error variables. Under these circumstances, 
measurement error in a continuous confounder results in an exposure effect estimate that is 
intermediate between the true value and the crude estimate obtained by omitting the 
confounder from the analysis. This was shown by Greenland's in the case of a dichotomous 
exposure and confounder. 
Measurement error in a continuous exposure and confounder was considered by Phillips and 
Davey Smith. 41 Both the exposure and confounder were subject to random, non-differential 
measurement errors that were uncoffelated. Bias in the exposure effect estimate, obtained by 
logistic regression, increased with increasing correlation between the explanatory variables. It 
was possible for the estimated exposure-outcome association to show an effect in the opposite 
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direction to the true effect when the exposure and confounder were correlated. These effects 
increased with increasing correlation between the explanatory variables and with increasing 
measurement error in the confounder. This suggests that measurement error in confounders is 
a potentially serious problem, and can lead to effect estimates that erroneously suggest harm or 
benefit from exposure. 
The effect of errors correlated with the true values of continuous confounders was considered 
by Wacholder35 in the context of linear regression. It was shown that the exposure effect 
estimate may be biased away from the null value when the covariance between the error and 
true confounder is negative and greater in absolute value than the variance of the true 
confounder. It was additionally required that the relationship between the true confounder and 
exposure is the same as the relationship between the measured confounder and exposure, and 
that the error is non-differential. 
Uncorrelated measurement errors in the exposure and a confounder were considered by 
Marshall and Hastrup. 20 Three cases were considered in which the outcome, exposure and 
confounder were either continuous or dichotomous. In the setting where the exposure had no 
causal effect on the outcome, error in the confounder biased the estimated exposure-outcome 
association and introduced an apparent effect. The bias in the estimated exposure-outcome 
effect was shown to increase with increasing error in the confounder, with the correlation 
between the exposure and confounder, and with the true association of the confounder with 
outcome. 
An extension of the expression for the effect of measurement error in a confounder on the 
exposure effect estimate given by Armstrone was provided by Kipnis, Freedman, Brown et 
al. 37 for a linear regression model. It was again assumed that there was a single confounder of 
the exposure-outcome association. The formula was not restricted by the assumptions of a 
classical measurement error model, and was able to account for errors that were 
heteroscedastic, correlated with the true variables and with other errors, and errors that were 
non-normally distributed. Expressions of a similar type, however, cannot be obtained for non- 
linear regression models, such as the logistic regression model. 
Correlated errors were investigated by Marshall, Hastrup and RoSS36 for linear or logistic 
regression analyses with a continuous exposure and confounder measured with error. They 
found that, in the presence of errors in both explanatory variables, the error correlation inflates 
or reduces the effect of measurement error on estimated exposure-outcome associations. The 
bias in the exposure effect estimate may be in either direction when error exists in both 
explanatory variables and the errors are correlated. 
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Armstrong, Whittemore and Howe32 provided formulae describing the effects of measurement 
error in explanatory variables in multivariable analyses with more than one confounder, 
assuming a multivariate normal discriminant analysis model for the measurement error. The 
bias in the exposure effect estimate was shown to have a complex relationship with the 
covariance matrices of the true explanatory variables and the error variables. Differential 
measurement errors, such as recall bias in case-control studies, introduced additional bias. For 
illustration, the. effects of measurement error for an exposure and a single confounder on the 
exposure effect estimate were described. Measurement error in the confounder results in 
residual confounding of the exposure effect estimate, with the direction of bias dependent on 
the correlation between exposure and confounder and the relationship of the confounder with 
outcome. Correlation between the errors in the exposure and confounder reduces the 
attenuation of the exposure effect estimate due to error in the exposure variable but introduces 
confounding by the effors. This confounding by errors acts in the same way as residual 
confounding, but does not necessarily bias effect estimates in the same direction. 
2.4.4. Summary 
The effects of measurement error or misclassification of confounders on exposure effect 
estimates are complex, and are surnmarised below. 
Measurement error in confounders can bias exposure effect estimates towards or away 
from the null value, even when the error is non-differential and random. For non- 
differential and random measurement error, and uncorrelated confounders, the observed 
exposure effect estimate is between the crude estimate and the true effect. 
The observed exposure effect estimates may be biased away from the true value in the 
opposite direction to the crude estimate, or further from the true value than the crude 
estimate if the confounder measurement error is systematic. 
0 Confounder measurement error may cause the observed exposure effect estimate to be in 
the opposite direction to the true effect if the explanatory variables are correlated. 
Confounder measurement error may induce an apparent exposure effect where there is 
none. 
9 Heterogeneity in straturn-specific exposure effect estimates may be caused or masked by 
confounder measurement error. 
Residual confounding caused by dichotomising a continuous confounder increases with 
the correlation between exposure and confounder, and is minin-dsed if the cutpoint is the 
mean of the continuous confounder. 
0 Confounder measurement error can result in p-values for estimated exposure effects that 
are too large or too small. 
Correlation between errors in the exposure and confounders reduces the attenuation of 
the exposure effect estimate due to exposure measurement error but introduces 
confounding by errors, which may bias the estimate in either direction. 
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2.5. The impact of unmeasured confounders 
In this section, the impact of unmeasured confounding on estimated exposure-outcome effects 
is described. This concept of the effect of unmeasured confounding was first introduced by 
Spearman3l in his 1904 paper. He showed that an unmeasured confounder may either reduce 
or enlarge the estimated correlation between two variables. 
Snedecor and Cochran42 described the effects of omitting a variable in a linear regression model, 
where the included variables were assumed to be measured without error. The correct linear 
regression model is assumed to be 
Yýa+ PEE+ PIXI +C, 
where Y is the outcome variable, cc is the intercept, Pi are the regression coefficients, E is the 
exposure, Xi is the confounder, and c is the error term with mean zero and uncorrelated with E 
A 
and X1. They showed that the estimated exposure-outcome effect, PEI obtained when the 
confounder is omitted from the analysis is 
Equation 2.2: h PE + Pjb1E f 
where blE is the coefficient of the linear regression of Xi on E. If the true model is instead 
Y"ý"+ PEE+ PIXI +P2X2 +ef 
where XI and X2 are both confounders, the estimated exposure-outcome effect when X2 is 
on-dtted from the analysis is 
ýE 
= PE + 02b2EIl " 
where b2EII is the regression coefficient for the effect of E on X2 adjusting for X1 obtained from a 
linear regression. 
Armstrong33 provided an expression for the estimated exposure-outcome relative risk (RR), 
when the RR is an exponential function of the exposure and confounder, the confounder is 
omitted from the analysis, and where the exposure may be measured with error as ZE. The 
estimated exposure-outcome RR was given by 
=R 





where REII is the conditional reliability of the exposure given the confounder, crz,, X, is the 
covariance between ZE and X1, and c; 
2 is the variance of the error-prone exposure ZE 
measurements. If E is measured without error, Equation 2.3 is the same as Equation 2.2 
provided by Snedecor and Cochran42 for the effects of an unmeasured confounder in linear 
regression. 
These expressions show that the estimated exposure-outcome effect may be either larger or 
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smaller than the true exposure-outcome effect in the presence of an unmeasured confounder. 
The direction in which the estimated effect is biased depends on the true effects of both the 
exposure and confounder on the outcome, and the covariance between the exposure (either 
perfectly measured or measured with error) and confounder. 
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Chapter 3. 
The impact of measurement error in explanatory variables and 
unmeasured confounding in epidemiological studies: A 
simulation study 
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Introduction 
In this chapter, the effects of residual and unmeasured confounding and exposure measurement 
error on estimated exposure-outcome associations are exan-dned using simulation studies. Each 
simulated dataset contains either two or four confounders, each of which may be affected by 
measurement error or omitted from the analysis. The exposure may also be measured with 
error. Measurement errors in exposure and confounders is quantified by the intra-class 
correlation coefficient OCC), and ICCs equal to 0.75 and 0.5 are used to generate the 
mismeasured variables. Logistic regression is used to estimate the exposure-outcome odds 
ratio (OR) in situations in which the exposure has no true association with outcome (exposure- 
outcome OR - 1), or in situations in which there is a true association between exposure and 
outcome (exposure-outcome OR = 2). The results in Section 3.3.1 are the same as those 
presented by Fewell, Davey Smith and Steme. 43 
3.2. Methods 
Notation and terminology 
The following is a list of the notation that will be used throughout this chapter. 
E= perfectly measured exposure variable. 
ZE = exposure variable measured with error. 
Xi - perfectly measured confounders, for M, ..., n. 
Z- confounders measured with error, for M, ... ' P. 
Y= dichotomous outcome variable. 
Throughout this chapter the term residual confounding will be used to refer to confounding due 
to measurement error in a confounder included in a model, and unmeasured confounding win be 
used to refer to confounding due to omission of a confounder from the model. 
3.2.2. Dataset structure 
Figure 3.1 shows a common situation in epidemiological studies. The dotted arrows indicate 
possible correlations between exposure and confounders. Often several factors are measured as 
surrogates for a causal factor, or a causal factor is measured directly but with error. The 
measured factors ZE and Zi, M, ..., p, may also be correlated. The measured factors are used to 
estimate the effect of the causal factors on the dichotomous outcome variable Y. The focus 
throughout this chapter will be on the simpler case where n=p and each causal factor is 
represented by one measured factor (Figure 3.2). The causal factors, and therefore the 
measured factors, can be correlated, as indicated by the dotted arrows. 
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The logistic model is assumed to relate the causal factors and the outcome. 
Equation 3.1: ln(T-" = a+PEE+P, Xl +... +P,, X,, 
Here, a is the probability of the outcome. The exposure and confounders are all normally 
distributed with mean zero and variance one. Two true exposure-outcome log ORs are 
considered. In the first, the exposure is assumed to have no causal relationship with the 
outcome and PE is 0. The literature described in Chapter 2 shows that the effect of random, non- 
differential measurement error in the exposure attenuates exposure effect estimates towards the 
null. In the first situation, the true effect estimate and the null value are equal. For the second 
scenario, exposure will be assumed to have a causal relationship with outcome, and PE is ln2 per 
standard deviation increase. The true confounder-outcome log ORs, Pi, ..., P, are ln2 per 
standard deviation increase. The parameter a is set to InO. 1 throughout. Other than changing 
the number of outcome events in the dataset, the choice of a is not important and changing a 
would not affect the results presented in this chapter. 
Figure 3.1: General relationship between causal factors, measured factors and outcome in an 
epidemiological study. In the general case, the number of causal factors may differ ftom the number of 
measuredfactors. The measuredfactors are less than perfect substitutes for the causal factors. 









Figure 3.2: Simplified relationship between causal factors, measured factors and outcome in an 
epidemiological study, assumed in this study. The measuredfactors are less than perfect substitutesfor 
the causalfactors. 
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cy 2+ cr 2 ue 
where CIU2 is the variance of the true measurements and CF. 2 is the error variance. An ICC of one 
implies that Cre2=0 and that there is no measurement error. If CTJ=0.2., the ICC will equal 0.5. An 
ICC of zero implies that CIU2=0, and that the observed variation in the variable is entirely due to 
error. In epidemiological studies with paired measurements, the usual method for estimating 
the ICC is to calculate the Pearson correlation with each pair entered twice, once in reverse 
order. Alternatively, the ICC can be estimated using one-way analysis of variance, or by using 
a simple random effects model. 44 Error is introduced into the exposure, E, to create the variable 
ZF, and into the confounders, X1, ..., X,,, to create variables 
Z1, ..., 7m. 
Equation 3.2 ZE=E+co 
Zi=Xi + ci for i=l, ..., n 
where corr(ei, cj)=O if W-j for ij=O, ..., n (i. e. measurement errors are independent of each other). 
For simplicity, it is also assumed that ei-N(O, cre2), and different distributions for the errors are 
not considered. The error variance, cr. 2, is either 1 or 1/3, corresponding to ICCs of 0.5 and 0.75 
respectively. These are plausible values for ICCs that can occur in epidemiological studies. For 
example, Satia-Abouta, Patterson, King et al. 45 show a test-retest ICC of 0.74 for iron, and of 0.76 
for chromium for mean supplement intake over 10 years from a self-administered 
questionnaire. Schroder, Covas, Marrugat et al. 46 show an ICC of OA9 for percentage of energy 
intake in the diet made up by carbohydrate when measured by 72 hour recall, and an ICC of 
0.52 for percentage of energy intake in the diet made up by fat when using a food frequency 
questionnaire. Friesema, Veenstra, Zwietering et al. 47 show a test-retest ICC of 0.75 for 
frequency of drinking in adulthood among women, and of 0.50 for quantity of drinking at age 
61 or over among women from the Lifetime Drinking History questionnaire. There are many 
other examples of ICCs of these sizes in the literature. 48-53 Once the mismeasured exposure 
variable, ZF, is created, it is divided by its standard deviation. This results in no change if the 
ICC of ZE is one, division by 2,5/3 if the ICC of ZE equals 0.75, and division by V-2 if the ICC 
Of ZE is 0.5. Using this transformation, estimated ORs for the exposure-outcome association can 
be interpreted as the OR per standard deviation increase in ZE- 
The first stage in generating the simulated datasets was to draw the exposure E, confounders Xi 
and error variables ei from a multivariate normal distribution, where the correlation between 
each pair of variables was specified and 500,000 observations per dataset were generated. The 
mismeasured exposure and confounders were then created according to Equation 3.2. To 
generate the dichotomous outcome variable, first a uniformly distributed variable between zero 
and one was generated for each observation in the dataset. The probability of outcome, x, was 
then calculated for each observation using Equation 3.1 and the values of the parameters 
28 
Unmeasured confounding and measurement error in explanatory variables 
specified previously. From the properties of the uniform distribution, the probability of the 
uniform variable being less than 7c equals 7c. The outcome was therefore defined to be one if the 
uniform variable was less than 7r, and zero otherwise. This simulates a Bernoulli trial for each 
observation in the dataset, and creates an outcome variable that has the correct probability, 7r, of 
being equal to one. 
The correlations between the exposure E and the confounders were assumed to be 0.1,0.3 or 0.5, 
while the correlation between confounders was either 0 or 0.5. Such correlations are not 
uncommon in epidemiological studies. For example, Osganian, Stampfer, Spiegelman et al. 54 
report a correlation between serum levels of folic acid and vitamin B6 of 0.48 and between 
serum homocysteine and body mass index of 0.09 in a study of 3,524 children from the Child 
and Adolescent Trial for Cardiovascular Health. They also report that there was no correlation 
between serum homocysteine and diastolic blood pressure or serum lipids. Variables from the 
British Women's Heart and Health Study also show correlations of a similar size to those 
considered here. For example, the correlation between total serum protein concentration and 
diastolic blood pressure was 0.10, between weight at age 21 and present weight was 0.30, and 
between serum albumin concentration and mean cellular haemoglobin concentration was 0.49. 
No generality is lost by considering only positive correlations between exposure and 
confounders; the corresponding results for negative correlations can be obtained by inverting 
ORs. Tables of results for correlations between confounders of 0.1,0.2,0.3 or 0.4 for the results 
presented in Section 3.3.1 are provided in Appendix 1. 
Once the datasets had been simulated, logistic regression was used to estimate the exposure- 
outcome OR when the exposure was either perfectly measured or measured with error, and the 
confounders were either perfectly measured, measured with error, or omitted from the analysis. 
Each dataset used in the analyses was simulated 50 times, using a different random number 
seed on each occasion. Odds ratios presented in this chapter are the geometric means of the 
ORs from these 50 simulations. Fifty simulations each of 500,000 observations resulted in small 
95% simulation intervals around the geometric means, with widths no more than 0.011. Stata 
8.2 was used for all analyses, using the corr2data command with the seed option to generate 
the normally distributed variables. Two situations are considered in which there are either two 
confounders or four confounders. 
3.3. Residual and unmeasured confounding 
In this section, simulations in which the confounders may be measured with error or omitted 
from the analysis are investigated. The extension to include the situation in which the exposure 
is also measured with error is provided in Section 3.4. 
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3.3.1. Exposure unrelated to outcome 
First, simulations in which there is no causal effect of exposure on outcome are considered. 
3.3.1.1 Two confounders 
In this section simulations in which there are two confounding variables, X, and X2. are 
considered. 
Table 3.1 displays estimated ORs for the association between E and the binary outcome, based 
on simulations in which the confounders are uncorrelated. For each combination of correlations 
between E and XI, and E and X2, the crude OR, the ORs adjusted for ZI alone, and the OFS 
adjusted for both ZI and Z2 are shown. Note that when the ICCs of both Zi and Z2 equal one, 
then ZI=Xi and Z2=X2. SO the adjusted OR for E is equal to one (no residual confounding). In all 
other situations, unmeasured and/or residual confounding bias the estimated OR away from 1. 
The crude ORs increase with increasing correlations of E with Xi and X2. and are symmetric 
with respect to these correlations. The maximum crude OR is 1.93 when the correlations of E 
with Xi and X2 are each 0.5. 
There are nine sets of nine ORs adjusted for both Zi and Z2; these correspond to the residual 
confounding caused by imperfect measurement of the two confounders. When the correlation 
between E and XI is equal to the correlation between E and X2, the ORs adjusted for Zi and Z2 
are symmetric with respect to the measurement error in Z, and Z2. Where the correlation 
between E and X, is not equal to the correlation between E and X2, the ORs adjusted for Z, and 
Z2 are asymmetric with respect to the measurement error. For example, when the correlation of 
Xi with E is 0.5, and the correlation Of X2 with E is 0.1, the OR adjusted for both Z, and Z2 is 1.05 
when ZI is measured with ICC=1 and Z2 is measured with ICC=0.5. When the ICC of Zi is 0.5 
and the ICC of Z2 is 1, the OR adjusted for both ZI and Z2 is 1.22. 
When the correlations between E and Xi and E and X2 are equal, the OR adjusted for ZI only, 
when Zi is measured without error, is equal to the estimated OR adjusted for ZI and Z2 when 
both have an ICC of 0.5. As the confounders have equal correlation with exposure, their effects 
on the estimated exposure-outcome OR are equal. An ICC of 0.5 means that half of the variance 
of the mismeasured confounder is due to error, and therefore controlling for it in the analysis 
only removes half of its influence on the exposure-outcome OR. Therefore, controlling for two 
confounders with an ICC of 0.5 removes as much bias from the crude OR as controlling for one 
confounder with an ICC of 1. 
In general, the ORs adjusted for both Z, and Z2 are larger when there is more measurement 
error (smaller ICC) and when the correlations between E and the confounders are higher. In 
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because of unmeasured confounding. 
Having considered the situation in which the two confounders are uncorrelated, the 
implications of a correlation between the confounders of 0.5 are now examined. Table 3.2 
shows the crude OR, the ORs adjusted for Zi alone, and the ORs adjusted for both Zi and Z2 for 
each combination of correlations of E with Xi and X2. Because of the correlation between the 
confounders the ORs displayed in Table 3.2 are generally smaller than those in Table 3.1. The 
maximum crude OR is 1.85, when the correlations of E with X1 and X2 are 0.5. 
In general, as the correlation of E with X, and X2 increases, the OR adjusted for ZI alone or both 
Zi and Z2 increases. There are exceptions to fl-ds general rule. For example, when the 
correlation between E and Xi is 0.1, the correlation between E and X2 is 0.5 and Z, is measured 
without error (ICC=1), the OR adjusted for ZI only is 136 (crude OR 1A3). This is greater than 
the corresponding OR of 1.25, when the correlation between E and X, is 0.5, even though the 
corresponding crude OR is 1.85. This effect occurs because Xi is perfectly measured OCC=1), 
and is also correlated with X2. The increased confounding when the correlation between E and 
Xi is 0.5 is offset by the correspondingly improved indirect control for the um-neasured 
confounder (X2). 
Generally, more measurement error in ZI or Z2 (smaller ICC) results in larger estimated ORs 
(more residual confounding). Again there are exceptions to this general rule. For example, 
when the correlation between E and XI is 0.1, between E and X2 is 0.5, Zi is measured without 
error (ICC=1) and Z2 is measured with ICC=0.5, the OR adjusted for both ZI and Z2 is 1.22. 
When the ICC of ZI is 0.5 (measurement error increases), the OR adjusted for Zi and Z2 
decreases to 1.20. This effect is due to the partial correlation between the exposure and 
confounder, controlling for the other confounder. 
The partial correlation between E and X1 controlling for X2 is defined by: 
rEx, - rEX., rX, X, 
rEXIX2 ý2 X1 
_ rX2, 
v(1 
- rtX2 X2) 
where rEx, is the correlation between E and Xi, rEx2 is the correlation between E and X2, and 
rX, X2 is the correlation between the confounders XI and X2. Table 3.3 shows the partial 
correlation between E and X, when controlling for X2 when the correlation between the 
confounders is 0.5. With this correlation between confounders, a correlation between E and Xi 
of 0.1, and between E and X2 of 05, the partial correlation between E and X1, conditional on X2, 
is negative. In this situation the effect of increasing X1, while keeping X2 fixed, is to reduce the 
estimated exposure-outcome OR. it follows that as measurement error in Z, increases, the 
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Table 33: Partial correlation between E and Xi, controllingfor X2, by the correlation betuven E and 
X, 
and between E and X2. The correlation between confound"s is 0-5. 
Coffelation between Coffelation between E and X2 
E and X, 0.1 03 05 
01 0.06 -0.06 -0.20 
03 0.29 0.18 0.07 
05 0.52 0.42 033 
When the correlations between E and X, and E and X2 are equal, controlling for Zi only with an 
ICC of 1 no longer produces the same estimated exposure-outcome OR as controlling for Zi and 
Z2 when they both have an ICC of 0-5. The correlation between the confounders amplifies the 
effect of the measurement error, which means that the bias when controlling for both Zi and Z2 
with an ICC of 0.5 is worse than when controlling for a perfectly measured Z2. 
Although in general unmeasured confounding results in larger estimated ORs. there are 
examples where the OR is smaller with greater unmeasured Confounding. When the correlation 
between E and XI is 0.5, the correlation between E and X2 is 0.1. and both confounders have 
ICC=0.5, the OR adjusted for Z, and Z2 is 1.20. When adjusting only for Zt, the OR decreases to 
1.17. Again, this combination of correlations leads to a negative partial correlation between E 
and X2, conditional on Xi. Omitting X2 from the analysis therefore decreases the estimated 
exposure-outcome OR 
Intuitively, it would be expected that either unmeasured or residual confounding will lead to 
imperfect control and hence to adjusted ORs that are intermediate between the crude OR and 
the correct value of 1.0. However, in Table 3. Z estimated ORs less than one occur when the 
correlation of E with one of the confounders is 0.1, and the correlation of E with the other 
confounder is either 0.3 or 0.5. This effect occurs when one confounder is weak CLe- has a 
correlation of 0.1 with exposure), and the other is both stronger (correlation of 03 or 0.5 with 
exposure) and is measured without error. Again, this is due to a negative partial correlation 
between E and the weaker confounder. 
3.3.12 Four confounders 
The results of simulations including four confounders are now considered. To reduce the 
number of datasets to be simulated, all correlations between pairs of confounders were 
assumed equal, and were again either 0 or 0.5. The exposure-outcome associations controlling 
for either one or two confounders were estimated in the analyses. 
Table 3.4 displays estimated ORs for the association between exposure and the binary outcome, 
based on simulations in which the confounders are uncorrelated. For each combination of 
correlations between E and XI, and E and X2, the crude OR, the OR adjusted for Z, only, and the 
OR adjusted for Zi and Z2 are shown. To ensure that the correlation matrix was positive 
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Unmeasured confounding and measurement error in explanatory variables 
not simulated. Table 3.4 therefore displays results where the correlation between E and X3 is 
0.5, and the correlation between E and X4 is 0.3, as these were the highest correlations available 
that held for all correlations of E with Xi and X2. 
Because there is always unmeasured confounding by X3 and X4, the estimated ORs in Table 3.4 
never equal the correct value of 1. In general, the ORs adjusted for Z, alone, or Zi and Z2 are 
larger when the correlations of E with Xi and X2 are larger. More measurement error (smaller 
ICC) results in larger estimated ORs, and unmeasured confounding increases the estimated 
ORs. The estimated ORs are larger than those in either Table 3.1 or Table 3.2 due to the larger 
amount of unmeasured confounding, and crude ORs as large as 3.27 are seen. Residual 
confounding is now relatively unimportant compared with unmeasured confounding. 
Table 3.5 shows results from simulations in which the correlation between the confounders is 
0.5. To enable comparison between Table 3.4 and Table 3.5, the correlations between E and X3, 
and between E and X4 are again set to 0.5 and 0.3 respectively. 
Because of the correlation between the confounders, the ORs displayed in Table 3.5 are smaller 
than those in Table 3.4. However they are larger than those in Table 3.1 and Table 3.2 because 
of the larger amount of unmeasured confounding. Although the relations of the degree of bias 
due to residual and unmeasured confounding observed in Table 3.4 still hold in general, there 
are exceptions. There are instances of increasing measurement error (decreasing ICC) or 
increasing correlation between exposure and confounders leading to smaller estimated ORs. 
There are also examples of unmeasured confounding leading to decreases in the estimated OR. 
As discussed in detail in the context of Table 3. Z the correlations between the underlying 
confounders X1 to X4 lead to complex relationships of the adjusted ORs with the strength of 
confounding (correlation with E), and measurement error in the confounders. Table 3.6 shows 
the partial correlation between E and X1, controlling for X2, X3 and XG for the correlations 
between confounders used in Table 3.5. 
Table 3.6: Partial correlation between E and X1, controllingfor X2, X3, and X4, by t1m correlation between 
E and XI and between E and X2. The correlation between confounders is 0.5, between E and X3 is 0.5, 
and between E and X4 is 0.3. 
Correlation between E Correlation between E and X2 
and Xi 0.1 0.3 0.5 
0.1 -0.19 -0.26 -0.35 
0.3 0.11 0.04 -0.04 
0.5 0.41 0.33 0.27 
Figure 3.3 displays the effect of controlling for all four confounders, where the confounders are 
measured with varying amounts of error. For simplicity, all confounders are assumed to have 
the same ICC and the correlations between all pairs of confounders are assumed equal, unless 
the confounder-exposure correlation is 0.5. In this case, the correlation between E and X4 is 0.3, 
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and the correlation between all other confounders and exposure is 0-5- The residual 
confounding of the exposure-outcome OR increases with the measurement error. The adjusted 
OR increases as the correlation of each confounder with exposure increases, and as the 
correlations between pairs of confounders decrease. The largest adjusted OR of 2.81 is when the 
ICC=0.5, the confounders are uncorrelated and the confounder-exposure correlation is 0.5. 
Figure 3.3 shows that exposure effects may be estimated with substantial bias due to residual 
confounding alqne. 
Figure 3.3: Relationship of the exposure-outcome odds ratio adjusted for all four confounders with 
confounder measurement error, correlation between confounders and confounder-exposure correlation. 
Measurement error and confounder-exposure correlations are assumed to be equal for all confounders. 
For a confounder-exposure correlation of 0.5, the correlation between E and X4 is 0.3. 
0 
C, 4 - 









ICC of all confounders=0.5, correlations between confounders=0 
ICC of all confounders=0.75, correlations between confounders=O 
ICC of all confounders=0.5, correlations between confounders=0.5 
ICC of all confounders=0.75, correlations between confounders=0.5 
The y-axis is plotted on a log scale OR-odds ratio 
ICC-intra-class correlation coefficient 
The effect of different numbers of ururneasured confounders on the estimated exposure-outcome 
OR is displayed in Figure 3.4. For simplicity all confounders are assumed to be measured 
without error, and the correlations between each confounder and exposure are assumed equal, 
except when the confounders have a correlation of 0.5, in which case the correlation between E 
and X4 is 0.3 while all other confounders have a correlation of 0-5 with exposure. The estimated 
OR increases as the number of confounders controlled for decreases, and as the correlation 
between confounders and exposure increases. Bias due to unmeasured confounding is worse 
when the confounders are uncorrelated. When the exposure-confounder correlation is 0.5, there 
is serious bias in the estimated exposure-outcome OR of 2.2Z even when three confounders are 
controlled for. 
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Figure 3.4: Relationship of the exposure-outcome odds ratio with the number of confounders controlled 
for, confounder-exposure correlation, and correlation between pairs of confounders. All confounders are 
assumed to be measured without error (ICC=1), and the confounder-exposure correlations are assumed to 
be equalfor all confounders. 
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* The y-axis is plotted on a log scale 
OR-odds ratio 
ICC-intra-class correlation coefficient 
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3.3.2. Exposure related to outcome 
In this section, simulations in which the true exposure-outcome OR equals two are considered. 
3.3.2.1 Two confounders 
Table 3.7 shows the results for simulations with two confounders in which the confounders are 
uncorrelated. The patterns observed are the same as those observed when there was no true 
relationship between exposure and outcome in Section 3.3.1.1. In particular, increasing the 
measurement error in the confounders increases the bias in the estimated exposure-outcome 
OR, increasing unmeasured confounding by omitting confounders from the analysis increases 
bias, and increasing the correlation between the exposure and each confounder increases bias. 
The estimated ORs in Table 3.7 are much larger than those estimated in Table 3.1 due to the 
increase in the true association between the exposure and outcome. 
Table 3.8 displays the results from simulations with two confounders in which the correlation 
between the confounders equals 0.5. Negative partial correlations between exposure and a 
confounder, controlling for the other confounder, can lead to reversals of the trends observed 
when the confounders are uncorrelated. It is possible for increased measurement error in a 
confounder to decrease the bias in the estimated exposure-outcome OR. Increasing 
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Unmeasured confounding and measurement error in explanatoryvariables 
bias, and increasing the correlation between the exposure and each confounder can also lead to 
a decrease in bias. These effects were all observed in Table 3. Z in which there was no true 
association between exposure and outcome. 
3.3.2.2 Four confounders 
Table 3.9 shows the results of simulations in which there are four confounders and the 
confounders are uncorrelated. These results show that as the correlation between exposure and 
each confounder increases, so does the bias in the estimated exposure-outcome OR. This was 
also shown in Table 3.4, where the exposure had no true association with outcome. 
In Table 3.9, increasing measurement error in the confounders can cause a decreased bias of the 
exposure-outcome OR. Consider, for example, when the correlation between E and X1 equals 
0.1 and the correlation between E and X2 equals 0.5. If only Zi is adjusted for in the analysis, 
and is measured without error, the estimated OR is 4.32. Introducing measurement error into 
Zi so that the ICC equals 0.75 reduces the estimated OR to 4.30. A further increase in the 
measurement error of Zi so that the ICC equals 0.5 results in a further reduction of the 
estimated OR to 4.28. These are, however, modest differences. 
In addition, increased unmeasured confounding can decrease the bias. Consider, for example, 
when the correlation between E and X1 is 0.1 and the correlation between E and X2 is 0-5- If Only 
Zi is adjusted for in the analysis, and is measured without error, the estimated exposure- 
outcome OR is 4.32. When both confounders are on-titted from the analysis, the estimated crude 
exposure-outcome OR is 4.25, which is closer to the true OR of two. 
Previously, these counterintuitive effects (i. e. decreasing bias with increasing measurement 
error or unmeasured confounding) were due to negative partial correlations between the 
exposure and a confounder. This is not the case in Table 3.9. Instead, these effects are due to 
the fact that there is now a true association between exposure and outcome. Several authors 
have shown that the estimated exposure-outcome effect in the presence of residual or 
unmeasured confounding is a function of the true effects between all explanatory variables and 
the outcome, and elements of the covariance matrices between the explanatory variables and 
the errors (see, for example, Armstrong, Whittemore and Howe, 32 or Equation 2.3 derived by 
Armstrong33). Although these expressions have been derived for models other than the logistic 
regression model used in this chapter, the results are likely to approximately hold. The 
estimated exposure-outcome OR is therefore composed of two parts; one of which depends on 
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Unmeasured confounding and measurement error in explanatory variables 
where the a are constants which depend on elements of the covariance matrix between the true 
exposure and confounders and elements of the covariance matrix between the errors. As 
measurement error in the confounders increases, aE may decrease. It is also possible that the 
decrease in CCEPE I caused by increased measurement error in the confounders, is greater than 
n 
the corresponding increase in j]ajPj . Therefore, reduced bias may be observed with 
increased measurement error or unmeasured confounding. When there is no true association 
between exposure and outcome, as in Section 3.3.1, measurement error in the confounders 
cannot cause a decrease in aEPE, because PE is equal to zero and therefore patterns of bias are 
more predictable. 
Table 3.10 shows the results of simulations in which there are four confounders, the correlations 
between pairs of confounders equals 0.5, and the true exposure-outcome OR is two. Bias in the 
estimated exposure-outcome OR can be decreased with increased measurement error in the 
confounders, increased unmeasured confounding, and increased correlation between the 
exposure and each confounder. This is caused by the correlation between the confounders. 
These effects were observed in Table 3.5, where there was no true association between exposure 
and outcome. 
3.4. Residual and unmeasured confounding and exposure 
measurement error 
In this section, the results presented in Section 3.3 are extended to the situation in which the 
exposure is also measured with error. 
3.4.1. Exposure unrelated to outcome 
First, simulations in which there is no causal effect of exposure on outcome are investigated. 
3.4.1.1 Two confounders 
The results of simulations in which there are two confounders, where the confounders and 
exposure can be measured with error are now considered. 
Table 3.11 and Table 3.12 show the effect of measurement error in the exposure and 
confounders for exposure ICCs of 0.75 and 0.5 respectively, for the situation in which the 
confounders are uncorrelated. 
Table 3.11 and Table 3.12 show that the estimated OR increases with increasing measurement 
error in the confounders (decreasing ICC) and with greater correlation between the exposure 
and confounders. Unmeasured confounding, caused by omitting Z2 from the analysis, also 
45 
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Unmeasured confounding and measuremenf error in explanatory ariables 
increases the estimated OR. These trends are the same as those observed in Table 31, in which 
there was no measurement error in the exposure. 
The estimated ORs in Table 3.12 are smaller than those in Table 3.1, and the ORs presented in 
Table 3.11 are intermediate between the values shown in Table 3.1 and Table 3.12. For example, 
the maximum crude OR in Table 3.1 is 1.93 when the correlations between both confounders 
and exposure are 0.5. The corresponding crude OR in Table 3.12 is 1-57, and in Table 3.11 is 
1.75. The reasoning behind this effect is straightforward. Non-differential and random 
measurement error in the exposure attenuates the estimated exposure-outcome OR towards the 
null value. As the exposure measurement error for the values displayed in Table 3.12 is greater 
than that in Table 3.11, with an ICC of exposure equal to 0-5 rather than 0.75, the oRs in Table 
3.12 show a greater attenuation towards the null value of one. 
Note that, although the exposure is measured with error in Table 3.11 and Table 3.12, there is no 
bias in the estimated exposure-outcome OR if both confounders are included in the analysis and 
measured perfectly. The estimated OR observed when exposure is measured with error will be 
closer to the null value than the estimated OR when there is no exposure measurement error- If 
the estimated OR equals the null value when there is no exposure measurement error, then it 
follows that introducing measurement error into the exposure win have no effect on the 
estimated exposure-outcome OR, and will still produce an OR equal to one. 
Having considered the effect of measurement error in the exposure and confounders when the 
confounders are uncorrelated, the scenario in which the confounders are correlated is now 
investigated. 
Table 3.13 and Table 3.14 display the estimated ORs from simulations in which the exposure 
has an ICC of 0.75 and 0.5 respectively. The confounders are assumed to have a correlation of 
0.5. Although in general the estimated ORs increase with increasing measurement error in the 
confounders, increasing correlation between the confounders and exposure, and increased 
unmeasured confounding, there are exceptions to all of these generalisations. 
For example, bias in the estimated OR decreases as measurement error increases when the 
correlation between E and X1 equals 0.1, and between E and X2 equals 0.5 in both Table 3.13 and 
Table 3.14. Considering Table 3.14, if the ICC of Z, is one and the ICC of Z2 is 0.5, the estimated 
OR is 1.14. Increasing measurement error in Z, so that the ICC equals 05 results in an 
estimated OR of 1.12, which is closer to the true OR of one. 
Reduced bias is observed with increased confounder-exposure correlation when the correlation 
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Unmeasured confounding and measurement error in explanatory variables 
correlation between E and Xi equals 0.1, the estimated OR in Table 3.14 equals 1.07. Increasing 
the correlation between E and Xi to 0.5 decreases the estimated OR to 1.01. 
Decreased bias with increased unmeasured confounding is observed when the correlation 
between E and X, equals 0.5 and between E and X2 equals 0.1. When the ICCs of both 
confounders are 0.5, and both are included in the analysis, the estimated OR in Table 3.14 is 
1.12. When Z2 is omitted from the analysis, the estimated OR is 1.11. 
These reversals of trend are due to the partial correlations between exposure and confounders. 
These have been shown in Table 3.3. 
The estimated ORs in Table 3.13 and Table 3.14 are all less than those in Table 3. Z due to 
measurement error in the exposure. In addition, the values displayed in Table 3.13 are 
intermediate between the values estimated when the exposure is measured without error (Table 
3.2), and when the exposure ICC equals 0.5 (Table 3.14). For example, the maximum crude OR 
estimated in Table 3.2 is 1.85 when the correlations between the confounders and exposure are 
0.5. The corresponding OR in Table 3.14 is 1.53, and in Table 3.13 is 1.69. Again, measurement 
error in the exposure variable does not produce any bias in the estimated exposure-outcome OR 
if both confounders are measured perfectly and included in the analysis. 
3.4.1.2 Four confounders 
The situation in which there are four confounders is now considered. The exposure and 
confounders may all be measured with error. 
Table 3.15 and Table 3.16 show the results of simulations with four confounders in which the 
exposure ICC is 0.75 and 0.5 respectively, and the correlation between the perfectly measured 
confounders is 0. The trends in exposure-outcome OR found in Table 3.4 again hold for Table 
3.15 and Table 3.16. The estimated OR increases as the correlation between E and Xi or X2 
increases, as measurement error in the confounders increases (ICC decreases), and as 
unmeasured confounding increases. The ORs displayed in Table 3.15 and Table 3.16 are all 
smaller than those in Table 3.4. Furthermore, the ORs in Table 3.16 are all smaller than those in 
Table 3.15. This is due to increasing measurement error in the exposure variable attenuating the 
exposure-outcome effect estimate. For example, the maximum crude OR in Table 3.4 occurs 
when the correlation between E and Xi, and E and X2 are both 0.5, and is equal to 3.27. The 
corresponding crude OR in Table 3.15 is 2-64, and in Table 3.16 is 2.13. The estimated ORs 
adjusted for the four perfectly measured confounders are not displayed in Table 3.15 and Table 
3.16, but again exposure measurement error does not create any bias in this situation. 
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Unmeasured confounding and measurement error in explanatory variables 
uncorrelated, correlations between confounders of 0.5 are now considered. Table 3.17 and 
Table 3.18 show the estimated exposure-outcome ORs for exposure ICCs of 0.75 and 0.5 
respectively in this setting. 
Although the general trends in the estimated exposure-outcome OR estimated in Table 3.15 and 
Table 3.16 still hold in general, there are exceptions to the rules. In Table 3.17 and Table 3.18, 
the estimated ORs can decrease as the correlation between exposure and the confounders 
increases, as measurement error in the confounders increases, and as unmeasured confounding 
increases. This was also shown in Table 3.5 when the exposure was measured without error. 
Again, the ORs presented in Table 3.17 and Table 3.18 are smaller than those shown in Table 
3.5, and the ORs shown in Table 3.18 are smaller than those in Table 3.17, which indicates that 
increasing exposure measurement error attenuates the estimated OR in this setting. For 
example, the maximum crude OR in Table 3.5 is 2.36. The corresponding crude OR in Table 
3.17 is 2.05, and in Table 3.18 is 1.77. The correlation between the confounders means that the 
ORs shown in Table 3.18 are smaller than those in Table 3.16, and the ORs in Table 3.17 are 
smaller than those in Table 3.15. 








Confounder correlation =0 = Os 
23401 




* The y-axis is plotted on a log scale OR-odds ratio ICC-intra-class correlation coefficient 
Figure 3.5 demonstrates the effect of exposure measurement error on the estimated exposure- 
outcome OR When the confounder correlation is 0, the figure displays estimated exposure- 
outcome ORs when the correlation between exposure and the confounders X1, X2 and X3 are all 
0.5, and the correlation between E and X4 is 0.3. When the correlation between the confounders 
56 
Unmeasured confounding and measurement error in explanatory variables 
is 0.5, the correlation between E and all confounders is 0.5. 
As seen previously in Figure 3.4, the effect of unmeasured confounding on the exposure OR is 
greater when the confounders are uncorrelated. This effect still occurs when the exposure is 
measured with error, although the difference between corresponding ORs estimated when the 
confounder correlation is 0 and 0.5 decreases. The attenuation effect of exposure measurement 
error is greater when the confounders are uncorrelated, which can be seen by the larger distance 
between the lines. 
These results have shown the joint effect of residual and unmeasured confounding and 
exposure measurement error in simulations in which there is no true relationship between 
exposure and outcome. In this situation, the bias induced by measurement error in the 
exposure attenuates the estimated ORs towards the true value, as it happens to equal the null 
value. It is of interest to investigate the effects of exposure measurement error in situations in 
which the exposure has a true effect on outcome. These results are now presented. 
3.4.2. Exposure related to outcome 
3.4.2.1 Two confounders 
First the situation in which there are two confounders is considered. When the exposure is 
measured without error, the same patterns of bias are observed as when the exposure has no 
true association with the outcome. Tables presenting these results have been described in 
Section 3.3.2.1. 
Table 3.19 and Table 3.20 show the results obtained when the ICC of exposure is 0.75 and 0.5 
respectively and the two confounders are uncorrelated. In both tables, the estimated OR is 
larger when the confounders are measured with more error (smaller ICC). Unmeasured 
confounding, such as including only Zi in the analysis or omitting both confounders, increases 
the estimated OR. When the ICC of exposure equals 0.75, the estimated ORs are smaller than 
those estimated when exposure is measured without error (see Section 3.3.2.1). Increasing the 
measurement error in the exposure so that the ICC is equal to 0.5 results in a further decrease in 
the estimated ORs. These trends are the same as those observed in Table 3.11 and Table 3.12. 
The estimated ORs in Table 3.11 and Table 3.12 were generally larger than the true OR. In Table 
3.19 and Table 3.20, the estimated ORs generally underestimate the association between 
exposure and outcome. Residual and unmeasured confounding, however, mean that it is also 
possible to overestimate the true exposure-outcome OR. 
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Unmeasured confounding and measurement error in explan itory variables 
confounders does not always result in an increase in the estimated OR. Consider, for example, 
Table 3.19. When the correlation between E and X, is 0.1, the correlation between E and X2 is 
0.5, and both confounders are perfectly measured, the estimated OR is 1.72. Increasing the 
correlation between E and Xi to 0.3 leads to a decrease in the estimated OR to 1.69. A further 
increase in the correlation between E and X, to 0.5 creates an estimated OR of 1.61, which is 
again smaller. This effect is expected as, in the absence of residual and unmeasured 
confounding, t4e attenuation effect of exposure measurement error will be amplified by 
correlations between the exposure and confounders. 
More generally, this effect occurs when one of the confounders is perfectly measured (ICC=1), 
and the correlation between the perfectly measured confounder and exposure increases. In this 
situation, the exposure error is acting to decrease the OR, and this effect is amplified by 
correlations between exposure and confounders. There is also the additional effect of residual 
confounding, which acts to increase the OR, with the effect also being amplified by the 
correlation between the confounder and exposure. When one confounder is measured without 
error, the increase of the OR caused by residual confounding is not as large as the reduction in 
the OR due to exposure error. The overall effect is that the estimated OR decreases as the 
correlation between exposure and confounder increases. 
Non-monotonic trends of the estimated OR with the correlation between exposure and 
confounders can be seen in Table 3.20. For example, when the correlations between both 
confounders and exposure are equal to 0.1, the ICC of ZI equals 0.75 and Z2 is measured 
without error, the estimated OR is 1.61. When the correlation between E and X, increases to 0.3, 
the estimated OR increases to 1.62. When the correlation between E and X1 increases further to 
0.5, the estimated OR decreases to 1.61. In this case, the effect of residual confounding to 
increase the estimated OR is initially greater than the attenuating effect of exposure error, 
causing an increase in the estimated OR. As the correlation between exposure and confounder 
increases further the relationship is reversed, and the estimated OR decreases. 
Table 3.21 and Table 3.22 show the results of simulations in which the ICC of exposure is 0.75 
and 0.5 respectively and the correlation between the confounders equals 0.5. When the 
confounders are correlated, increasing measurement error can decrease the bias in the estimated 
exposure-outcome OR. The correlation between exposure and confounders can act to decrease 
the estimated OR. Omitting confounders from the analysis can cause a decrease in the bias of 
the estimated exposure-outcome OR. All of these effects have been seen previously in Table 
3.13 and Table 3.14. The estimated ORs in Table 3.13 and Table 3.14 are generally larger than 
the true exposure-outcome OR, while the estimated ORs in Table 3.21 and Table 3.22 in general 
underestimate the true exposure-outcome association. 
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Unmeasured confounding and measurement error in explanatory variables 
3A. 2.2 Four confounders 
Having considered the impact of exposure measurement error and residual and unmeasured 
confounding when there are two confounders, the situation with four confounders is now 
considered. 
Table 3.23 and Table 3.24 show the results obtained when the four confounders are 
uncorrelated, with the exposure ICC equal to 0.75 and 0.5 respectively. The estimated 
exposure-outcome ORs shown in Table 3.23 are smaller than those obtained when the exposure 
is measured without error (see Section 3.3.2.2), and the results shown in Table 3.24 are smaller 
than those in Table 3.23 due to an increase in the exposure measurement error. As the 
estimated exposure-outcome ORs displayed in Table 3.23 and Table 3.24 are all subject to 
unmeasured confounding, the estimated ORs are overestimates of the true exposure-outcome 
OR of two. This contrasts with the results shown in Section 3.4.2.1, where in general the 
estimated exposure-outcome ORs were underestimates of the true effect. 
In Table 3.23 and Table 3.24, increased measurement error does not necessarily lead to an 
increase in the estimated exposure-outcome association. Consider, for example, Table 3.23, and 
the scenario in which the correlation between E and Xi equals 0.1 and the correlation between E 
and X2 equals 0.5. When controlling only for Zi in the analysis, and the ICC of Zi equals one, 
the estimated exposure-outcome OR is 3.20. When measurement error in Zi increases, so that 
the ICC equals 0.5, the estimated OR decreases to 3.19. This occurs because there is a true 
exposure-outcome association, as explained in Section 3.3.2.2. 
Increased unmeasured confounding may also lead to a decrease in the bias in the estimated 
exposure-outcome OR. Consider again Table 3.23, and the scenario in which the correlation 
between E and Xi is 0.1 and the correlation between E and X2 equals 0.5. When only Zi is 
controlled for in the analysis, and is measured without error, the estimated OR is 3.20. 
Increasing unmeasured confounding by omitting Zi from the analysis leads to a crude 
estimated OR of 3.17. Again, this occurs because of the true exposure-outcome association, as 
described in Section 3.3.2.2. 
In Table 3.23, the estimated OR increases as the correlation between exposure and each 
confounder increases. This is in contrast to the results observed in Table 3.19 where there were 
only two confounders. As Table 3.23 describes simulations in which there are four 
confounders, there is a greater residual and unmeasured confounding effect acting to increase 
the estimated exposure-outcome OR. This is not counteracted by exposure measurement error 
acting to decrease the estimated OR, and hence a decrease in the estimated OR with an increase 










tý -a i 











p -2 4 
C) 
cu 
1.0. -ý tý 







= r. ýz 
Lr) 1,0 c\ Co v-i e Lr) Co A a, r4 r4 cli Cfi tIri r4 
cý 
jýý 
r4 c-i N tfi efi N efi cli tfi 
ON CN ON T-4 
r, - 9-1 %0 ýII Co 
r4 cq cq m tfi cli MMM Qpn, z 
11 
rý ri 
LO 22 T-4 
ei Ci 
%ýo 
t2 00 , 10 IZZ 
c: ý cs 
CO-, CLO 'CD 
10 cs r4 r4 r4 Cfi r4 N 
, ýo %M %0 Ilm%Q%m 110 00 Kp " v-, 1,0 Z C> 0 N el N N cq N 2 i N 
,e IN f2 EI 110 K QQ 0" u-, gi ý r4 r4 cq 
Ln 
00 00 00 aý (> cn C, 4 
00 00 w 
LA Ln Uli LO Ul) LO 0 (Y, %C In N"R (: OD 
ä 
r4 cq ei ei r4 cq r4 r4 cq %i .Z 
in Ul) Lr) "0 c: i fl, t' N" CD 
r 
-<a 
bl) In Lri 
LO to Lf) fý 0 c> %M "0 l*I 9 r, clý -: ý eg ci 
IZ %M Uli 
U') U') Lt) 
F2 %M CD 
"0 "0 













c v d z 
g 
ri ri U) 












,: 3 ;G Kn 
C5 
N 
2 't3 1ý 
:. ; Zý 
u C3 t 
































Lf) Lr) le -e 011 en le cm r-4 
CD C> CD (Z) CD rq r-4 (Z 
N C-1 r4 cq týI C-4 C-1 (-i 
A LO le 
r-4 V-1 T-4 
m (> -e 
r-4 V-4 
Ul) m en 
m V-4 
r4 r4 r4 C, 1 
m , r' 121 m 
tq ei cli N 
T-4 C, 4 C, 4 C14 N en Lfl) Z9 04 104 . 14 Lq -14 -14 Lo 




ýlo "0 Z Lri CD U) 1-e ne tn CD CD CD r-4 r-4 CD rq r-4 CD 
cq (, j r4 cq 
V-4 V-4 Uli CD 
ri T1 T-4 r-4 
C, 4 (14 cli ei c-i cq cq CA 
Lr) Ln Uli C\ Ln m 
r. 4 ri v-! 
r4 cq cq r4 
Cf) 00 Cf) It p 
cr) C14 't Cf) 
C14 C4 04 C4 C4 C4 r4 eq c4 
V-4 C) 
r*l LO T-4 %D lt 1 , q V-4 T-4 q 4 1- 4 c 
C14 C14 C14 C4 c4 C-4 r-4 c-4 r4 
N tlý N LO V4 %. 0 9 Lo ýo 
Cý (R CR ri ri q T-4 CD 
N C-4 C14 C14 NN C4 Cl t4 
tý V, N in r-4 '. 0 ' 1 1L r l 
CD CD CD V-4 ý4 CD T 4 C 1 4 
c-4 C4 c-4 C'i C'i C, 4 C-1 r4 C4 
"0 
(L) - 







UN Lt) Ln ý t*'ý r-4 LO 
u-, 





















Unmeasured confounding and measurement error in explanatory variables 
In contrast, Table 3.24 does show a decrease in the estimated OR with an increase in the 
correlation between exposure and each confounder. Consider, for example, when the 
correlation between E and X1 equals 0.1 and the correlation between E and X2 equals 0.3. When 
both Zi and Z2 are measured without error the estimated exposure-outcome OR is 2.06. 
Increasing the correlation between E and X1 to 0.3 leads to a decrease in the estimated OR to 
2.05. A further increase in the correlation between E and X1 to 0.5 leads to a further decrease in 
the estimated OR to 2.03. This contrast between Table 3.23 and Table 3.24 is explained by the 
increase in exp osure measurement error between the two tables. While in Table 3.23 the 
amount of exposure measurement error was not sufficient to counteract the effect of any 
residual or unmeasured confounding, the greater exposure measurement error in Table 3.24 is 
able to counteract the effect of any residual and unmeasured confounding in some cases. 
Table 3.25 and Table 3.26 show the results when the correlation between the confounders is 0.5 
and the exposure ICC is 0.75 and 0.5 respectively. Again, increasing exposure measurement 
error leads to a decrease in the estimated exposure-outcome OR, which is shown by the fact that 
the ORs displayed in Table 3.25 are smaller than those observed when exposure is measured 
without error (see Section 3.3.2.2), and the ORs displayed in Table 3.26 are smaller than those in 
Table 3.25. In general, the estimated ORs shown in Table 3.25 overestimate the true exposure- 
outcome OR, while those in Table 3.26 generally underestimate the true exposure-outcome OR. 
Table 3.25 and Table 3.26 show that the estimated exposure-outcome OR can decrease with 
increasing measurement error in the confounders. It is also possible for the estimated OR to 
decrease with increased unmeasured confounding, and to decrease with increased correlation 
between exposure and each confounder. These results are unsurprising, as the results of 
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3.5. Discussion 
3.5.1. Summary of results 
The validity of an epidemiological study may be threatened by both residual and unmeasured 
confounding. With plausible assumptions about residual and unmeasured confounding, effect 
sizes of the magnitude frequently reported in observational epidemiological studies can be 
generated. This study has shown that if the confounders are uncorrelated, bias in the estimated 
exposure-outcome ORs increases as error in the measured confounders increases, as the number 
of unmeasured confounders increases, and as the correlation of the confounders with exposure 
increases. If the confounders are correlated, or there is a true association between the exposure 
and outcome, bias in the estimated ORs can decrease as measurement error increases, and as 
unmeasured confounding increases. Correlated confounders can also cause bias in the 
estimated ORs to decrease as the correlations between exposure and confounders increases. 
Unmeasured confounding is a more serious problem when the confounders are uncorrelated, 
and can result in substantial bias in the estimated exposure-outcome OR, even when only one 
confounder is on-dtted from the analysis. 
When the effects of exposure measurement error were also considered, in general the trends 
observed were similar to those observed in Section 3.3 and therefore due to residual or 
unmeasured confounding. The combined effect of exposure measurement error and residual 
and unmeasured confounding was more unpredictable when the exposure had a true effect on 
the outcome, and was able to cause a decrease in the estimated exposure-outcome OR with 
increased correlation between exposure and each confounder, even when such a decrease was 
not predicted by residual or unmeasured confounding. One constant trend was observed 
throughout the investigation of exposure measurement error; the effect of random, non- 
differential and additive measurement error in the exposure is to attenuate the estimated ORs 
towards the null value. 
3.5.2. Strengths and weaknesses 
Only the case in which the errors in the exposure and the confounders are uncorrelated has 
been considered. Returning to the motivating example of the effect of antioxidant vitamins on 
cardiovascular outcomes presented in Chapter 1, this assumption may not be realistic. If 
quantities of nutrients are derived from a questionnaire containing questions about the 
frequency and quantity of consumption of certain food types, errors in variables may well be 
correlated. Errors in reporting a food type that contains two nutrients will result in the errors in 
the quantities of those two nutrients to be correlated. 
Here, simulation studies have been used to illustrate the results. While analytic results are 
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always desirable, they are not always possible to obtain. As stated by GustafsonP5 
"unfortunately, closed-form expressionsfor the bias induced by measurement error in logistic regression 
do not exist". The aim here is to examine the effects of unmeasured and residual confounding 
given parameter combinations representing situations commonly seen in epidemiological 
research. 
Care should be ýaken in generalizing from the results of a simulation study. 56 Here, it has been 
assumed that both exposure and confounders were normally distributed with mean zero and 
variance one. Continuous variables in epiden-dological studies may not have a normal 
distribution, but logarithm or square-root transformations can improve normality (although 
this can cause added difficulty in interpreting the results of a regression analysis). The results 
do not depend on the choice of mean and can be interpreted, without loss of generality, as the 
effect of a single standard deviation increase in the exposure and confounders. Often, in 
epidemiological studies, some or all of the confounders and/or the exposure are categorical. 
The results presented here will not generally apply in this situation. Misclassification of 
categorical (or binary) variables is a more complex problem, as errors will be correlated with the 
true valueS. 57 Extensions of the work presented here to deal with categorical exposures and 
confounders would be desirable. 
3.5.3. Implications 
Usually, when analyzing an epidemiological study, the true model is not known. We do not 
reliably know which variables are confounders of the association of interest, the form in which 
they should enter the model, or the time scale over which they act. It has been suggested that 
confounders can be identified by evaluating the change in the exposure-outcome estimate. M 
For example, if the estimate adjusted for a variable is more than 15% different from the estimate 
obtained without adjusting for the variable, then the variable is considered to be a confounder. 
Strict adherence to such a rule could lead to true confounders being disregarded. Consider, for 
example, Table 3.1. If the correlation between both E and Xi and E and X2 was 0.1, the OR 
adjusted for each of them separately would only differ from the crude OR by between 2.7 and 
5.6 percent, depending on measurement error. This would lead us to believe that X1 and X2 
were not confounders, and that the crude OR was the true exposure effect estimate. Rules such 
as the change in estimate criterion should be applied carefully, or not at all. 59 
This chapter highlights the need to perform sensitivity analyses to assess whether unmeasured 
confounding is a likely problem. Unmeasured confounders have been shown to have a 
cumulative effect on the bias of exposure effect estimates. The possibility of several 
unmeasured confounders should be taken into account when performing sensitivity analyses. 
It may not be enough to state that a single unmeasured confounder would need an implausibly 
large OR to remove the observed effect. Several unmeasured confounders with small or 
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moderate effects may be able to produce the same effects. Sensitivity analysis methods to assess 
the possible effects of selection bias, misclassification of covariates and unmeasured 
confounding have been proposed and illustrated by, for example, Greenland60 and Lash and 
Fink. 61 Sensitivity analysis methods will be discussed in Chapter 4. 
If information is available on confounders, it should be used in the estimation of effect 
estimates. For example, Khaw, Bingham, Welch et al. 5 note in their discussion that while 
information on social class and physical activity of the participants was recorded, they were not 
used in the reported analysis. If these variables were indeed confounders of the relationship 
between ascorbic acid and mortality, even a moderate effect of each would result in sizable 
residual confounding in the reported estimates, as shown by Lawlor, Davey Smith, Bruckdorfer 
et al. 11 Confounders may be omitted from the analysis because of missing data leading to loss of 
information. In these situations, missing data methods (e. g. multiple imputation6Z 63) can be 
used to avoid bias due to unmeasured confounding. 
When there is a true association between exposure and outcome, the true effect can be either 
underestimated or overestimated, depending on the amount of residual and unmeasured 
confounding. Investigators should therefore take care about stating that any exposure 
measurement error will have resulted in a conservative estimate of the exposure effect without 
considering the additional effect of measurement error in confounders, or of confounders 
omitted from the analysis. As shown in this chapter, the effects of measurement error in 
explanatory variables may not be easy to predict. If no residual or unmeasured confounding 
exists, exposure error of the type considered here will cause an underestimate of the true 
association, in which case investigators would be correct to state that the observed estimate is 
conservative. 
The effect of measurement error on exposure effect estimates should be explored, either by 
adjusting the estimates based on knowledge of the likely measurement error, or by performing 
sensitivity analyses. Of course, the ideal is that the variables are measured without error, but 
this is unlikely to occur in reality. While effort should be used to minimize the measurement 
error that occurs, evaluation of the measurement error that has occurred should be quantified 
and used in the final estimate. A wide variety of methods are available to correct exposure 
effect estimates for measurement error (see Chapter 4). 
3.5.4. Future research 
As an extension to the results presented in this chapter, further simulation studies could be 
carried out to investigate the effects of systematic and/or differential measurement errors on 
estimated exposure-outcome associations. An investigation of the effect of measurement errors 
in non-normally distributed continuous explanatory variables, or misclassification of 
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explanatory variables could be carried out. Additionally, the effects of measurement errors that 
act multiplicatively on the true variable of interest, or errors that are correlated with other errors 
or the true underlying variable could be investigated. 
A further issue when considering the effects of measurement errors in explanatory variables in 
epidemiological studies is recovering the true exposure effect estimate, given information about 
the amount of measurement error or n-tisclassification in the explanatory variables. In Part B, 
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Introduction 
As shown in Chapter 3, measurement error in epidenýdological studies can bias the estimates of 
the exposure-outcome association, and lead to incorrect conclusions about the size or direction 
of the association. Measurement error adjustment methods have been devised to combat this 
problem. These methods generally assume that an internal or external validation study, or 
replicate measures of the variables measured with error exist to enable estimation of the 
measurement error parameters. Section 4.2 briefly describes methods to estimate measurement 
error parameters. Some methods to correct for measurement error in epidemiological studies 
are described in Section 4.3. If the measurement error or n-dsclassification parameters are not 
known and cannot be estimated, sensitivity analysis can be used to investigate the possible 
impact of various values of the mismeasurement parameters on the effect estimates from 
epidemiological studies. Sensitivity analysis methods are described in Section 4A. 
4.2. Estimation of measurement error or misclassification 
parameters 
In many epidemiological studies, regression analysis is used to estimate exposure effects. 
Consider the simple example in which outcome is binary, and there is a single continuous 
exposure variable. Logistic regression is used to estimate the exposure-outcome OR, and the 
logistic model is 
( 7C ) 
In ý1 --n j= CC + 
PEE 
Here, n is the probability of the outcome, E is the exposure variable measured without error, 
and PE is the parameter of interest, the exposure-outcome log OR. If the exposure is measured 
with error as ZE, and a classical measurement error model is assumed, then 
ZE-E+E 
2 where e is the measurement error variable, and is assumed to have mean zero and variance cre . 
The logistic regression model using the available data is therefore 
In 
( 7c 
In general, PE * PE, and in order to obtain an estimate of PE the measurement error parameters 
must be estimated. In the case of continuous variables measured with error, the measurement 
error parameter is usually the variance of the errors, which can be estimated using, for example, 
the intra-class correlation coefficient (see Section 3.2.2). For n-dsclassified categorical variables, 
the measurement error parameters of interest are usually the probabilities of misclassification. 
In the special case of binary variables, there are two misclassification probabilities of interest, 
known as the sensitivity and specificity. 
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Known measurement error parameters 
The simplest case occurs when the measurement error parameters are known. In this situation, 
there is no need for any parameter estimation. For example, in the simulation studies presented 
so far, the measurement error variance is a parameter defined in the simulation stages, and thus 
is known. This means that, to correct the residual confounding in the simulations presented in 
Chapter 3, the known measurement error variance can be used. This situation is unlikely to 
occur in epidemiological studies, and the measurement error parameters will usually need to be 
estimated. 
4.2.2. Validation study 
In validation studies, the variable is measured without error using a gold-standard 
measurement process, and the variable measured with error is also recorded. There are two 
types of validation studies. In internal validation studies, the perfectly measured variable is 
recorded on a subset of the participants in the main study. External validation studies involve a 
sample of the population not included in the main study. The measurement error parameters, 
such as the error variance, or sensitivity and specificity, relating the true and error-prone 
measures can then be estimated. 
4.2.3. Replicate measures 
Certain variables in an epidemiological study may be measured more than once, at different 
points in time. These replicate measurements can provide an estimate of the measurement 
error variance, using a one-way analysis of variance, the Pearson correlation coefficient with 
each pair of measurements entered twice, once in reverse order, or a simple random effects 
model. 44 Misclassification probabilities can also be estimated from replicate measures. 
4.2.4. Transportation 
If validation study data or replicate measures are not available, parameters from other studies 
may be used to estimate the measurement error parameters. If the same measurement error 
model does not hold for the two populations, this method carries a risk of introducing bias into 
the main regression analysis. 
4.3. Measurement error correction methods 
While it is important to recognise the potential effects of measurement error in explanatory 
variables on estimated exposure-outcome associations in epidemiology, it is desirable to be able 
to correct the estimates. This has received considerable attention in the literature, with many 
methods available. Much is concerned with studies in which validation data are available, and 
therefore the measurement error parameters can be estimated. In this section, some methods 
for measurement error correction are reviewed. As there is a large amount of literature on this 
subject, the review here does not include all available publications. Further references can be 
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found from other published reviews of measurement error correction methods. For example, 
Thomas, Strarn and Dwyer64 review methods for correcting for exposure measurement error. 
Carroll, Ruppert and Stefanski6s review methods available for measurement error correction in 
non-linear models. ThOrigen, Spiegelman, Blettner et al. 66 provide a review of correction 
methods applicable to case-control studies. Bayesian methods for measurement error correction 
are reviewed by Gustafson. 55 
The following literature is organised into five categories. The first two categories describe 
functional modelling and structural modelling methods (Section 4.3.1 and Section 4.3.2 
respectively). The definitions of these methods are the same as those used by Carroll, Ruppert 
and Stefanski. 65 Suppose that X is the vector of the exposure and confounders of interest, which 
is measured without error and unobserved. Functional models make few, if any, assumptions 
about the distribution of X, and therefore do not parametrically model the distribution of X. In 
contrast, the distribution of X is parametrically modelled in structural models. Functional 
modelling is appealing in situations in which measurements of the exposure and confounders 
are made only on the units of interest, rather than on a random sample of a population. In this 
situation, the true values of the exposure and confounders can be considered unknown 
constants, and no assumptions about their distribution are required. Alternatively, if 
measurements are made on a random sample from a population, it would be desirable to model 
the distribution of the exposure and confounders in that population, and therefore adopt a 
structural modelling approach. Functional modelling is still useful where the exposure and 
confounders are random variables, as the lack of assumptions made about their distributions 
makes functional modelling approaches robust to misspecification of the distribution models. 
The third section considers Bayesian methods (Section 4.3.3). These approaches define a prior 
distribution for the parameter of interest, based on available knowledge about its distribution. 
From Bayes theorem, the posterior distribution of the parameter given the observed data is 
proportional to the product of the model for the observed data given the parameter and the 
prior distribution. The point estimate can be defined as, for example, the mean, median or 
mode of the posterior distribution, and a (100-cc)% credible interval, which is analogous to a 
frequentist confidence interval, is defined as the interval with probability (1-0.01a) under the 
posterior distribution. The posterior distribution can be difficult to compute, and numerical 
integration methods, such as Markov Chain Monte Carlo algorithms, are often used. 
The fourth section describes matrix methods for obtaining parameter estimates when 
categorical variables are misclassified (Section 4.3.4). In principle, these are simple to apply, 
and are based on the idea that the observed matrix of data is equal to the true matrix of data 
multiplied by the matrix of n-dsclassification probabilities. The true data is then obtained by 
multiplying the observed data by the inverse of the matrix of n-dsclassification. probabilities, and 
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used to obtain effect estimates. The final section describes methods for correcting for 
measurement error which do not fit into any of the other categories (Section 4.3.5). 
Functional modelling methods 
4.3.1.1 Regression calibration 
In regression calibration models, the relationship between the error-prone variables and the 
error-free variables is used to either estimate the values of the unobserved true variables to be 
used in the main regression analysis, or to correct the parameter estimates obtained from the 
main regression analysis in which the effor-prone variables are included as covariates. 
A regression calibration method was described by PrentiCe67 to correct estimated regression 
parameters in Cox proportional hazards models for measurement error. In this method, the 
regression of the unobserved perfectly measured covariates on the observed, effor-prone 
covariates and observed perfectly measured covariates is used to correct the parameter 
estimates from the main regression model for measurement error. Although confidence 
interval estimation was not considered by Prentice, 67 later work on regression calibration has 
included methods for estimating confidence intervals that can be used in this situation. Rosner, 
Willett and Spiegelman68 and Rosner, Spiegelman and Willett69 developed a regression 
calibration estimator in the logistic regression setting that is equivalent to the estimator 
described by Prentice. 67 
A second regression calibration method was described by Carroll and Stefanski. 70 This method 
was further described in Carroll, Ruppert and Stefanski, 65 and differs slightly from the 
approach described by Rosner et 41.68,69 Rather than correcting the parameter estimates from the 
main regression model, Carroll and Stefanski7O estimated the values of the true variable in the 
main dataset, and use this estimated variable in the main regression analysis. This regression 
calibration method is described in more detail in Section 5.2.4. The two regression calibration 
methods described by Rosner et al. 68,69 and Carroll and Stefanski7O have been shown to be 
equivalent under fairly general assumptions in main study/external validation study designs 
by Thurston, Spiegelman and Ruppert. 71 
Extensions to the basic regression calibration method of Rosner et al. 68,69 have been proposed. 
Kipnis, Carroll, Freedman et al. 72 described an extension to deal with errors that are correlated 
with the true values of a variable, and correlated systematic errors. Special cases of this model 
have been previously proposed by Freedman, Carroll and Wax, 73 and Spiegelman, Schneeweiss 
and McDermott. 74 A problem with this regression calibration method is that the parameters 
cannot all be identified by standard validation study designs. This problem was considered by 
Spiegelman, Zhao and Kim, 75 who described study designs and estimation methods that allow 
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the model parameters to be estimated. A further extension to the basic regression calibration 
model of Rosner et al. 69 to include studies with internal validation designs has been described 
by Spiegelman, Carroll and Kipnis. 76 
A regression calibration method for logistic regression and case-control data was described by 
Armstrong, Whittemore and Howe. 32 This method assumed a normal discriminant analysis 
model for the measurement error, and also allows for differential measurement errors. The 
method is similar to that of Rosner et al., 68,69 in that the naYve estimates are corrected for 
measurement error using estimates of the covariance matrices of the unobserved, perfectly 
measured variables and the error variables. These estimates can be obtained from repeated 
measures. The variance formulae provided for the corrected regression parameters do not 
account for the additional variability caused by estimation of the covariance matrices. 
Tosteson, Stefanski and Schafer77 described a regression calibration method for probit models. 
This method assumed a Berkson measurement error model, and the parameters of the 
measurement error model were assumed to be known. In reality, these parameters win usually 
be estimated from a validation study. The additional variability of the corrected probit 
regression parameters caused by estimation of the measurement error model parameters was 
not considered. 
Gleser78 proposed a regression calibration approach for linear regression analyses with errors in 
continuous covariates. In this method, the reliability matrix of the covariates was estimated 
using a validation study or replicate measurements, and used to transform the observed 
covariates. These transformed covariates were then used in a linear regression model to 
estimate the parameters of interest. This approach is similar to that of Carroll and Stefanski. 70 
Xie, Wang and Prentice79 also described a regression calibration estimator for use in a Cox 
proportional hazards model. Using replicate measures, and assuming a classical measurement 
error structure, the model was recalibrated at each distinct failure time. This method was 
extended by Gorfine, Hsu and Prentice8O to account for stratified Cox proportional hazards 
regression models. This extension did not perform well in simulations in which the covariates 
were non-normally distributed. 
White, Frost and Tokunaga57 considered a regression calibration approach to non-differential 
measurement error in both binary and continuous variables, using replicates to estimate the 
measurement error probabilities. They assumed that the outcome was continuous, and the 
mismeasured continuous variables were assumed to be uncorrelated with their errors. For 
binary variables, the measurement error probabilities were unidentified if only two replicates 
were available. This is not a concern if the binary variable is a confounder, but if it is the 
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exposure either three replicates or further assumptions are required for identifiability. 
Although the outcome variable was assumed to be continuous, the method would 
approximately apply to other generalized linear models. 
4.3.1.2 Simulation extrapolation 
Simulation-extrapolation is a method for correcting for measurement errors in continuous 
variables, and has been described by Cook and Stefanski, 81 Carroll, Kuchenhoff, Lombard, et 
al., 82 and Carroll, Ruppert and Stefanski. 65 The method involves adding further measurement 
error to the observed effor-prone variables, estimating the exposure-outcome association for 
several values of additional measurement error, and extrapolating the true exposure-outcome 
association from the observed relationship between the estimated exposure-outcome 
association and measurement error. Three extrapolant functions are generally considered. 
These are linear, quadratic, and rational linear (i. e. a ratio of two linear expressions) functions of 
the amount of measurement error. Cook and Stefanski8l showed that using a linear or 
quadratic extrapolant generally produces conservative corrections for measurement error. The 
rational linear extrapolant may produce better corrections for measurement error, but it can be 
numerically unstable when the effects of measurement error on the parameter of interest are 
small, and therefore the extrapolant is an almost horizontal line. It may also produce 
singularities in the region of measurement error between the observed parameter and the 
extrapolated parameter corrected for measurement effor. 65 The simulation-extrapolation 
method is described in more detail in Section 5.2.3. A major advantage of the method is that it 
is not restricted to a particular regression model. The method is, however, computationally 
intensive. 
Fung and Krewski83 used a simulation study to compare a regression calibration method with 
simulation extrapolation when a single variable is measured with error in a logistic regression 
analysis. They simulated an exposure and a single confounder, and only one of these was 
measured with error. They found that the regression calibration method worked well when the 
measurement error was additive, or for Berkson measurement error when the correlation 
between the exposure and confounder was close to zero. The method did not perform as well 
when the measurement error was Berkson and the exposure and confounder were highly 
correlated. Simulation-extrapolation was not as successful as regression calibration at removing 
bias due to measurement error in the effect estimates. 
4.3.1.3 Semi-parametric methods 
In sen-d-parametric methods, the measurement error model is partially or fully unspecified. 
These methods may involve non-parametric estimation of the distributions of the perfectly 
measured or effor-prone covariates, non-parametric estimation of the moments of the 
conditional distributions of the perfectly measured or error-prone covariates, or non-parametric 
estimation of the likelihood. 
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A semi-parametric approach to correcting for measurement errors in covariates has 
been 
described by Robins, Rotnitzky and Zhao84 and Robins, Hsieh and Newey. 85 This approach 
involves a parametric model for the relationship between outcome and the explanatory 
variables, but no parametric assumptions are made about the measurement error model. The 
proposed estimator is consistent and semi-parametric efficient. This semi-parametric approach 
can be used in a variety of epidemiological situations, as it can account for both continuous and 
categorical outc9mes, validation studies that are not randon-dy selected, and any number of 
mismeasured covariates. In addition, the method does not require the assumption that 
measurement error is non-differential. Spiegelman and Casel1a86 demonstrated that the 
expressions provided by Robins, Hsieh and Newey8s simplify if the outcome variable is binary, 
the validation sample is randomly selected, and there is one covariate measured with error. 
Simulation studies were used by Starmer, Thilrigen, Spiegelman et al. 87 to compare the 
performance of Rosner et al. '08,69 regression calibration model, and the semi-parametric method 
for correcting for measurement error described by Robins, Hsieh and NeweyP The results of 
the simulation studies showed that the semi-parametric approach was affected less by large 
error variances and differential errors than the regression calibration estimate. The semi- 
parametric approach is, however, complex. In situations in which the assumptions of the 
regression calibration model hold, investigators may prefer to use this intuitively and 
computationally simpler method. 
A sen-d-parametric mixture model was proposed by Roeder, Carroll and Lindsay8s to account 
for misclassification in case-control studies. Although the method was developed in terms of 
misclassification of a categorical variable, the results extend to the case of a continuous 
covariate. The method was developed in settings with internal validation studies, but can also 
be used if external validation data is available, as long as the measurement error is non- 
differential with respect to the outcome. The method can also account for additional perfectly 
measured covariates, but was developed in the situation where only one covariate is measured 
with error. 
Gorfine, Hsu and Prentice8O proposed a non-parametric estimator to correct for measurement 
error in Cox proportional hazards model. Using simulation studies, their estimator was shown 
to substantially reduce bias when the covariates were non-normally distributed. This 
robustness to the measurement error model may be important in practical applications, where 
the true measurement error model is not known. 
4.3.1A Other functional modelling methods 
A functional method involving correcting the partial likelihood score functionS9 in Cox 
proportional hazards models was originally proposed by Nakamura.. 90 This method assumes 
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additive and normally distributed measurement errors with a known covariance matrix. In 
practical applications, the covariance matrix of the errors may not be known, and will have to 
be estimated. The method was extended by Huang and Wang9l to the situation in which the 
measurement error parameters are estimated using replicated data. This extension only 
assumes additive measurement errors, and does not make any further assumptions about the 
distributions of the covariates or measurement errors. Another extension to Nakamura's9O 
method was proposed by Hu and Lin, 92 where the measurement error parameters are estimated 
using either a randomly selected validation sample, or replicated measures. In this extension, 
no assumptions are made about the distributions of the covariates, but the errors are assumed 
to have a symmetric distribution. 
Gorfine, Hsu and Prentice8O extended two functional methods91,92 for use with stratified Cox 
regression models. The extensions of Huang and Wang's9l method, and Hu and Lin'S92 method 
tended either not to converge, or to be highly biased even when the measurement error 
variance was small. 
Measurement error in continuous explanatory variables and matched case-control studies was 
considered by McShane, Midthune, Dorgan, et al. 93 A conditional scores method for logistic 
regression analysis was developed assuming normally distributed, non-differential 
measurement errors. Using simulation studies, the conditional scores method was compared 
with a regression calibration method and was shown to be superior when the explanatory 
variables were non-normally distributed and highly skewed. 
4.3.2. Structural modelling methods 
A pseudolikelihood method was proposed by Carroll, Gail and Lubin94 to deal with 
measurement errors in covariates in case-control studies. They used a prospective logistic 
regression model and a parametric measurement error model to express the retrospective 
likelihood. Pseudolikelihoods were obtained by substituting the true values of the parameters 
of the measurement error model with estimates of the parameters, and pseudolikelihood 
estimates of the regression parameters of interest were acquired. The method can account for 
differential errors, and for errors in both categorical and continuous covariates, and was 
developed in the setting of an internal validation study. 
Measurement error in covariates in case-control studies and retrospective logistic regression 
was considered by Forbes and Santner. 95 Three estimators of the conditional maximum 
likelihood were presented that used different information about the measurement error model. 
The first estimator was a bias-corrected version of the uncorrected conditional maximum 
likelihood estimator (MLE) based on its asymptotic bias. For the second estimator, the 
measurement errors were assumed to be normally distributed. The third estimator was based 
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on score equations in which the measurement error was not assumed to be normally 
distributed. The properties of the three estimators were investigated using simulation studies, 
and the bias-coffected estimator was found to perform best in the presence of measurement 
error. 
In segmented regression, the analytical form and parameters for the model relating the 
exposure and confounders to the outcome may be different for different values of the 
explanatory variables. Threshold models are a special case of segmented regression. 
Kilchenhoff and Carroll96 considered measurement error in explanatory variables in segmented 
regression analyses. They described a MLE that assumed a parametric distributional form for 
the unobserved, perfectly measured covariate. They found that the MLE, when the model was 
correctly specified, was much less variable than regression calibration or simulation- 
extrapolation estimates. When the model was misspecified, the MLE did not perform well. 
Measurement error in a single continuous covariate in a Cox proportional hazards model was 
considered by Hu, Tsiatis and DavidianY7 Their method used a likelihood-based approach. 
This approach has been extended by Liu, Mazumdar, Stone et al. 98 to include an additional, 
perfectly measured binary variable. The extension also allows measurement errors to be 
differential with respect to the binary covariate, and allows for correlations between repeated 
measures of the error-prone variable. 
Kosinski and Flanders99 proposed a method for correcting for misclassification of a binary 
exposure in which a gold standard measurement is not required, and instead two imperfect test 
results are available. The method models the probabilities of exposure, test one, and test two by 
logistic regression analyses, and can accommodate both differential and non-differential 
misclassification errors. An expectation-maximisation (E" algorithm is used to obtain the 
maximum-likelihood estimates of the required parameters. The odds ratio is then 
approximated using the ratio of exposure odds for diseased subjects relative to undiseased 
subjects. The method allows for additional covariates, and is easily implemented in standard 
statistical packages. 
Spiegelman, Rosner and Logan'00 proposed a method for estimation of logistic. regression 
parameters that corrects for both measurement error in continuous covariates and 
n-dsclassification of categorical covariates. Measurement error in the continuous covariates was 
assumed to have a multivariate normal distribution, and the misclassification of the categorical 
variables was described using a chain of logistic regression models. Maximum likelihood 
estimates were obtained for the parameters of the logistic regression model in the main study 
and the measurement error and misclassification models. Simulation studies were used to 
compare the MLE with a regression calibration estimate. These studies showed that regression 
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calibration may be preferable for situations in which the validation study size is between 100 
and 200 and the true regression parameter of interest is close to the null. The MLE performed 
better than regression calibration when the value of the true parameter was not close to the null, 
and data from an internal validation study was available. The MLE did not perform well when 
validation data came from an external study, and in these situations regression calibration may 
be a preferable approach. 
A method for correcting for misclassification of a binary outcome and measurement error in a 
single covariate has been described by Roy, Banerjee and Maiti. 101 The method was developed 
for both probit and logistic regression models, and the parameters of the models were estimated 
using maximum likelihood methods. Simulation studies showed that the model works fairly 
well for correcting for n-dsclassification of outcome and measurement error in a single covariate. 
Measurement errors in multiple covariates cannot be corrected for using the described method, 
and the method assumes that measurement errors and n-dsclassifications are non-differential. 
4.3.3. Bayesian methods 
Bayesian methods have been proposed to account for measurement error in epidemiological 
studies. Several of these methods apply to analysis of case-control studies. 
MitHer and Roeder'02 described a Bayesian semi-parametric approach for case-control studies 
with errors in variables. Measurement error was assumed to be non-differential and to only 
affect a single explanatory variable. A mixture of multivariate normal models for the covariates 
was assumed, with a Dirichlet process prior model on the unknown mixture measure. This 
method is computationally complex. Using multivariate normal kernels implies continuous 
covariates, and extensions to the model would be required for categorical covariates. 
A method for correcting for measurement error in the exposure in unmatched case-control 
studies was described by Gustafson, Le and Vall6e. 103 They used a normal discriminant model 
for the unobserved true exposures, and assumed that measurement error was non-differential. 
The method allows for any number of explanatory variables. The assumption of a normal 
discriminant model means that the exposure variables must be continuous, and that the model 
cannot be used in situations with categorical explanatory variables. 
Another Bayesian method for use in case-control studies with errors in covariates was described 
by Gustafson, Le and Vall6e. 104 The conditional variance of the error-prone variable, Z, given 
the perfectly measured variable X and the outcome Y was assumed not to vary with Y. This is a 
weaker assumption than that of non-differential errors, which assumes that the conditional 
distribution of Z given X and Y does not depend on Y. The method involves assun-ting that the 
distribution of Z is discrete, using a support grid with grid points chosen according to the study 
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design. Markov Chain Monte Carlo methods are then used to sample from the distribution, 
and an importance weighting scheme used for parameter inference. The method was 
formulated using a single n-dsmeasured exposure, and more work is required on the best way to 
include additional precisely measured covariates into the analysis. 
Exposure misclassification in matched case-control studies with a variety of matching ratios 
was explored by Rice. 105 The method can be viewed as either a random effects model, or as a 
Bayesian method. In the simplest case of 1: 1 matching, the method uses error matrices to 
correct the observed data, and then the MLE to find the point estimate. For more complex data 
structures, the Bayesian method is simpler to implement. Only a single exposure variable was 
considered, which therefore limits the method's applicability to more general epidemiological 
studies where confounding is likely. 
Prescott and Garthwait6106 proposed three methods for misclassified binary data from a 
matched case-control study with a validation sub-study. The first two models proposed 
examine the data in two stages. The first stage combines the data from the validation sub-study 
with a non-informative prior distribution. The resulting posterior distribution is used as the 
prior distribution for the second stage. This is then combined with the main study data. The 
third model uses a hierarchical structure to model the relationship of the exposure probabilities 
of the matched sets. Much of the paper was concerned with the situation in which each case is 
matched with a single control, although an extension to multiple matched controls for each case 
was considered. Throughout, only misclassification in the binary exposure variable was 
considered, and the models only included the outcome and exposure, with no confounders. 
This situation is highly unlikely in observational epidemiology, although the authors state in 
the discussion that the models could be extended to accommodate binary or categorical 
perfectly measured confounders. 
There have also been applications of Bayesian methods to measurement error problems outside 
of the case-control setting. 
Richardson, Leblond, jaussent et al. 107 considered studies in which there is a validation sub- 
study. They assumed that a single explanatory variable was measured with error, and that the 
error was non-differential. Their emphasis was on specifying the prior distribution for the 
analysis, for which they used a mixture of normal distributions with an unknown number of 
components. Markov Chain Monte Carlo methods were then used for estimation of the model 
parameters. 
In Chapters 4 and 5 of his book, Gustafson55 described Bayesian methods for correcting for 
measurement error in continuous and categorical variables, respectively. Methods for both 
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prospective (e. g. cohort studies) and retrospective (e. g. case-control studies) analyses were 
considered. The emphasis was on a single n-dsmeasured explanatory variable, and the chapter 
on misclassification of categorical variables only considered the special case where the 
mismeasured variable was binary. 
4.3.4. Matrix methods 
Methods for adjusting for measurement error in continuous variables, and those for adjusting 
for misclassification in categorical variables are often quite different. One reason for the 
difference is that, in categorical variables, the error is correlated with the true value of the 
variable. As explained by White, Frost and Tokunaga, 57 with binary variables if the true value 
of the variable is zero, then the error is zero or one. If the true value of the variable is one, the 
error is either zero or -1. The error is therefore negatively correlated with the true value. 
Matrix methods, which use the misclassification matrices, are simple methods to correct for 
misclassification in categorical variables. 
Much of the earlier work on misclassification. of discrete data focussed on W contingency 
tables. Barron'08 described a simple method for correcting relative risks from W tables, using 
the observed classification matrix, and the two matrices of the conditional probabilities of 
misclassifying each element in the observed W table. This method assumed that 
n-dsclassification was non-differential. 
Brenner27 described a similar matrix method to correct for non-differential exposure 
misclassification when trend is being assessed. In the method, exposure was categorical and 
could have more than two levels. The observed matrix of numbers of cases and controls for 
each exposure level was corrected for misclassification by post-multiplying by the inverse of the 
misclassification matrix. 
Copeland, Checkoway, McMichael et al. 109 described a method to correct observed relative risks 
for exposure misclassification using the sensitivity and specificity of exposure classification. 
The method can be applied to data from cohort studies and unmatched case-control studies. 
The exposure was assumed to be binary, and it was assumed that there are no confounders of 
the exposure-outcome association. It was additionally assumed that the misclassification was 
random, i. e. that the sensitivity and specificity of exposure classification were the same for both 
the exposed and unexposed populations. Variance estimation, and therefore correcting 95% Cls 
for exposure misclassification, was not considered. 
An extension to Copeland, Checkoway, McMichael et al. 's'09 method to matched case-control 
studies was described in Greenland"O and Greenland and Kleinbaum, "' using the sensitivity, 
specificity, false positive rate and false negative rate among cases and control separately. 
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Greenland and Kleinbaurn"I also considered differential misclassifications, as an extension to 
Barron's'08 method. Variance estimation for the corrected estimates was considered by 
Greenland. 112 Duffy, Rohan, Kandel et al. 113 extended this methodology'10-112 to the situation of 
variable and multiple controls per case. All of these methods considered a single binary 
exposure, although extensions to accommodate more than one explanatory variable, and more 
general categorical variables are possible. 
Espeland and HUi114 proposed an approach for analysing W tables that are subject to 
misclassification. The method is more complex than previously proposed methods for 
n-dsclassification of W tables, but provides variance estimates that are often not available in the 
simpler methods. Log-linear models are used to describe the misclassification, and a gold 
standard measurement of the variable of interest is required. The method can be extended to 
polytomous variables, and to situations with more than two variables. If the misclassification 
cannot be described by a log-linear model, as would be the case, for example, with 
n-dsclassification in polytomous variables in a matched case-control study, the proposed 
method cannot be used. 
Weinkam, Rosenbaum and Sterling"s considered obtaining corrected relative risk estimates 
when a categorical exposure and a single confounder may be n-dsclassified. The 
n-dsclassification was assumed to be non-differential. They used the misclassification matrix to 
recover the true relative risk estimates. Unlike many other methods for misclassified data, they 
demonstrated their method on categorical data with more than two levels. 
One general problem in using matrix methods to correct for misclassification is that the 
misclassification matrix may be singular, and therefore not invertible. This problem is unlikely 
to occur in reality unless the classification process is very unreliable. "' 
4.3.5. Other methods 
A method for correcting exposure-outcome ORs for non-differential misclassification in a 
binary confounder was described by Savitz and Bar6n. 116 They focussed on the case with 
binary exposure and a single binary confounder. The correction was based on the crude 
observed OR, the OR adjusted for the misclassified confounder, and estimates of the sensitivity 
and specificity of the confounder misclassification. The method does not account for sources of 
bias other than from the misclassification of the single confounder, which may limit the 
applicability of the method in practice. In addition, the method used simulated data to estimate 
the effect of sensitivity and specificity on the bias in the observed OR. If the assumptions used 
for the simulations do not hold for a real-life application, the correction method may not 
perform wel 
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Liu and Liang'17 considered non-differential n-dsclassification in generalized linear models. 
They focussed on the case where multiple observations of a surrogate of the variable of interest 
were available. These can be viewed as replicate measures of the true variable subject to 
misclassification. The method used latent class analysis, with an EM algorithm to estimate the 
regression parameters. The method can only be applied to generalized linear models in which 
all explanatory variables are categorical. A further possible problem with the method is that the 
number of parameters that must be estimated increases as the number of variables measured 
with error, and the number of categories in those variables, increases. This method has been 
further extended to the situation in which data is collected through two-stage sampling by 
Emsley, Gao, Hall et al. 118 
A method for correcting for n-dsclassification of a categorical exposure was described by Reade- 
Christopher and Kupper. 119 The method modelled disease risks using logistic models, and 
disease rates using log-finear models. The method accounted for an exposure with any number 
of categories, and any number of additional categorical confounders. Misclassification of 
confounders was not accounted for. 
Wang and Pepe'20 described a method to allow for measurement error in covariates using 
expected estimating equations (EEE). The method can be used when replicate measurements 
on the variable measured with error are available. The EEE estimator is equivalent to the MLE 
when the score equations are derived from the likelihood, and conditional expectations are 
conditioned on the complete dataset. A pseudo-EEE estimator was also developed to reduce 
the computational complexity of the EEE estimator. Simulation studies were used to evaluate 
the performance of the EEE and pseudo-EEE estimators, and compared with the performance of 
a regression calibration estimate. These simulations showed that if the relationship between the 
covariate measured with error and outcome was not too large, and the sample size was 
moderate, the regression calibration estimate performed the best. For larger sample sizes and 
covariate effects, the EEE estimator performed the best. 
4.3.6. Summary 
This review has shown that there are many methods available to correct observed exposure- 
outcome effects for the effects of measurement error in exposures and confounders. These 
methods are not routinely used in the analysis of epidemiological data, where it is likely that 
some, or even all, of the explanatory variables will be measured with error. Choosing which of 
these methods to use in a practical application will generally depend on the data in question. 
The assumptions for each of the models should apply to the data to be analysed. The regression 
calibration methods of Rosner et al. 68,69 and Carroll and Stefanski70 require the exposure and 
confounders to have a multivariate normal distribution. If this is not the case, other methods 
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may be more appropriate. Many of the methods assume non-differential measurement error, 
which may not be an appropriate assumption in, for example, case-control studies where there 
may be recall bias. In this situation, methods that have been developed to allow for differential 
measurement error, such as the method described by Armstrong et al., 32 should be used. 
Structural modelling methods make assumptions about the distribution of the perfectly 
measured variables, which should be checked. The use of functional modelling methods 
reduces the number of assumptions made. Violations of the model assumptions may lead to 
bias in the corrected estimates, and therefore should be considered carefully. 
A further consideration is the applicability of the method to the data. Some of the methods are 
suitable for only continuous, or only categorical data. In situations in which both types of data 
are present, methods which accommodate both are appropriate. In addition, several methods 
allow only for measurement error in a single variable. If there are multiple variables measured 
with error, as is likely in an epidemiological study, these methods will not be appropriate. It 
may also be important for the method to allow for additional, perfectly measured variables. 
Age, for example, is commonly included as a confounder in analyses of epidemiological studies, 
and is generally considered to be measured without error. The form of the outcome variable, 
and therefore the disease model, should also be considered. Some of the methods proposed are 
restricted to a particular type of outcome variable, such as a survival time outcome, or a 
continuous outcome. The measurement error correction method chosen should apply to the 
outcome in question. Several methods, such as regression calibration, simulation-extrapolation, 
and the semi-parametric approach of Robins et al., K 85 allow for several types of outcome. 
Ease of implementation may also be a consideration when choosing a measurement error 
correction method. For example, programs to implement regression calibration methods are 
available for Splus, SAS and Stata. Difficulties with programn-ting for the more complex 
methods may be the main barrier to their implementation. Thilrigen, Spiegelman, Blettner et 
al. 66 suggested that there are two conflicting aspects to consider when choosing a measurement 
error correction method. Methods that are easy to use may not provide estimates that are as 
precise as other methods, but methods that are theoretically precise may not be easy to 
implement. 
The motivation for the literature review presented in this section is to find methods to correct 
the estimates obtained from some of the simulation studies in Chapter 3 for measurement error. 
As the exposure and confounders in the simulations were all continuous, the matrix methods 
described in Section 4.3.4 are not applicable. The simulation studies investigate the impact of 
measurement error in the exposure and confounders in a frequentist logistic regression model, 
and therefore Bayesian methods to correct for measurement error will not be considered. 
Additionally, using a Bayesian method to correct for measurement error in the simulation 
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studies would be extremely computationally intensive. The main concern with structural 
modelling methods is misspecification of the distribution of the unobserved, perfectly 
measured variables. Although this will not be a problem if using a structural modelling 
method to correct for measurement error in the simulation studies, as the distributions of all 
variables are known, there is a possibility of model misspecification when using structural 
modelling methods for real epidemiological data. Although there is still a possibility for model 
misspecification for functional modelling methods, fewer assumptions are made and therefore 
there is less scope for misspecification. Functional modelling methods, and in particular 
regression calibration and simulation-extrapolation, will therefore be used in Chapter 5 to 
correct for measurement error in the exposure and confounders in the simulation studies. 
These two methods are intuitively simpler than many of the other available methods, are 
applicable to a range of regression models, and are available in several commonly used 
statistical programs (e. g. SAS and Stata). Carroll, Ruppert and Stefanski6s have termed these 
methods the "default approaches" (page xviii) to measurement error correction problems. 
4.4. Sensitivity analysis methods 
If the measurement error variance or misclassification parameters cannot be estimated using 
validation studies or replicate measures, sensitivity analysis methods can be used to investigate 
the possible impact of measurement error and n-tisclassification on exposure-outcome effect 
estimates. Sensitivity analysis can also be used to investigate the possible impact of 
unmeasured confounding and selection bias on effect estimates. 
4.4.1. Methods for unmeasured confounding 
One of the first examples of using sensitivity analysis in epidemiology was given by Cornfield, 
Haenszel, Hammond, et al. 121 They used sensitivity analysis to show that the observed 
association between cigarette smoking and lung cancer was unlikely to be due to unmeasured 
confounding. 
Bross'22 developed a method to detern-dne whether an observed exposure effect is due to a 
single binary unmeasured confounder. Let Y denote the binary outcome, E denote the binary 
exposure, and X denote the binary unmeasured confounder. The. size of the association 




In this formula, A is the ratio of the expected number of people with E=1 and X=O to the 
expected number of people with E=1 and X=1. B is the ratio of the expected number of people 
with E=O and X=O to the expected number of people with E=O and X=1, and V is the 
confounder-outcome risk ratio. Estimates of A, B and V will need to be obtained from external 
data. If the size of U* is not as large as the observed effect of exposure on outcome, then the 
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observed effect cannot be said to be due to unmeasured confounding. This method is very 
simple to apply, and can be applied when information on the relationship between exposure 
and confounder is available. When this information is not available, Bross'23 provided an 
extension to allow the calculation of the minimum value of the association between the 
unobserved confounder and outcome that could explain the observed exposure-outcome 
association for various relationships between the exposure and confounder. This method only 
applies to binary outcome and exposure and a single binary confounder. 
Schlesselman'24 extended Bross's'22 method to allow for an interaction between the exposure 
and confounder. In the method, the observed exposure-outcome relative risk is adjusted for an 
unmeasured confounder using the relative risk of disease due to the confounder in the absence 
of the exposure, the relative risk of disease due to the confounder in the presence of the 
exposure, and the prevalences of the confounder in the exposed and unexposed populations. It 
was shown that, if there is an interaction between the exposure and confounder, previously 
described methods'21,122 may either underestimate or overestimate the effect of the unmeasured 
confounder. Once again, it was assumed that the outcome and exposure were binary, and that 
there was a single unmeasured binary confounder. The method used by Schlesselman to 
estimate the prevalences of the confounder in the exposed and unexposed populations has been 
corrected by Simon, 125 who also noted that correcting the observed confidence limits in the same 
way as the relative risk (by dividing by the effect of the unmeasured confounder on the 
estimated exposure-outcome association) is only appropriate in large samples. 
A method for assessing the sensitivity of results to an unmeasured binary confounder was 
described by Rosenbaum and Rubin. 126 The method assumes a binary outcome, binary 
exposure, and a categorical confounder. The sensitivity parameters are the log ORs between the 
exposure and the unmeasured confounders, the log OR between the outcome and the 
unobserved confounder, and the probability that the unobserved confounder is zero. These 
sensitivity parameters can vary across strata of the observed confounder, although the 
sensitivity analysis could become very large if all parameters are allowed to vary across all 
categories of the observed confounder. Estimates of the expectations of the proportion of 
subjects improved by exposure can then be calculated using various values of the sensitivity 
parameters. 
Yanagawa'27 presented a method for calculating the upper and lower bounds on an estimated 
exposure-outcome OR from a case-control study in which there is unmeasured confounding. It 
was assumed that disease, exposure and the unmeasured confounder were binary variables. 
The adjustment used the confounder-outcome ORs among the exposed and unexposed subjects, 
and the exposure-confounder ORs among the cases and controls. One problem with this type of 
sensitivity analysis is that the sensitivity parameters are treated as known. Yanagawa'27 dealt 
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with this complication by suggesting that the 95% confidence intervals for the sensitivity 
parameters obtained from external studies be used to calculate conservative bounds on the 
estimated exposure-outcome OR. 
Lin, Psaty and Kronmal'28 presented a method for assessing the sensitivity of results from 
regressions on binary or censored failure time outcomes to unmeasured confounding. For 
binary outcomes, the model described is slightly different from the logistic regression model, 
but is a good approximation of it for rare outcome events. For censored failure time outcomes, 
a Cox proportional hazards model is used. When the unmeasured confounder is binary, the 
sensitivity parameters are the association between the confounder and outcome in the exposed 
and unexposed groups, and the prevalences of the confounder in the exposed and unexposed 
groups. If the unmeasured confounder is normally distributed, the sensitivity parameters are 
the associations between the confounder and outcome in the exposed and unexposed groups, 
and the means of the confounder in the exposed and unexposed groups. These sensitivity 
parameters are then used to adjust the observed exposure-outcome association. This method 
can only assess the impact of a single unmeasured confounder. 
A method to investigate the impact of several unmeasured confounders has been proposed by 
StUrmer, Schneeweiss, Avorn, et al. 129 Ibis propensity score calibration method combines 
propensity scores with regression calibration. Propensity scores, which are the conditional 
probability of exposure given the other covariates, are estimated in the main study in which 
information on all relevant confounders is not available. A validation study, in which 
information on additional confounders is available, is used to estimate the relationship between 
the propensity score which is subject to unmeasured confounding and the propensity score in 
which all relevant confounders are included. The main study estimates, in which the 
propensity scores are subject to unmeasured confounding, are then corrected using the 
estimated relationship between the confounded and unconfounded propensity scores from the 
validation data. 
4.4.2. External adjustment 
A simple method of sensitivity analysis, given by Greenland, 60,130,131 is the method of external 
adjustment, which can assess the impact of unmeasured confounding, misclassification, and 
selection bias. External adjustment involves using sources of data external to the study in 
question to adjust the observed effect estimates. Unmeasured confounding is adjusted for by 
assuming values for the association between outcome and the unmeasured confounder, and 
prevalences of the confounder in the exposed and unexposed populations. The impact of 
misclassification of a dichotomous exposure variable is investigated by assuming different 
values for the sensitivity and specificity of misclassification. Selection bias is analysed by 
assuming probabilities of selection. For all of the above corrections, assuming different values 
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for the required parameters leads to a sensitivity analysis. This method of sensitivity analysis 
could lead to a large number of parameters being varied, particularly if more than one source of 
bias or variable are being investigated. Presentation of results from such a sensitivity analysis 
would be complex, and possibly difficult to interpret. The methods apply to categorical 
variables, and were illustrated using the special case of binary variables, but are not applicable 
to continuously distributed variables. 
Gail, Wacholder and LubinIn described a method of external adjustment to assess the 
sensitivity of estimated relative risks to a binary unmeasured confounder. Adjustments to the 
observed crude relative risk estimate were made using the confounder-outcome relative risk 
and the probability of having the confounder in the exposed and unexposed populations. 
Extemal adjustment for additive models involves correcting the observed risk difference using 
the confounder-exposure risk difference, and again the probability of having the confounder in 
the exposed and unexposed groups. 
4A. 3. Monte Carlo risk analysis 
Greenland'33 used the term 'Monte Carlo risk analysis' to refer to methods in which sensitivity 
parameters are drawn from a probability distribution, and the conventional analysis is repeated 
for multiple draws. 
A Monte Carlo risk analysis method was described by Lash and Fink, 61 in which the 
counterfactual dataset was reconstructed. A counterfactual dataset is the dataset that would 
have been observed had the various sources of bias, such as n-isclassification, selection bias and 
unmeasured confounding not been present. Selection bias in the example given was due to 
outcome status being unknown for some of the study subjects. This was adjusted for by 
guessing" the status of these subjects, informed by the data for subjects whose outcome was 
known. 
To assess the impact of misclassification in a binary explanatory variable, triangular probability 
distributions were defined to represent the sensitivity and specificity of the variable. For a 
single reconstruction, a sensitivity and specificity were chosen from the probability 
distributions and used to calculate the positive and negative predictive values respectively. For 
each subject who may have been misclassified, a Bernoulli trial was performed using either the 
positive or negative predictive value, depending on the subjecirs observed status, to model 
whether misclassification had occurred. Subjeý identified as misclassified were then 
reclassified. A SAS macro to investigate the impact of misclassification of binary variables on 
estimated exposure-outcome associations was developed by Fox, Lash and Greenlan&I The 
macro allows for uniform, triangular and trapezoidal probability density functions. 
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To assess the effect of an unmeasured confounder, Lash and Fink6l created a dichotomous 
variable by specifying the prevalence of the confounder in subsets of the population. A 
Bernoulli trial was performed to assign whether a subject had the confounder. 
Once the counterfactual dataset had been reconstructed, standard analyses were used to obtain 
an estimate of the exposure-outcome association. Multiple reconstructions were made, and the 
50th percentile of the cumulative probability distribution was used to define an overall point 
estimate. The 2.5th and 97.5th percentiles were used as the 95% simulation interval. This 
analysis ignores sampling variation (the error due to analysing a sample of the true population), 
so a bootstrap sample of each reconstructed dataset was taken, and the same method used to 
obtain a point estimate and 95% simulation interval. 
A similar method, with the same data as used by Lash and Fink, 61 appeared in Lash and 
Silliman. 135 Phillips'36 also presented a similar method, although the order in which the 
corrections should be applied was emphasized. Figure 4.1 shows the order in which bias in 
observational studies occurs, from left to right. Phillips argued that the corrections in the 
sensitivity analysis should be performed from right to left. 
Figure 4.1: Order of bias in observational studies (source: PhillipS136) 
True causal ýI True values for Observe __j 
Observed 
relationship A L-"OL actual population sample data 
Confounding Random sampling error Measurement 
and error 
selection bias 
4.4.4. Other methods 
Sensitivity analysis methods for specific analysis models have been proposed. 
Test statistics are often used in observational epidemiological studies to test for relationships 
between exposure and outcome. In these analyses, it is assumed that the exposure in each pair 
is randomly assigned. Rosenbaum'37-140 and Rosenbaum and Krieger141 have presented a 
sensitivity analysis that investigates the impact of degrees of departure from this assumption of 
random assignment of exposure. Departure from the assumption is parameterised using a 
sensitivity parameter. This parameter is then varied, and bounds on the significance level of the 
test statistic calculated to show how conclusions could be altered with different amounts of 
non-random treatment assignment. This approach can be applied to many test statistics, such 
as Wilcoxonýs signed rank test for matched pairs with continuous outcomes, the McNemar-Cox 
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test for paired binary outcomes, Gehan and log-rank tests for censored outcomes, and Fisher's 
exact test for binary responses. 
J0142 proposed a sensitivity analysis method to investigate the impact of model misspecification 
when estimating treatment efficacy in RCrS in which there are departures from randon-dy 
allocated treatment. One method of estimating treatment efficacy in RCrs is to estimate the 
complier average causal effect (CACE), 143 which is described in more detail in Section 8.2.1.1. 
CACE estimation relies on several assumptions including the exclusion restriction assumption. 
This assumption states that, if randomisation does not affect the treatment actually received, 
then randomisation also has no effect on outcome. The proposed sensitivity analysis 
investigates the impact of violation of the exclusion restriction assumption in CACE estimation. 
4.4.5. Summary 
Only a single source of bias is considered in the sensitivity analysis methods for the impact of 
unmeasured confounding on exposure effect estimates. Epidemiological studies may be subject 
to several sources of bias, such as measurement error or selection bias, and therefore using a 
sensitivity analysis to allow for just unmeasured confounding may not be adequate. Sensitivity 
analysis methods that allow for multiple sources of bias simultaneously, such as external 
adjustment and Monte Carlo risk analysis, may therefore be preferable to methods that allow 
for only a single source of bias. Presentation of the results of a sensitivity analysis may also 
cause problems. If several sources of bias are being investigated, and several values of the 
relevant parameters are used for each source of bias, a large number of results will be obtained, 
and presenting these in a comprehensible way will be difficult. This problem affects all of the 
sensitivity analysis methods described in this section, other than Monte Carlo risk analysis. 
The motivation for the literature described in this section is an analysis of the effect of residual 
confounding (caused by measurement error in the confounders) and exposure measurement 
error on the association between C-reactive protein and coronary heart disease, which will be 
presented in Chapter 7. The data for this analysis do not allow estimation of the measurement 
error parameters, and therefore sensitivity analysis methods must be used. The impact of 
unmeasured confounding will not be considered in Chapter 7, and therefore the sensitivity 
analysis methods for unmeasured confounding described in Section 4.4.1 above will not be 
used. In common with the simulation studies presented in Chapter 3, only measurement error 
in continuous variables will be considered. External adjustment (Section 4.4.2) will therefore 
also not be used. Monte Carlo risk analysis will be used. An advantage of this method over 
many other sensitivity analysis methods is that the results are easy to display in terms of a point 
estimate and simulation interval. Monte Carlo risk analysis is also applicable to a range of 
regression models, is able to investigate the joint impact of uraneasured confounding, 
measurement error in explanatory variables and selection bias on exposure effect estimates, and 
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is applicable to both categorical and continuous explanatory variables, This makes it an 
attractive option for any sensitivity analysis. 
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Chapter 5. 
Correcting for measurement error in explanatory variables in 
epidemiological studies: A simulation study 
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5.1. Introduction 
In this chapter, two methods for correcting for measurement error, simulation-extrapolation 
(SimEx) and regression calibration, are investigated using simulation studies. 
Correction for 
residual confounding, caused by measurement error in the confounders, is investigated 
in 
simulated datasets which contain either two or four confounders. For datasets with two 
confounders, each may be measured with error or omitted from the analysis. For datasets with 
four confounders, two confounders are omitted from every analysis, and the remaining two 
may be either measured with error or omitted from the analysis. Correction for exposure 
measurement error, as well as residual confounding, is investigated using simulated datasets 
with two confounders, where again the confounders may be measured with error or omitted 
from the analysis. For all analyses, logistic regression is used to estimate the corrected 
exposure-outcome odds ratios (ORs) in situations in which the exposure has no true association 
with the outcome (exposure-outcome OR=1). 
5.2. Methods 
5.2.1. Notation and terminology 
The following is a list of the notation that will be used throughout this chapter. 
a2. variance of the true measurements U 
Cy 2= measurement error variance e 
ji, = mean of the observed measurements of S 
W vector of variables observed without error 
X vector of unobserved perfectly measured variables 
Z vector of observed variables measured with error 
E, t = variance-covariance matrix between variables S and T 
i= estimated vector of perfectly measured variables 
k= number of replicates of the observed variables measured with error 
Throughout this chapter, the results presented in Chapter 3 will be referred to as narve estimates, 
and corresponding analysis method as the nalve analysis. Results corrected by the SimEx 
method will be referred to as the SimEx corrected estimates, and results corrected by the 
regression calibration method will be referred to as the regression calibration corrected estimates. 
The term overcorrection will refer to corrected estimates that are further from the na*i*ve estimates 
than the estimate obtained when the variables included in the analysis are measured without 
error. This is not necessarily the true exposure-outcome OF, as the estimate may be biased by 
unmeasured confounding. The term intennediate will refer to corrected estimates that are 
between the nave estimate and the estimate obtained when there is no measurement error in 
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any of the variables included in the analysis. The corrected estimates will generally be 
compared with the estimates obtained when there is no measurement error in the confounders 
included in the analysis as, although the aim is to recover the true exposure-outcome OR, in the 
presence of unmeasured confounding this will be impossible using methods to correct for 
measurement error. When comparing two estimates, the term more extreme will be used to refer 
to the fact that one estimate is further from the true exposure-outcome OR than the other, 
regardless of the direction of the estimated effect. 
Due to the complexity of the tables presented in this chapter, where examples are given in the 
text the relevant results in the tables will be labelled. 
5.2.2. Simulated datasets 
The datasets were simulated in the same way as described in Section 3.2.2. Briefly, the datasets 
consisted of an exposure and either two or four confounders, all with standard normal 
distributions. The exposure-outcome log OR was zero, while the confounder-outcome log ORs 
were ln2 per standard deviation increase for all confounders. Datasets in which the exposure 
was causally related to the outcome were not simulated. The correlations between the exposure 
and each confounder was 0.1,0.3 or 0.5, and the correlations between pairs of confounders was 
either 0 or 0.5. If four confounders were simulated, the correlations between pairs of 
confounders were equal for all pairs. Measurement error was introduced into the exposure and 
each confounder to generate intra-class correlation coefficients (ICCs) of either 0.75 or 0.5, 
which correspond to error variances of 1/3 or 1 respectively. justification for these choices of 
correlations and ICCs was provided in Section 3.2.2. For simulations in which the exposure was 
measured with error, the error-prone exposure variable was transformed to have variance equal 
to one. The estimated exposure-outcome ORs can then be interpreted as the OR per standard 
deviation increase in the error-prone exposure variable. The binary outcome was generated by 
simulating a Bernoulli trial for each observation in the dataset, using the probability of outcome 
defined by the logistic regression model. For each simulated dataset, 500,000 observations were 
generated. Following simulation of the datasets, SimEx or regression calibration was used to 
correct the estimates for exposure measurement error and residual confounding. This 
simulation and correction process was repeated 50 times for each combination of correlations 
between explanatory variables. The ORs presented in this chapter are the geometric means of 
the corrected ORs from each of the 50 repetitions. Fifty simulations each of 500,000 
observations resulted in small 95% simulation intervals around the geometric means, with 
widths no more than 0.014. 
5.2.3. Simulation-extrapolation 
The SimEx method was originafly proposed by Cook and Stefanski. 81 First, the observed data is 
used to estimate the uncorrected parameter estimates, and if necessary the measurement error 
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variances. Pseudoerrors are then generated to be mutually independent, independent of the 
observed data and the true underlying variables, and identically distributed standard normal 
variables. These pseudoeffors are used to add extra measurement error to the n-dsmeasured 
variables. The amount of measurement error added is defined by a scale factor X and the 
estimated or known measurement error variance. A scale factor of zero corresponds to using 
the observed variables with no change. Scale factors greater than zero correspond to increasing 
amounts of measurement error. The variables with extra measurement error are then used in 
the required regression analysis to obtain an estimate of the parameter of interest. 
The parameter estimates for increasing amounts of measurement error can then be used to 
extrapolate back to the parameter that would be estimated if there was no measurement error. 
This corresponds to. %=-l. There are many forms that the extrapolant function can take. Hardin, 
Schmiediche and Carroll'44have written a Stata command, simex, which implements the SimEx 
method for generalised linear models with measurement error. The command allows use of 
quadratic, rational linear, and simple linear extrapolants. The quadratic extrapolant involves 
fitting the following model to the data, where 6 is the estimated parameter of interest from the 
error-prone data. 
0-40 +01"P21ý1 
The rational linear extrapolant takes the following forra: 
6=00+ pi P2+1' 
and the simple linear extrapolant is the following: 
O=Po +plx. 
The corrections in this chapter used the quadratic extrapolant. 
For each value of the scale factor, the pseudoerrors are generated B times, and the estimate of 
the parameter of interest is taken to be the mean of the parameters obtained from each of the B 
repetitions. In this chapter, B was equal to 50. This process is repeated for increasing values of 
the scale factor. 
The SimEx method for the datasets containing 5W, 000 observations is computationally 
intensive. Simulations are therefore not performed for correlations between pairs of 
confounders of 0.1, O. Z 03 or 0.4. In addition, for simulations with four confounders, the 
correlation between exposure and X3 is fixed to be 0-5, and the correlation between exposure 
and X4 is set to be 03. These values correspond to the values used for the results presented in 
Chapter 3. 
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5.13.1 Example analysis 
Table 5.1: Examvle data from a simulation 







1 0 -1.85 -0.0039 1.21 0.21 
2 0 0.44 -0.049 -1.13 -0.41 
3 0 2.12 -1.64 -1.08 -0.58 
4 1 0.33 0.50 1.21 0.68 
5 0 -0.69 -1.30 -1.44 -1.05 
6 0 1.27 0.63 0.55 0.59 
7 0 -0.43 -1.02 0.58 -0.11 
8 0 -1.75 -0.062 -0.048 -0.30 
9 0 -0.49 0.26 -0.84 -0.34 
10 1 0.77 -0.24 1.11 0.50 
11 0 1.61 0.84 1.91 1.25 
12 0 -1.37 -0.16 2.19 0.64 
13 1 1.26 0.31 1.90 1.05 
14 0 0.69 -1.89 -2.02 -1.25 
15 0 0.79 1.06 -0.22 0.33 
16 0 -1.07 -0.57 -0.76 -0.63 
17 0 1.47 1.90 -0.29 0.64 
18 0 -1.97 0.53 0.22 -0.057 
19 0 1.81 -0.11 0.27 0.35 
20 0 -0.55 -0.56 0.59 0.00014 
a This column does not relate to the example of SimEx correction, but shows the estimated values of the 
perfectly measured confounder 2 from the example analysis using regression calibration correction 
described in Section 5.2.4.1. 
Table 5.1 shows the first 20 observations from a simulated dataset of 500,000 observations with 
two confounders in which confounder 2 is measured with error, with an ICC of 0.5. The 
exposure and confounders are all standard normal variables. The correlation between the 
exposure and confounder 1 is 0.1, the correlation between exposure and confounder 2 
(measured without error) is 0.3, and the correlation between the two confounders (measured 
without error) is 0.5. The true exposure-outcome OR is one, and the ORs between the perfectly 
measured confounders and outcome are both two. A logistic regression analysis to estimate the 
association between exposure and outcome, adjusting for confounder 1 and the error-prone 
measurements of confounder Z gives an estimated exposure-outcome OR of 1.12. 
Figure 5.1 shows the simulation-extrapolation results for this example dataset. The naive point 
estimate is plotted at the value X=O. Measurement error is then added to confounder Z and the 
point estimate plotted at values of X greater than one. These values are then extrapolated back 
to the value X=-1 to provide the SimEx estimate of the exposure-outcome OR of 1.07. 
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NaYve estimated odds ratio: 1.12 SIMEX corrected odds ratio: 1.07 
5.2.4. Regression calibration 
The regression calibration method used in this chapter is the one described by Carron and 
Stefanski-70 The basis of this method is to estimate the values of the unobserved true covariates, 
based on the values of the mismeasured covariate and any perfectly measured covariates. The 
estimated values of the unobserved variables are then used in a regression analysis to provide 
an estimate that is corrected for measurement error. 
The unobserved variables, X, are estimated by the following equation: 




where W denotes the observed error-free variables, ii. is the mean of the repeated 
measurements of the error-prone observed variables, ttx is the mean of variable X, Exw is the 
variance-covariance matrix between variables X and W, Euu is the covariance matrix of the 
measurement errors, and k is the number of repeated measurements of the error-prone 
variables. If there is only one measurement of an error-prone variable available in the dataset, 
k=1 and Zi. is replaced by Z. For the analysis in this chapter, the error variance was known, 
and there was a single replicate of each error-prone variable. Note that not all parameters in 
Equation 5.1 are observed, because X is unobserved. The variance-covariance matrices are 
replaced by matrices estimated using the observed variables. The mean of the unobserved 
variables, gX, is replaced by Az, because the measurement error is assumed to be random, and 
therefore the expected values of the measurement errors is zero. Calculation of the estimated 
covariance matrices is described below for the situation in which there is a single measurement 
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of the error-prone variables and the covariance matrix of the measurement errors is known. 







the estimated variance-covariance matrix between the unobserved and observed perfectly 
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The unobserved perfectly measured variables are therefore estimated using the following 
equation: 
R. AZ+ (iiw.. 
X), 
(t. + FIUU 
ixw )-' ( 
Zi -Az iwx 2 
%VW 
wi 
-aw) These equations are similar to those given in Hardin, Schn-dediche and Caffoll145 and Carroll, 
Ruppert and Stefanski, 65 with differences due to notation and the fact that in the analysis 
presented in this chapter, k=1 and the measurement error variance-covariance matrix is known. 
The Stata command rcal, written by Hardin, Schmiediche and Carroll, 145 is used to correct the 
simulation studies for residual confounding. 
5.2.4.1 Example analysis 
The same dataset is used for this example analysis as for the example SimEx analysis described 
in Section 5.2.3.1. Table 5.1 shows the first 20 observations of the simulated dataset. A logistic 
regression analysis to estimate the association between exposure and outcome, adjusting for 
confounder 1 and the error-prone measurements of confounder Z gives an estimated exposure- 
outcome OR of 1.12. The final column in Table 5.1 shows the values of confounder 2 estimated 
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A logistic regression analysis to estimate the association between exposure and outcome, 
adjusting for confounder 1 and using the estimated values of confounder 2 rather than the 
effor-prone measurements, gives an estimated exposure-outcome OR of 1.01. 
5.3. Results 
5.3.1. Two confounders 
In this section, the results for simulations with two confounders, which may be measured with 
error or omitted from the regression analysis, are presented. Throughout this section the 
exposure is assumed to be measured without error. 
Simulation-extrapolation 
Table 5.2 shows the results of SimEx correction for the case in which the confounders are 
uncorrelated. The bold numbers are the SimEx corrected estimates, while the numbers in italics 
are the nave estimates (as shown in Table 3.1). For analyses in which the confounder or 
confounders were not measured with error, the SimEx corrected estimate was not calculated. 
This is indicated in Table 5.2 by dashes. 
The SimEx corrected estimate is always less biased than the na*fve estimate. However, the 
SimEx method very rarely removes all of the bias due to residual confounding. Out of the 90 
pairs of na*fve and SimEx corrected estimates presented in Table 5. Z only two of the SimEx 
corrected estimates have removed all bias. It is not surprising that in analyses in which only ZI 
was controlled, the SimEx method does not remove all bias. In these analyses, the bias is due to 
both residual and unmeasured confounding. The SimEx method only attempts to correct for 
the confounder measurement error that results in residual confounding of the exposure- 
outcome OF. 
Considering the SimEx corrected estimates only, bias is increased by uruneasured confounding, 
more measurement error (lower ICC) in the confounders, and by greater correlation between 
the exposure and the perfectly measured confounders. These patterns are the same as those 
observed for the nave estimates presented in Table 3.1. 
Table 53 shows the results of SimEx correction when the confounders have a correlation of 0.5. 
Again, the bold numbers are the SimEx corrected estimates, the numbers in italics are the naive 
estimates (as shown in Table 3.2), and a dash indicates analyses in which SimEx correction was 
not used. 
The SimEx corrected estimates are generally less biased than the naTve estimates. There is, 
however, one exception to this rule. Consider when the correlation between E and Xi is 0.5, the 
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correlation between E and X2 is 0.1, and the ICC of Zi is 0.75. In the nave analysis, the OR 
when adjusting for Z, only is 1.03 (labelled a in Table 5.3). The SimEx corrected estimate, 
however, is 0.92 (labelled b in Table 5.3). This corrected estimate is more extreme than the nal've 
estimate, and the effect is in the opposite direction. This is, however, not an overcorrection by 
the SimEx method, because the corrected estimate of 0.92 is intermediate between the na7fve 
estimate of 1.03 and the estimated OR of 0.88 (labelled c in Table 5.3) which is not subject to 
residual confounding by X, but is biased by unmeasured confounding by X2. 
Generally, the SimEx corrected estimate is intermediate between the naYve estimate and the 
estimate that would be obtained in the absence of residual confounding. There is one exception 
to this rule, where the SimEx method overcorrects the nave estimate. Consider when the 
correlation between E and X, is 0.5, and the correlation between E and X2 is 0.1. For analyses in 
which both confounders are controlled for, when the ICC of ZI is 0.75 and the CC Of Z2 is 0-5 
the na*fve estimate equals 1.07 (labelled d in Table 5.3). The SimEx corrected estimate in this 
situation is 0.99 (labelled e in Table 5.3), which is further from the nave estimate than the true 
exposure-outcome OR of 1.00. This overcorrection is, however, very small. 
The SimEx method seems to be slightly better at correcting for measurement error when the 
confounders are correlated than when the confounders are uncorrelated. In Table 5.3, seven of 
the Sim. Ex corrected estimates have completely removed the bias observed in the nal*ve 
estimate. 
Considering the SimEx corrected estimates only, in general bias in the estimates increases with 
unmeasured confoundin& increasing measurement error in the confounders (decreasing ICC), 
and increasing correlation between E and the perfectly measured confounders. There are, 
however, exceptions to all of these generalisations, as was also the case with the results 
presented in Table 3.2. The bias in the SimEx corrected estimates may decrease as ururneasured 
confounding, measurement error in the confounders, or the correlation between the 
confounders and exposure increases. 
Correcting for measurement error using SimEx with the rational linear extrapolant was 
investigated in a simulation study limited to the situation in which the correlation between 
exposure and each confounder is 0.5, and both confounders are included in the analysis and 
have an ICC of 0.5. When the confounders are uncorrelated, SimEx correction with the rational 
linear extrapolant overcorrects for measurement error and produces an estimated exposure- 
outcome OR of 0.37. Table 5.2 shows that the neve estimated exposure-outcome OR in this case 
is 1.56, while the SimEx corrected estimate, using the quadratic extrapolant, is 1.37. The SimEx 
corrected estimate when using the rational linear extrapolant is more extreme than the corrected 
estimate using the quadratic extrapolant and the na*fve estimate. When the correlation between 
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the confounders is 0.5, the SimEx corrected estimate using the rational linear extrapolant is 0.89. 
The SimEx corrected estimate using the quadratic extrapolant in this case is 1.19, while the 
naYve estimate is 139 (see Table 53). The overcorrection. of measurement error when using the 
rational linear extrapolant is not as severe when the confounders have a correlation of 0.5 as 
when the confounders are uncorrelated. In neither of these situations, however, has the SimEx 
method recovered the true exposure-outcome OR of 1.00. 
Figure 5.2 shows the results of using SimEx with the rational linear extrapolant for a single 
simulated dataset from the analysis in which the correlation between exposure and each 
confounder is 0.5, and both confounders are included in the analysis and have an ICC of 0.5. 
For this particular simulated dataset, the naive exposure-outcome OR is 1.56 and the SimEx 
corrected OR is 0.41. Considering the estimated exposure-outcome log ORs for X. -! O, increasing 
measurement error in the confounders has a small effect on the estimated exposure-outcome log 
OR. This may be the reason that the rational linear extrapolant does not provide an adequate 
correction for measurement error in this analysis, as the parameters of the extrapolant function 
may be nearly unidentifiable. 65 
Figure 5.2: Results of simulation extrapolation using the rational linear extrapolant for a single 
simulated dataset with two confounders in which the correlations between the exposure and the 
confounders are 0.5, the correlation between the confounders is zero, and both confounders are measured 





x SIMEX Estimate 
0 
NaYve estimated odds ratio: 1.56 SIMEX corrected odds ratio: 0.41 
53.12 Regression calibration 
Table 5.4 shows the results of regression calibration correction for simulations with two 
uncorrelated confounders. 
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Correctingfor measurement error in explanatory variables 
The regression calibration method removes all bias when both confounders are included in the 
analysis. Regression calibration occasionally overcorrects for measurement error when only 
one confounder is included in the analysis. This can be seen when the regression calibration 
corrected estimate is less than the na*fve estimate with a perfectly measured confounder. The 
overcorrection, however, is small, with a difference between the nal've estimate and the 
regression calibration estimate of 0.01. The corrected estimates are still biased by unmeasured 
confounding. This is expected, as the regression calibration method only corrects for 
measurement errors. 
Table 5.5 shows the results of regression calibration correction when the two confounders have 
a correlation of 0.5. Again, regression calibration correction removes all bias due to residual 
confounding when both confounders are included in the analysis. When only one confounder 
is included in the analysis, the regression calibration method tends to overcorrect more 
frequently when the confounders are correlated than when they are uncorrelated. In Table 5.4, 
five of the regression calibration corrected estimates when one confounder is included in the 
analysis are overcorrected for measurement error, compared with ten in Table 5.5. The size of 
the overcorrection may also be larger when the confounders are correlated than when the 
confounders are uncoffelated. The largest overcorrection observed in Table 5.4 results in a 
difference between the regression calibration corrected estimate and the estimate obtained in 
the absence of measurement error of 0.01. Consider, for example, the situation where the 
correlation between E and X, is 0.1 and the correlation between E and X2 is 0.5. When only Zi is 
included in the analysis and is measured without error (ICC=1), the estimated exposure- 
outcome OR is 1.40 (labelled a in Table 5.4). The naYve estimate when Zi is measured with ICC 
equal to 0.5 is 1.43 (labelled b in Table 5.4), which is larger than the estimate obtained without 
measurement error. The regression calibration corrected estimate when the ICC of Z, equals 0.5 
is 1.39 (labelled c in Table 5.4), which is smaller than the naYve estimate when Zi is measured 
without error. In comparison, the corresponding regression calibration corrected estimate in 
Table 5.5 is 1.33 (labelled a in Table 5.5), compared with a nave estimated OR of 1.36 (labelled b 
in Table 5.5) when the confounder is measured without error, and a naYve estimated OR of 1.39 
(labelled c in Table 5.5) when the ICC of Z, equals 0.5. The overcorrection in this situation 
results in a difference between the regression calibration corrected estimate and the estimate 
obtained in the absence of measurement error of 0.03. 
5.3.2. Four confounders 
The results of simulations with four confounders are now presented. For all of the results 
displayed in this section there are at least two unmeasured confounders, and the remaining two 
confounders may be either measured with error or omitted from the analysis. Once again, the 
exposure is assumed to be measured without error. The results in this section are only briefly 
described as residual confounding is relatively unimportant when compared with the effect of 
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uruneasured confounding in this situation, and therefore the correction methods wiR never 
recover the true exposure-outcome OR of 1.00. 
5.3.2.1 Simulation-extrapolation 
Table 5.6 and Table 5.7 show the SimEx corrected results for simulations in which the 
correlation between the confounders is zero or 0.5 respectively. The bold numbers show the 
SimEx corrected estimates, with the corresponding nalfve estimates in italics. Analyses in which 
SimEx correction was not used, because there was no measurement error in the confounders 
included in the analyses, are indicated by a dash. 
Only very rarely does the SimEx method remove all of the bias due to residual confounding. 
Generally, the SimEx corrected estimate is intermediate between the naYve estimate and the 
estimated OR in the absence of residual confounding. When the confounders are uncorrelated, 
this means the SimEx corrected estimates are closer to the true exposure-outcome OR of 1.00 
than then naYve estimates. For correlated confounders, this is not necessarily the case, and the 
SimEx corrected estimates may be more extreme than the naYve estimate. There are examples of 
overcorrection of the nalve estimate when the confounders are correlated, where the SimEx 
corrected estimates are further from the naYve estimate than the estimate obtained in the 
absence of residual confounding, but these instances are rare. 
Correcting for measurement error using SimEx with the rational linear extrapolant was 
investigated in a simulation study limited to the situation in which the correlation between 
exposure and X1, X2 and X3 is 0.5, the correlation between exposure and X4 is 0.3, and ZI and Z2 
are included in the analysis and have an ICC of 0.5. When the confounders are uncorrelated, 
SimEx correction with the rational linear extrapolant overcorrects for measurement error and 
produces an estimated exposure-outcome OR of 2.44. Table 5.6 shows that the naive estimated 
exposure-outcome OR in this case is 3.14, while the SimEx corrected estimate, using the 
quadratic extrapolant, is 3.06. The SimEx corrected estimate when using the rational linear 
extrapolant is further from the exposure-outcome OR of Z88 obtained when the confounders 
are measured without error than the corrected estimate using the quadratic extrapolant and the 
nal've estimate. When the correlation between the confounders is 0.5, the SimEx corrected 
estimate using the rational linear extrapolant is 0.94. The SimEx corrected estimate using the 
quadratic extrapolant in this case is 1.43, while the nalive estimate is 1.71 (see Table 5.7). The 
overcorrection. of measurement error when using the rational linear extrapolant is not as severe 
when the confounders have a correlation of 0.5 as when the confounders are uncorrelated, and 
produces a corrected estimate that is closer to the estimate obtained when the confounders are 
measured without error than the SimEx corrected estimate using the quadratic extrapolant, or, 
the na7fve estimate. 
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Correctingfor measurement error in explanatory variables 
5.3.2.2 Regression calibration 
Table 5.8 and Table 5.9 show the regression calibration corrected results for simulations in 
which the correlation between the confounders is zero or 0.5 respectively. The bold numbers 
show the regression calibration corrected estimates, with the corresponding nalVe estimates in 
italics. Analyses in which regression calibration correction was not used, because there was no 
measurement error in the confounders included in the analyses, are indicated by a dash. 
In contrast with the results observed for the SimEx corrected estimates, in general the regression 
calibration method overcorrects the nave estimate when there are unmeasured confounders. 
This results in regression calibration corrected estimates that are further from the naYve estimate 
than the estimate obtained when the confounders are measured without error. When the 
confounders are uncorrelated, the regression calibration corrected estimates are therefore 
generally closer to the true exposure-outcome OR of 1.00 than the naive estimate. Consider, for 
example, the situation in Table 5.8 when the correlations between the exposure and X1, and 
between the exposure and X2, are 0.1. When both ZI and Z2 are included in the analysis, and 
both are measured with ICC equal to 0.5, the naYve estimate is 1.73 (labelled a in Table 5.8). The 
regression calibration corrected estimate is 1.64 (labelled b in Table 5.8), which is closer to the 
true exposure-outcome OR of 1.00 than the naY`Ve estimate, but further from the naYve estimate 
than the estimate of 1.68 (labelled c in Table 5.8) obtained when both confounders are measured 
without error. Regression calibration has overcorrected the naive estimate, but the result is a 
corrected estimate that is closer to the true exposure-outcome OR and therefore the 
overcorrection may not be considered a problem. 
It is also possible for the regression calibration corrected estimates to be further from the 
estimate obtained in the absence of measurement error than the naive estimate. This occurs, for 
example, in Table 5.9 when the correlations between each confounder and the exposure are 0.1. 
When both Zi and Z2 are adjusted for in the analysis, the estimate obtained in the absence of 
measurement error is 1.54 (labelled a in Table 5.9). When both confounders are measured with 
error with an ICC of 0.5, the naive estimate is 1.53 (labelled b in Table 5.9). In this situation, the 
regression calibration corrected estimate is 1.43 (labelled c in Table 5.9), which is further from 
the estimate obtained in the absence of measurement error than the naive estimate. The 
regression calibration corrected estimate is, however, closer to the true exposure-outcome OR 
than either the estimate obtained in the absence of measurement error or the naive estimate. 
The fact that the regression calibration method has adjusted the estimate away from the 
estimate obtained in the absence of measurement error may not, therefore, be considered a 
problem. 
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extreme than the naYve estimate. This occurs, for example, in Table 5.9 when the correlation 
between exposure and X, is 0.5 and the correlation between exposure and X2 is 0.1. When Zi 
and Z2 are included in the analysis, and measured with ICCs of 1 and 0.5 respectively, the nalve 
estimated OR is 1.22 (labelled d in Table 5.9). The regression calibration corrected estimate is 
1.38 (labelled e in Table 5.9), which is intermediate between the na*ive estimate and the estimate 
of 1.42 (labelled f in Table 5.9) obtained when Z, and Z2 are measured without error. In this 
situation, regression calibration has not overcorrected for measurement error, but the corrected 
estimate is further from the true exposure-outcome OR of 1.00. 
From the results presented in this section, overcorrection appears more likely when the effects 
of residual and unmeasured confounding all act in the same direction. The correlation structure 
of the datasets simulated for this chapter means that the effect of residual and unmeasured 
confounding acts to increase the exposure-outcome OR away from the true exposure-outcome 
OR when the partial correlations between the exposure and confounders are positive. When the 
confounders are correlated, it is possible for the partial correlations between the exposure and 
confounders to become negative (as shown in Chapter 3) and the effect of residual confounding 
then acts to decrease the estimated exposure-outcome OR. In this situation, regression 
calibration has produced a corrected estimate that is intermediate between the na7fve estimate 
and the one obtained in the absence of measurement error. 
Consider the example provided by Armstrong33 for the effects of measurement error and 
unmeasured confounding on the estimated exposure-outcome relative risk (RR) (see Section 2.5 
and Equation 2.3). To correct for the effects of exposure measurement error, assuming no 
unmeasured confounding, the regression calibration procedure is equivalent to dividing the 
2 
naYve exposure effect estimate, PE, by the ICC of exposure, R where C; 2 is the variance 2E CIZE 
of the perfectly measured exposure, and cr 
2 is the variance of the imperfectly measured ZE 
exposure. 65 The corrected exposure-outcome effect estimate is 
. 
RE,, Crz x Equation 5.2: PCEOrl - PE +' PIP R Rc; 2zE 
where R Ell is the conditional reliability of the exposure given the confounder, and CFZEIXI 
is the 
covariance between the error prone exposure measurements and the confounder. The 
circumstances in which correcting for exposure measurement error will result in overcorrection 
of the naYve estimate, corrected estimates that are intermediate between the naYve estimate and 
the estimate obtained in the absence of measurement error, or corrected estimates that are 
further from the estimate obtained in the absence of measurement error than the naYve estimate 
can be derived from Equation 2.3 and Equation 5.2. Generally, R, 41 ý: R, with equality only if 
both the exposure and the confounder are measured without error. If CE, X, denotes the 
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covariance between the perfectly measured exposure and the confounder, overcorrection, when 
the corrected estimate is further from the na*fve estimate than the estimate obtained in the 
absence of measurement error, occurs when 
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Corrected estimates that are intermediate between the na7fve estimate and the estimate obtained 
in the absence of measurement error occur when 
crz"x, Ra 2 cr _2 Equation 5.4: P, and PE 
Zle E, X, 
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The final option is that the corrected estimate is further from the estimate obtained in the 
absence of measurement error than the naYve estimate. This will occur when 
22 
CFZ,,, X, GECFZ,, X, -. CTZ, CYE, X, Equation 5.5: 2. 
P, < PE < (1-R 22 
PI, or 
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Even in this relatively simple example of the effect of correcting for exposure measurement 
error in the presence of a single unmeasured confounder, there is a complex relationship that 
determines whether overcorrection occurs or not. In situations with more confounders the 
relationship between the nalive estimate, the corrected estimate and the estimate obtained in the 
absence of measurement error is likely to be even more complex, and predicting when 
overcorrection will occur will be difficult. Note that the relationships that have been derived 
above do not exactly apply to parameter estimates from a logistic regression analysis, but if the 
outcome is rare, the effects of measurement error and correction on the parameter estimates are 
likely to be close to those described above. The overcorrection of the exposure-outcome OR 
when using regression calibration observed in this chapter is therefore likely to be due to the 
correlation structure of the simulated datasets, and different correlation structures may produce 
corrected estimates that are more likely to be intermediate between the na*fve estimate and the 
estimate obtained in the absence of measurement error. Different correlation structures may 
also result in a greater frequency of corrected estimates that are more extreme than the nayve 
estimates. 
5.3.3. Exposure measured with error 
In this section, corrected exposure effect estimates from simulations in which the exposure was 
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measured with error, with either an ICC of 0.75 or 0.5, are presented. Only simulated datasets 
with two confounders are presented, as residual confounding in simulations with four 
confounder is relatively unimportant when compared with the effects of unmeasured 
confounding. In addition, only regression calibration corrected estimates are presented, as the 
previous sections have shown that SimEx in general does not remove all of the bias due to 
measurement error. 
Table 5.10 and Table 5.11 show the regression calibration corrected estimates when the 
confounders are uncorrelated and the ICC of exposure is 0.75 and 0.5 respectively. Table 5.12 
and Table 5.13 show the regression calibration corrected estimates when the correlation 
between the confounders is 0.5 and the ICC of exposure is 0.75 and 0.5 respectively. The bold 
numbers show the regression calibration corrected estimates, with the corresponding na7ive 
estimates in italics. These four tables show that, if all confounders are included in the 
regression analysis, regression calibration corrects perfectly for the effects of measurement error 
in the exposure and confounders and produces estimates that are equal to the true exposure- 
outcome OR. When there are unmeasured confounders, the method generally overcorrects for 
the effects of measurement error and results in regression calibration corrected estimates that 
are further from the nali've estimate than the estimate that would be obtained in the absence of 
measurement error. When the effects of measurement errors in the different variables act in 
different directions, overcorrection can also result in corrected estimates that are further from 
the estimate that would be obtained in the absence of measurement error than the naYve 
estimate. This can be seen, for example, in Table 5.11. When the correlation between E and X1 
is 0.3 and the correlation between E and X2 is 0-1. the estimate obtained in the absence of 
measurement error when only Xi is included in the analysis is 1.08 (see Table 5A). The naNe 
estimate when the ICC of Z, is 0.75 is 1.09 (labelled a in Table 5.11), while the regression 
calibration corrected estimate is 1.11 (labelled b in Table 5.11). In this situation, overcorrection 
of the effect of measurement error in the exposure has increased the regression calibration 
corrected estimate, and has outweighed any effect of correcting for measurement error in Zi. 
In the four tables presented in this section, correcting for measurement error in the exposure has 
resulted in a corrected crude OR that is more extreme than the nave OR. This demonstrates the 
importance of considering the effects of measurement error in, or omission of, all of the relevant 
variables. When there is residual and/or unmeasured confounding, and the exposure is 
measured with error, the na*fve estimate is not necessarily closer to the null value than the true 
exposure-outcome OR. Correcting for exposure error alone, may result in corrected estimates 
that are further from the true estimate than the na7fve estimate. Davey Smith and Phillips'46 also 
made the point that if measurement error correction is used, then it should be used to correct 
for the effects of measurement errors in the exposure and the confounders, rather than for only 
errors in the exposure. 
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5.4. Discussion 
Summary of results 
In this chapter, SimEx and regression calibration were used to correct some of the estimates 
obtained from the na*fve analyses presented in Chapter 3 for measurement error. 
Simulation-extrapolation removed some of the residual confounding bias from the naYve 
estimates. Full correction, however, was rarely observed. Carroll, Ruppert and Stefanski6s 
noted that using the quadratic extrapolant tends to produce conservative corrections for the 
effects of measurement error. This may explain the results seen in this chapter. Cook and 
Stefanski8l provided an example showing successful correction for the effects of measurement 
error in a logistic regression model when using the rational linear extrapolant, with the 
quadratic and linear extrapolants providing conservative corrections. A limited number of 
simulations were performed to investigate the effect of using SimEx with the rational linear 
extrapolant, and this method appeared to overcorrect the estimates, with the overcorrection 
being worse when the confounders were uncorrelated and producing corrected estimates that 
were no closer to the estimate obtained in the absence of measurement error than the SimEx 
corrected estimate using the quadratic extrapolant, or the naYve estimate in which no 
consideration is given to the effects of measurement error. 
The trends observed in the SimEx corrected estimates were driven by the underlying structure 
of the confounding. This means that the observed trends in the estimated exposure-outcome 
OR shown in Chapter 3 were still observed for the SimEx corrected estimates. The SimEx 
method very rarely resulted in an overcorrection of the naYve estimates, where the SimEx 
corrected estimates were further from the naYve estimate than the estimate obtained when the 
confounders were measured without error. This may also be due to using the quadratic 
extrapolant, as overcorrection is less likely when the correction for measurement error is 
conservative. 
Regression calibration was extremely successful in correcting for measurement error of the kind 
generated in the simulation studies when there was no unmeasured confounding. In contrast 
with the SimEx corrected estimates, the regression calibration commonly overcorrected for the 
effects of measurement error when there were unaneasured confounders in the analysis. The 
expressions derived in Equation 5.3, Equation 5.4 and Equation 5.5 indicate that the 
circumstances under which overcorrection occurs has a complex relationship with the 
covariance structure of the data. In the simulations considered in this chapter overcorrection 
may be considered a minor issue, as it generally results in corrected estimates that are closer to 
the true exposure-outcome OR. 
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For both methods, correction may result in a corrected estimate that is further from the true 
exposure-outcome OR than the naYve estimate when the confounders are correlated. This is due 
to the effects of negative partial correlations between the exposure and confounders, described 
in Chapter 3, where residual confounding acts to decrease the overall bias in the estimated 
exposure-outcome OR. The correction methods will therefore attempt to counteract this effect, 
and the corrected estimates will be more biased than the naYve estimates, when compared with 
the true exposure-outcome OR. 
5.4.2. Strengths and weaknesses 
Only one example of a simulation study comparing regression calibration and SiMEx was 
located in the published literature. 83 The results presented in this chapter extend the results for 
additive measurement error presented by Fung and Krewski83 to the situation with multiple 
explanatory variables measured with error, and to cases in which there are urumeasured 
confounders. In this chapter, the performances of both Sin-tEx and regression calibration as 
measurement error correction methods have therefore been investigated in situations closer to 
those that would be observed in a real-life epidemiological study, where there are likely to be a 
large number of confounders. 
The measurement error generated in these simulation studies had a simple structure. Errors 
were assumed to be random, non-differential and normally distributed with no correlation 
between the errors or other variables. The results presented in this chapter are therefore only 
applicable to this situation, and generalisations should not be made about the performance of 
either regression calibration or SimEx when the errors do not follow the structure of the 
simulations. 
Cook and Stefanski8l recommend using a rational linear extrapolant. Due to the instability of 
this extrapolant function (see Section 4.3.1.2), and the large number of simulations required to 
produce the results in this chapter, the quadratic extrapolant function was used instead to 
minimise analysis problems. 
5.4.3. Implications 
Both SimEx and regression calibration are methods applicable to a range of regression models. 
They are also easy to use in Stata, with user-written commands'44,145 available. The results of 
the simulation studies presented here suggest that regression calibration performs better than 
SimEx when there are no unmeasured confounders in the setting of random and non- 
differential measurement error which is uncorrelated with other errors or variables. Regression 
calibration is also much less computationally intensive than SimEx. These facts imply that 
regression calibration is a superior method for measurement error correction in exposures and 
confounders in classical measurement error models, provided there are no unmeasured 
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confounders. Fung and KrewskiS3 also concluded that regression calibration was preferable to 
SimEx for correcting for measurement error in a single explanatory variable. 
5.4.4. Future research 
For simulations in which SimEx was used to correct for measurement error, only the quadratic 
extrapolant was used. The method may have performed better if a different extrapolant, such 
as a non-linear extrapolant, was used, although the limited simulations performed using the 
rational linear extrapolant suggested a tendency to overcorrect for measurement error. Further 
research would be required to investigate this. Only random and non-differential measurement 
errors were considered. Further work would be required to investigate the relative 
performance of these two correction methods in more complex measurement error settings. 
Only corrections for residual confounding and exposure measurement error when there was no 
true association between the exposure and outcome was considered in this chapter. As seen in 
Chapter 3, if the exposure is causally associated with outcome some different trends in the 
estimated exposure-outcome OR can occur. It would therefore be interesting to evaluate the 
two correction methods when the exposure is causally related to outcome. These two 
extensions, however, would not be expected to change the overall trends observed in this 
chapter. In this setting, SimEx would still be expected to correct some, but not all, of the bias 
due to residual confoundin& with observed trends in the corrected estimates driven by the 
residual and unmeasured confounding. Regression calibration would be expected to remove all 
of the bias due to residual confounding when all confounders are included in the analysis, with 
some overcorrection in situations with unmeasured confounders. 
In this chapter, corrections have been based on the known measurement error variances used to 
simulate the datasets. As these are unlikely to be known in an epidemiological study, a further 
extension would be to simulate datasets with an internal or external validation study, or a 
dataset with repeated error-prone measurements, to investigate the performance of regression 
calibration and SimEx in these more complex, but more realistic, settings. 
Chapter 4 showed that there are a wide variety of methods available to correct for measurement 
error in epiden-dological studies. Only two of these methods have been considered in this 
chapter. Other methods could be investigated in a similar way. These methods would also be 
expected to perform well in situations in which there is no unmeasured confounding, but not as 
well when there are unmeasured confounders. 
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Chapter 6. 
Background literature: the association between C-reactive protein 
and coronary heart disease 
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6.1. Introduction 
C-reactive protein (CRP) is a marker of low-grade systen-tic inflammation. It has recently 
received attention in the literature, investigating its association with coronary heart disease 
(CHD) events. One hypothesis is that CRP is a predictor of the stability of atherosclerotic 
plaques. 147 148 It remains uncertain whether CRP is causally linked with CHD events, whether it 
is a marker of sub-clinical disease, or whether the estimated associations are a result of 
measurement error or unmeasured confounding. 
The literature described in this chapter was found by searching Medline for articles with the 
medical subject headings C-reactive protein and coronary disease or cardiovascular diseases. 
Only articles in English were included. Titles and abstracts of the articles were reviewed, and' 
those relevant to this literature review were obtained. Studies on populations with specific 
diseases at baseline, such as diabetes mellitus, were not included. Reference lists of the articles 
obtained were reviewed, and any further papers relevant to this review were acquired. The 
literature below is separated by study type, with sections describing estimated associations 
from cross-sectional studies, nested case-control studies, case-cohort studies, prospective cohort 
studies and meta-analyses. The chapter concludes with a surnmary of the published 
associations. 
6.2. The association between CRP and CHD 
Cross-sectional studies 
Data from the Turkish Adult Risk Factor Study was used by Onat, Sansoy, Yildirim. et aL149 
Analyses included 744 men and women. Adjustment for age, waist circumference, fibrinogen, 
total cholesterol and physical activity resulted in an odds ratio (OR) for prevalent CHD of 4.24 
(1.63-11.04) when comparing the top quartile of CRP with the bottom. Comparing the third 
quartile to the bottom gave an estimated OR for prevalent CHD of Z98 (1.13-7-85), and 
comparing the second quartile to the bottom quartile gave an estimated OR for prevalent CHD 
of 1.47 (0.514.25). In an analyses adjusted for age, sex, height, systolic blood pressure, 
fibrinogen and high density lipoprotein (HDL) cholesterol, the OR for prevalent CHD 
comparing the top quartile to the bottom quartile of CRP was 5.61 (2.04-15.44). Comparing the 
third quartile of CRP with the bottom quartile gave an OR for prevalent CHD of 4.07 (1.45-' 
11.41), and comparing the second quartile of CRP to the bottom quartile gave an OR for 
prevalent CHD of 1.80 (OS9-5.47). 
Jousilahti, Salornaa, Rasi et al. 150 used data from the Finnish Matelet Aggregation and 
Inflammation Study to assess the association between CRP and prevalent CHID. A total of 1,400 
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men were analysed. Tluee models were used to investigate the association between CRP and 
CHD. In model one, analyses were adjusted for age, smoking, cholesterol, blood pressure and 
body mass index (BMI). For this analysis, the OR for CHD comparing the top quartile for CRP 
with the bottom quartile was 2.65 (1.58-4.46). Comparing the third quartile to the bottom 
quartile of CRP gave an OR for CHD of 2.23 (1.31-3.79), and comparing the second quartile of 
CRP to the bottom quartile gave an OR for CHD of 1.90 (1.11-3.25). The p-value for trend in this 
analysis was less than 0.001. Model two adjusted for age, smoking, cholesterol, blood pressure 
and waist circumference. Comparing the top quartile of CRP with the bottom quartile gave an 
OR for CHD of 2.33 (1.36-3.99). Comparing the third quartile of CRP with the bottom quartile 
gave an OR for CHD of 2.05 (1.20-3.50), while comparing the second quartile of CRP with the 
bottom quartile gave an OR for CHD of 1.82 (1.06-3.12). The p-value for trend in this analysis 
was 0.003. The third model adjusted for age, smoking, cholesterol, blood pressure and waist 
hip ratio. Comparing the top quartile of CRP with the bottom quartile gave an OR for CHD of 
2.20 (1.29-3.75). Comparing the third quartile of CRP with the bottom quartile gave an OR for 
CHD of 1.98 (1.16-3.38), while comparing the second quartile of CRP with the bottom quartile 
gave an OR for CHD of 1.80 (1.05-3.08). The p-value for trend for this analysis was 0.006. 
Data from the Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) 
project in Glasgow, Scotland, were used by Woodward, Rumley, Lowe et al. 151 to investigate the 
cross-sectional association between CRP and cardiovascular disease (CVD). A total of 414 men 
and 550 women were analysed. Analyses on men were adjusted for age, total cholesterol, 
triglycerides, diastolic blood pressure, plasma vitamin C, smoking, cotinine and fibrinogen. 
Analyses on women additionally adjusted for menopause and hormone replacement therapy 
(HRT) status, and contraceptive pill use. The OR for prevalent CVD, comparing the top quartile 
of CRP with the bottom, was 1.16 (0.53-2.54) for men and 1.87 (0.90-3.88) for women. 
Comparing the third quartile to the bottom quartile gave and OR for CHD of 1.02 (0.47-2.22) for 
men and 1.27 (0.64-2.52) for women, while comparing the second quartile of CRP to the bottom 
quartile gave an OR for CHD of 0.76 (0.33-1.66) for men and 1.12 (0.56-2.27) for women. The p- 
values for trend were 0.44 for men and 0.09 for women. 
Anand, Razak, Yi et al. 152 investigated the association between CRP and CVD in a sample of 
people with South Asian, Chinese, European or Aboriginal ancestry living in Canada. The 
study included 1,250 people. Logistic regression models were adjusted for age, sex, systolic 
blood pressure, low density lipoprotein (LDL) cholesterol, HDL cholesterol, smoking, diabetes, 
atherosclerosis, waist circumference, BMI, triglycerides and ethnicity. The OR for prevalent 
CHD was 1.03 (1.00-1.06) for a 0.1 mg/L increase in CRP. 
Data from the British Women's Heart and Health Study (BWHHS) was used by Lawlor, Davey 
Smith, Rumley et al. 153 in a cross-sectional analysis. Using data from 2,987 women the 
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association between CRP and prevalent CHD was investigated. Analyses were adjusted for 
age, life course socio-economic position score, behavioural and physiological risk factors, adult 
anthropometry and forced expiratory volume in one second (FEVi). The OR for CHD for a 
doubling of CRP was 1.06 (0.98-1.15). 
The estimated associations described in this section are summarised in Table 6.1. Although 
many of the studies found a positive association between CRP and CHD or CVD, reverse 
causation, where CHD or CVD causes elevated levels of CRP, is a possible explanation for these 
results. 
6.2.2. Nested case-control studies 
A nested case-control study identifies cases and controls from the participants of an already 
existing cohort study or randomised trial. One advantage of this type of case-control study over 
a non-nested case control study is that exposures will often be measured at the beginning of the 
cohort study or randomised trial within which the study is nested, and therefore before the 
onset of disease. This will reduce the potential for recall bias, which may be a major problem in 
non-nested case-control studies. 
The Multiple Risk Factor Intervention Trial (MRFM was a randomised controlled trial in which 
a multifactorial intervention was used to prevent CHD morbidity and mortality in men at high 
risk of CHD but with no clinical evidence of the disease. Kuller, Tracy, Shaten et al. 154 used a 
nested case-control design to investigate the effect of CRP on CHD. The 246 cases comprised 98 
participants who had experienced a non-fatal MI, and 148 participants who died due to CHD. 
The 491 controls were matched with cases by age, smoking status, clinic, and study group 
(intervention or usual care). All analyses were adjusted for age, number of cigarettes smoked 
per day, diastolic blood pressure, triglycerides, LDL cholesterol and HDL cholesterol. The OR 
for CHD death was 2.8 (1.4-5.4) when comparing the top quartile of CRP with the bottom 
quartile. Comparing the third quartile of CRP to the bottom quartile gave an OR for CHD death 
of 2.7 (1.4-5.2), and comparing the second quartile of CRP to the bottom quartile gave an OR for 
CHD death of 1.6 (0.8-3.1). There was little evidence of an association between quartiles of CRP 
and non-fatal MI. Comparing the second quartile of CRP with the bottom quartile gave an OR 
for non-fatal MI of 0.6 (0.3-1.3), comparing the third quartile of CRP with the bottom quartile 
gave an OR for non-fatal MI of 0.9 (0.4-1.9), and comparing the top quartile of CRP with the 
bottom quartile gave an OR for non-fatal MI of 0.8 (0.4-1.7). When the analysis was restricted to 
smokers, the OR for CHD death was 4.3 (1.7-10.8) when comparing the top quartile of CRP with 
the bottom quartile, 3.2 (1.3-7.7) when comparing the third quartile of CRP with the bottom 
quartile, and 1.7 (0.74.3) when comparing the second quartile of CRP with the bottom quartile. 
There was little evidence of an association between quartiles of CRP and non-fatal MI among 
the smokers. The OR for non-fatal MI was 1.0 (0.4-2.5) comparing the top quartile of CRP with 
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the bottom quartile, 1.2 (0.4-3.2) comparing the third quartile of CRP to the bottom quartile, and 
0.7 (0.3-1.9) comparing the second quartile of CRP to the bottom quartile. 
The Cardiovascular Health Study (CHS) was a population based cohort study of CHD and 
stroke in adults aged 65 and over. Tracy, Lemaitre, Psaty et al. 155 used a prospective nested 
case-control study of participants of the CHS to investigate the effect of CRP on incident CHD 
events. A total of 146 cases were matched for sex, presence or absence of sub-clinical disease, 
and duration of follow-up with 146 controls. Statistical analyses accounted for all matching 
factors. The OR for incident CHD was 1.07 (0.52-2.22) for men when comparing the top quartile 
of CRP with the lower three quartfles. For women, the OR for incident CHD was 1.60 (0.73- 
3.53) when comparing the top quartile of CRP with the lower three quartiles. When anaIysing 
only participants with subclinical CVD at baseline, the OR for incident CHD among men was 
1.09 (0.49-2.37) when comparing the top quartile of CRP with the bottom quartile, and the OR 
for incident CHD among women was 2.33 (0.90-6.07) when comparing the top quartfle of CRP 
with the lower three quartiles. 
Tracy, Lemaitre, Psaty et al. 155 also considered a prospective nested case-control study to assess 
the effect of CRP on incident cardiovascular events in the Rural Health Promotion Project. The 
analysis included 145 cases and 146 controls matched for age and sex. For women, the OR for 
incident CHD was 2.7 (1.10-6.69) when comparing the top quintile of CRP with the lower four 
quintiles, and the OR for CHD death only was 3.74 (1.36-10.4) comparing the top quintile of 
CRP with the lower four quintiles. For men, the OR for incident CHD was 2.0 (0.824.87) when 
comparing the top quintile of CRP with the lower four quintiles, and the OR for CHD deaths 
only was 1.4 (0.50-3.95) when comparing the top quintile of CRP with the lower four quintiles. 
The Physicians' Health Study (PHS) was a2 by 2 factorial randomised controlled trial to assess 
the effect of aspirin and beta-carotene on prevention of CVD and cancer. Ridker, Cushman, 
Stampfer et al. 256 used a prospective nested case-control study of participants in the PHS to 
investigate the effect of plasma levels of CRP on incidence of MI, stroke or venous thrombosis. 
A total of 543 cases were matched for age, smoking status, and length of time since 
randorrdsation with 543 controls who had also provided blood samples at baseline. The OR for 
MI was 2.6 (1.6-4.4) when comparing the top quartile of CRP concentration with the bottom 
quartile, 2.4 (1.5-4.0) when comparing the third quartile of CRP with the bottom quartile, and 
1.5 (0.9-2.5) when comparing the second quartile of CRP with the bottom quartile. The p-value 
for trend was less than 0.001. This analysis adjusted for BMI, diabetes, history of hypertension 
and family history of coronary artery disease. No results from analyses in which adjustment for 
confounders was made were presented for the outcomes of stroke or venous thrombosis. 
Ridker, Buring, Shih et al. 157 analysed 122 cases and 244 age and smoking matched controls from 
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the Womenýs Health Study (WHS). The WHS included post-menopausal female health 
professionals, and was a RCr designed to investigate the effect of aspirin and vitamin E on 
CVD and cancer. In models allowing for the matching variables and adjusted for BML diabetes, 
hypertension, exercise, family history of coronary artery disease and treatment assignment, the 
OR for any cardiovascular event comparing the top quartile with the bottom quartile of CRP 
was 4.1 (1.7-9.9). Comparing the third quartile of CRP to the bottom quartile, the OR for any 
cardiovascular event was 23 (1.0,5.6), and the OR for any cardiovascular event was 2.0 (0.8-4.7) 
when comparing the second quartile of CRP to the bottom quartile. The p-value for trend for 
this analysis was 0.001. When the outcome events were restricted to N11 or stroke, the OR for MI 
or stroke was 5.5 (1.8-16.6) when comparing the top quartile of CRP to the bottom quartile. The 
OR for MI or stroke comparing the third quartile of CRP to the bottom quartile was 3.5 (1.1- 
10.4), and comparing the second quartile of CRP to the bottom quartile gave an OR for MI or 
stroke of 2.7 (0.9-8.1). The p-value for trend for this analysis was 0.002. 
Data from the WHS was again used in a nested case-control analysis by Ridker, Hennekens, 
Buring et al. 19 to investigate the association between CRP and cardiovascular events. A total of 
122 cases and 244 age and smoking matched controls were analysed. Analyses accounted for 
the matching variables and were adjusted for random assignment to aspirin or vitamin F, BIM, 
history of hypertension, history of diabetes, parental history of MI and other plasma markers of 
inflammation. For a single quartile increase in CRP, the OR for a cardiovascular event was 1.5 
(1.1-2.1). 
Packard, OReilly, Caslake et aL'59 conducted a nested case-control study within the West of 
Scotland Coronary Prevention Study (WOSCOPS). Tl-ds was a randon-dsed study of 6,595 men 
with LDL cholesterol between 174 and 232 mg/dL at baseline, but with no history of MI, to 
investigate the effect of pravastatin on CHD. The nested case-control study irvJ-uded 580 CHD 
cases, and 1,160 controls matched for age and smoking. Analyses adjusted for age, systolic 
blood pressure, triglycerides, LDL and HDL cholesterol, fibrinogen, white-cell count and 
lipoprotein-associated phospholipase A2. For a standard deviation increase in log CRP, the OR 
for CHD was 1.13 (0.98-129). 
The British Regional Heart Study was a prospective cohort study in which 7,735 men from 24 
British towns were followed up for all-<muse mortality and cardiovascular morbidity. Danesh, 
Whincup, Walker et aL160 used a nested case-control study design to investigate the effect of 
CRP, serum amyloid A protein, leukocyte count, and albumin on cardiovascular death and non- 
fatal MI. A total of 506 cases were matched with 1= controls based on town of residence and. 
age in five year bands. Multivariable analyses controlled for age, town, smoking, blood 
pressure, total cholesterol, HDL cholesterol, BMI, occupation, housing tenure, marital status. car 
ownership, and childhood socioeconomic factors. The OR for CHD was 2.13 (1-38-3.28) 
138 
Literature: 77ze association between CRP and CHD 
comparing the top tertile of CRP with the bottom tertile. When this analysis was restricted to 
men without evidence of CHD at baseline, the OR for CHD was 2.31 (1.42-3.76) when 
comparing the top tertile of CRP to the bottom tertile. The ORs for CHD comparing the middle 
tertile of CRP to the bottom tertile were not presented for either analysis. 
Roivainen, Viik-Kajander, Palosuo et al. 161 used data from the Helsinki Heart Study. This was a 
placebo-controlled RCT of gernfibrozil in dyslipidemic men on the primary prevention of CHD. 
The nested case-control study consisted of 241 cases who had suffered either MI or CHD death, 
matched with 241 controls for treatment group and area of residence. Adjusting for age and 
smoking, the OR for CHD comparing the top quartile of CRP with the bottom quartile was 3.66 
(1.97-6.81). Comparing the third quartile of CRP to the bottom quartile gave an OR for CHD of 
1.57 (0.87-2.82), and comparing the second quartile of CRP to the bottom quartile gave an OR 
for CHD of 0.98 (0.55-1.75). 
Pradhan, Manson, Rossouw et al. 162 conducted a nested case-control study of post-menopausal 
women in the observational study component of the Womenýs Health Initiative. This is a 
prospective cohort study of post-menopausal women, and is designed to investigate the 
association between many risk factors (clinical, socioeconomic, behavioural and dietary) and 
the incidence of several health outcomes, including MI. The nested case-control study consisted 
of 304 cases who had experienced a first MI during follow-up. The 304 controls were matched 
with the cases on age, smoking status, ethnicity and follow-up time. The analyses accounted for 
all matching variables, and additionally adjusted for the ratio of total cholesterol to HDL 
cholesterol, BMI, history of hypertension, family history of premature coronary artery disease, 
diabetes, exercise frequency, alcohol consumption, and use of HRT. The OR for incident MI, 
comparing the top quartile of CRP to the bottom quartile, was 2.1 (1.14.1). Comparing the third 
quartile of CRP to the bottom quartile gave an OR for incident MI of 1.4 (0.7-2.6), and 
comparing the second quartile of CRP to the bottom quartile gave an OR for incident MI of 1.4 
(0.8-2.8). The p-value for trend was 0.046. 
The Rotterdam Study is a prospective cohort study of people 55 years and older, designed to 
investigate risk factors for, and incidence of, chronic disabling diseases. Van der Meer, de Maat, 
Kiliaan et al. 163 conducted a nested case-control study within the Rotterdam Study. The cases 
were 157 people who experienced an MI during follow-up. The 500 controls were randon-dy 
selected from the people who had not had an MI during follow-up, and who had not died. 
Analyses adjusted for age, age squared, sex, current smoking, BMI, hypertension, diabetes 
mellitus, family history of early ML total cholesterol and HDL cholesterol. The OR for incident 
MI, comparing the top quartile of CRP with the bottom quartile, was 1.2 (0.6-2.2). When 
comparing the third quartile of CRP to the bottom quartile, the OR for incident MI was 1.0 (0.5- 
1.9), and when comparing the second quartile of CRP to the bottom quartile, the OR for incident 
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MI was 0.9 (0-5-1.7). The p-value for trend was 0.50. 
The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study is a cohort 
study in France and Northern Ireland to investigate the association between various risk factors 
and CHD. Luc, Bard, Juhan-Vague et al. 164 used a nested case-control study of PRIME 
participants to investigate the effect of CRP, interleukin-6 and fibrinogen on CHD. A total of 
317 cases were matched for recruitment in the same centre and on the same day with 609 
controls. Controls were free of CHD on the date of the event for the case. In a multivariable 
model in which age, diabetes, smoking, hypertension, LDL cholesterol, HDL cholesterol, and 
triglycerides were controlled, the OR for incident CHD was 2.16 (1.26-3.72) when comparing the 
top tertile of CRP with the bottom. Comparing the middle tertile of CRP to the bottom tertile, 
the OR for incident CHD was 0.81 (0.47-1.40). The p-value for trend was 0.002. When 
interleukin-6 and fibrinogen were also included in a logistic regression analysis, with 
adjustment for the same confounders, the OR for incident CHD was 1.02 (0.98-1.06), but the 
increase in CRP to which this relates is not clear. 
Data from the Reykjavik Study, a prospective study of CVD, was used by Danesh, Wheeler, 
Hirschfield et al. 165 in a case-control analysis. A total of Z459 cases with non-fatal MI or fatal 
CHD were matched by calendar year of recruitment, sex, and age with 3,969 controls. Analyses 
were adjusted for age, sex, calendar year of enrolment, smoking, systolic blood pressure, total 
cholesterol level, triglyceride level, BMI, FEVI, diabetes, socio-economic status, erythrocyte 
sedimentation rate and von Willebrand factor level. Comparing the top tertile of CRP with the 
bottom tertile, the adjusted OR for CHD was 1.36 (1.16-1.58). Restricting this analysis to people 
without evidence of CHD at baseline, the OR for CHD was 1.30 (1.10-1.52) when comparing the 
top tertile of CRP to the bottom tertile. The ORs for CHD comparing the middle tertile of CRP 
to the bottom tertile were not presented for either of these analyses. 
Pai, Pischon, Ma et al. 166 used a nested case-control design to investigate the association between 
CRP and CHD in the Nurses' Health Study (NHS), a prospective study of female registered 
nurses in the U. S., and the Health Professionals Follow-up Study (HPFS), a prospective cohort 
study of male health professionals. A total of 239 cases and 469 controls, matched for age, 
smoking status, date of blood sampling and fasting status at the time of blood sampling, were 
identified from the NHS. From the HPFS, 265 cases and 529 controls, matched for age, smoking 
status and date of blood sampling, were identified. Analyses investigating the association 
between quintiles of CRP and CHD were adjusted for the matching factors, parental history of 
CHD before age 60, alcohol intake, physical activity, ratio of total cholesterol to HDL 
cholesterol, BMI, diabetes, hypertension and, for the analyses on women, HRT. Among the 
women, the OR for CHD was 1.61 (0.84-3.07) comparing the top quintile of CHD to the bottom 
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2.30), and the OR for CHD was 0.89 (0.46-1.72) when comparing the third quintile of CRP to the 
bottom quintile. Comparing the second quintile of CRP to the bottom quintile, the OR for CHD 
was 1.23 (0.66-2.32). The p-value for trend was 0.08. In the analyses on men, the OR for CHD 
was 2.55 (1.40-4.65) comparing the top quintile of CRP to the bottom quintile, and the OR for 
CHD was 2.14 (1.18-3.88) comparing the fourth quintile of CRP to the bottom quintile. 
Comparing the third quintile of CRP to the bottom quintile gave an OR for CHD of 1.74 (0.96- 
3.15), and comparing the second quintile of CRP to the bottom quintile gave an OR for CHD of 
1.75 (0.97-3.16). The p-value for trend was 0.02. Analyses were also performed by categorising 
levels of CRP as low risk (< 1.0 mg/L), medium risk (1.0-2.9 mg/L), and high risk (ý: 3.0 mg/L). 
These analyses were adjusted for the same factors as the analysis for quintiles of CRP described 
above. For women, the OR for CHD was 1.53 (0.89-2.62) comparing high risk levels of CRP to 
low risk, and the OR for CHD was 1.17 (0-69-2.00) comparing medium risk to low risk. The p- 
value for trend was 0.09. For men, the OR for CHD was 1.79 (1.14-2.83) comparing high risk 
levels of CRP to low risk, and the OR for CHD was 1.60 (1.09-2.34) comparing medium risk to 
low risk. The p-value for trend was 0.03. In the analysis combining men and women, the OR 
for CHD was 1.68 (1.18-2.38) comparing high risk to low risk, and the OR for CHD was 1.44 
(1.05-1.96) comparing medium risk to low risk. 
The estimated associations described in this section are summarised in Table 6.2. 
6.2.3. Case-cohort studies 
Case-cohort studies are studies in which disease cases from an existing cohort study or 
randomised trial are compared with a random sample of the population at baseline. An 
advantage of this study design is that the same random sample of the study population can be 
used for analyses of several different outcomes. 
Folsom, Aleksic, Catellier et al. 167 used data from the Atherosclerosis Risk In Communities 
(ARIC) study to investigate the association between CRP and incident CHD. A total of 615 
cases occurring between 1987 and 1995 were used. In analyses adjusted for age, sex, ethnicity, 
centre, smoking, total cholesterol, HDL cholesterol, diabetes, systolic blood pressure, use of 
antihypertensives, fibrinogen, white blood cell count, and soluble intracellular adhesion 
molecule-1, the adjusted hazard ratio for CHD comparing the top quintile of CRP with the 
bottom quintile was 1.4 (0.7-2.8). Comparing the fourth quintile of CRP with the bottom 
quintile gave a hazard ratio for CHD of 2.1 (1.1-3.9), and comparing the third quintile of CRP to 
the bottom quintile gave a hazard ratio for CHD of 1.6 (0.9-3.0). The hazard ratio for CHD was 
0.8 (0.5-1.6) when comparing the second quintile of CRP with the bottom quintile. The p-value 
for trend was 0.06. 
ARIC study data was also used by Ballantyne, Hoogeveen, Bang et al. 168 in a case-cohort design 
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to investigate the association between CRP and incident CHD. The analysis included 608 cases 
and 740 non-cases. Levels of CRP were defined as high risk (>3.0 mg/L), medium risk (1.0-3.0 
mg/L) and low risk (< mg/L). Controlling for age, sex, ethnicity, smokin& systolic blood 
pressure, LDL cholesterol, HDL cholesterol and diabetes, the hazard ratio for incident CHD was 
1.72 (1.24-2.39) comparing high risk CRP levels with low risk. Comparing medium risk CRP 
levels to low risk, the hazard ratio for CHD was 1.31 (0.96-1.80). 
The estimated associations between CRP and CHD described in this section are summarised in 
Table 6.3. 
6.2.4. Prospective cohort studies 
Data from the MONICA project in Augsburg, Germany, were used by Koeni& Sund, Frohlich et 
al. 169 to perform a prospective analysis of the effect of CRP on fatal and non-fatal MI. The 
analysis included 936 healthy men. A change in estimate criterion, in which a variable was 
included in the analysis if it changed the hazard ratio by 5% or more, was used to identify 
potential confounders. The hazard ratio for MI for a standard deviation increase in log CRP, 
and controlled for age and smoking, was 1.50 (1.14-1.97). This estimate is likely to be biased by 
unmeasured confounding. As discussed in Chapter 3, the change in estimate criterion is not a 
reliable way to eliminate unmeasured confounding. 
Strandberg and Tilvis'70 used data on 455 people aged either 75,80 or 85 from the Helsinki 
Aging Study to investigate the association between CRP and ten year cardiovascular mortality. 
Adjusting for age and sex, the hazard ratio for ten year cardiovascular mortality was 1.22 (1.10- 
1.35) per 10 mg/L increase of CRP. 
Data from the Caerphilly Prospective Heart Disease Study was used by Mendall, Strachan, 
Butland et al. 171 to estimate the association between CRP and ischaen-dc heart disease (IHD). 
Analyses included 1,395 men, and adjusted for age, BMI, height, FEVI, alcohol, smoking, 
current social class, father's social class, systolic blood pressure, total cholesterol and fibrinogen. 
Comparing the top quintile of CRP to the bottom quintile, the OR for IHD was 0.96 (0.50-1.86). 
The OR for IHD was 1.14 (0.60-2.15) comparing the fourth quintile of CRP to the bottom 
quintile, and the OR for IHD was 0.92 (0.48-1.75) comparing the third quintile of CRP to the 
bottom quintile. Comparing the second quintile of CRP to the bottom quintile gave an OR for 
IHD of 1.11 (0.58-2.10). The p-value for trend was 0.8308. The association between CRP and 
fatal IHD was also investigated. Comparing the top quintile of CRP to the bottom quintile gave 
an OR for fatal IHD of 0.79 (0.34-1.84). The OR for fatal IHD was 1.20 (0.53-2.75) comparing the 
fourth quintile of CRP to the bottom quintile, and the OR for fatal IHD was 0.93 (0.39-2.19) 
comparing the third quintile of CRP to the bottom quintile. Comparing the second quintile of 
CRP to the bottom quintile gave an OR for fatal IHD of 0.72 (0.29-1.76). The p-value for trend 
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was 0.8430. 
Lowe, Yarnell, Run-dey et al. In used data from the SpeedweU study to investigate the association 
between CRP and Hil). Analyses were adjusted for age, whether the blood sample thawed 
during a freezer failure or not, smoking, BNH, diastolic blood pressure, total cholesterol, 
evidence of ischaemia at baseline, fibrinogen and fibrin D-dimer. In an analysis of 1,595 men 
with complete data on aU variables, the OR for IHD was 1A5 (0.79-2.66) comparing the top 
quintile of CRP with the bottom quintile. The p-value for trend was 0.16. The ORS for IM 
comparing other quintiles of CRP with the bottom quintile were not presented. 
Data from the WHS were used by Ridker, Rifai, Rose el aLM to estimate the association between 
CRP and CVD. Analyses included 27,937 women, and were adjusted for age, treatment 
assignment, smoking, diabetes, blood pressure and use of HRT. The hazard ratio for CVD was 
2.3 (1.6-3.4) comparing the top quintile of CRP to the bottom quintile. Comparing the fourth 
quintile of CRP to the bottom quintile gave a hazard ratio for CVD of 2.0 (13-3.0), and 
comparing the third quintile of CRP to the bottom quintile gave a hazard ratio for CVD, of 1.6 
(1.1-2.4). The hazard ratio for CVD was 1A (0.9-2.2) when comparing the second quintile of 
CRP to the bottom quintile. The p-value for trend was less than O. W1. 
Blake, Rifai, Buring et al. 174 also estimated an association between CRP and CVD using data 
from the WHS. Their analysis included 15,215 women who were not using HRT at baseline, 
and adjusted for age, random allocation to aspirin and vitamin E. BML smoking, LDL 
cholesterol, HDL cholesterol, diabetes and blood pressure. The hazard ratio for CVD was 1.44 
(p-value=0.005) when comparing CRP levels 2! 3 mg/L with CRP levels <3 mg/L 
Koenig, Sund, Frohlich ef al. 175 considered the impact of within-subject variation of CRP on the 
estimated association between CRP and CIID using data from the MONICA Augsburg Studies. 
Analyses included 936 subjects. The ICC of CRP was estimated as 0.54, and a Bayesian method 
was used to obtain the estimates corrected for within-subject variation. Adjusting for age and 
BMI, the uncorrected hazard ratio for Clil) was 1.55 (113-1.95) for a unit increase in log CRP. 
Allowing for within-subject variation in CRP, the corrected hazard ratio for CHD was 2.59 (1.61- 
4.16) for a unit increase in log CRP. 
Data from the Heal" Aging and Body Composition (I lealth ABq Study was used by Cessaxý_ 
Penninx, Newman et W76 to investigate the assocUtion between CRP and CVD. The study 
population consisted of 3,045 participants, aged between-M and 79 years at basefine. Analyses 
were adjusted for age, sex, ethnicity, education, smoking, diabetes. hypertension. cancer. BML 
total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides. creatinine. non-steroidal anti- 
inflammatory drugs, angiotensino-converting enzyme irthtibitors and statin use. Participants 
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with subclinical CVD were excluded from analyses with clinical CVD as the outcome. The OR 
for clinical CVD was 1.08 (0.96-1.21) per log 9g/ml increase in CRP. Comparing the top tertile 
of CRP with the bottom tertile gave an OR for clinical CVD of 1.34 (1.03-1.65), and comparing 
the middle tertile of CRP with the bottom tertile gave an OR for clinical CVD of 1.28 (0.99-1.64). 
In a separate publication, Cesari, Penninx, Newman et al. 177 again used data from the Health 
ABC Study to investigate the association between CRP and CHD. Their analysis included Z225 
subjects aged between 70 and 79 at baseline. Analyses adjusted for age, sex, ethnicity, smoking, 
diabetes, hypertension, BMI, HDL cholesterol, triglycerides and albumin. The hazard ratio for 
CHD was 1.13 (0.95-1.35) for a unit increase in log CRP. For a standard deviation increase in log 
CRP, the hazard ratio for CHD was 1.11 (0.96-1.29). Analyses were also conducted in which 
CRP was divided into tertiles. The hazard ratio for CHD was 1.09 (0.76-1.57) comparing the 
middle tertile of CRP to the bottom tertile, and the hazard ratio for CHD was 1.20 (0.83-1.75) 
comparing the top tertile of CRP to the bottom tertile. 
Lowe, Sweetnam, Yamell et al. 178 investigated the association between CRP and IHD using data 
from the Caerphilly and Speedwell prospective cohort studies. The multivariable analysis 
included 3,065 men, and adjusted for age, area, smoking, BMI, diastolic blood pressure, total 
cholesterol, evidence of ischaemia at baseline, fibrinogen and fibrin D-dimer. The OR for IFID 
was 1.51 (0.98-2.33) comparing the top quintile of CRP to the bottom quintile. The p-value for 
trend was 0.093. The ORs for IHD comparing lower quintiles of CRP with the bottom quintile 
were not presented. 
Data from the Strong Heart Study was used by Best, Zhang, Lee et al. 179. The study cohort 
consisted of 3,277 subjects without CVD at baseline. A stepwise selection method was used to 
identify the confounders of the association between CRP and CVD. This resulted in adjustment 
for sex, age, smoking, LDL cholesterol, HDL cholesterol, hypertension and diabetes. The 
hazard ratio for CVD was 1.25 (0.90-1.75) when comparing the top quintile of CRP to the bottom 
quintile. Comparing the fourth quintile of CRP to the bottom quintile gave a hazard ratio for 
CVD of 1.31 (0.95-1.81), and comparing the third quintile of CRP to the bottom quintile gave a 
hazard ratio for CVD of 1.17 (0.84-1.63). The hazard ratio for CVD was 1.0 (0.72-1.40) when 
comparing the second quintile of CRP to the bottom quintile. Analyses were also conducted in 
which subjects with baseline levels of CRP greater than 10 mg/L were excluded, leaving Z735 
subjects for the analysis. The hazard ratio for CVD was 1.63 (1.00-2.67) comparing high risk 
levels of CRP (> 3 mg/L) to low risk (< 1 mg/L). Comparing medium risk levels of CRP (1-3 
mg/L) to low risk, the hazard ratio for CVD was 1.35 (0.82-2.22). 
St-Pierre, Cantin, Bergeron et al. 180 used data from the Qu6bec Cardiovascular Study to 
investigate the association between CRP and IHD. Analyses included 1,982 men who did not 
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have IHD at baseline. In an analysis adjusted for age, BMI, systolic blood pressure, diabetes, 
medication use, LDL cholesterol, HDL cholesterol, triglycerides, fibrinogen and interleukin-6, 
the hazard ratio for incident IHD was 0.70 (0.43-1.13) when comparing the top quartile of CRP 
with the bottom quartile. Hazard ratios for IHD when comparing the second or third quartile 
of CRP with the bottom quartile were not given. 
Data from the WHS was used by Ridker, Rifai, Cook et al. 181 to investigate the association 
between CRP and ten year incidence of CVD, among women not using HRT at baseline. The 
analyses included 15,532 women, and were adjusted for age, blood pressure, BMI, diabetes and 
smoking. The hazard ratio for CVD was 2.98 (1.90-4.67) comparing the top quintile of CRP to 
the bottom quintile. Comparing the fourth quintile of CRP to the bottom quintile gave a hazard 
ratio for CVD of 2.38 (1.52-3.72), and comparing the third quintile of CRP to the bottom quintile 
gave a hazard ratio for CVD of 1.91 (1.21-3.03). The hazard ratio for CVD was 1.85 (1.16-2.96) 
comparing the second quintile of CRP to the bottom quintile. The p-value for trend was less 
than 0.001. 
Laaksonen, Niskanen, Nyyss(5nen et al. 182 used data from the Kuopio Ischaernic Heart Disease 
Risk Factor Study to investigate the association between CRP and CVD death. The analyses 
included 2,321 men without diabetes or cancer at baseline. Analyses were adjusted for age, year 
of examination, LDL cholesterol, systolic blood pressure, use of blood pressure medication, 
cigarette smoking, dietary variables, insulin resistance, exercise, alcohol intake and 
socioeconomic status. Classifying people's CRP levels into low risk (< 1 mg/L), medium risk 
(1-<3 mg/L) and high risk (ý: 3 mg/L), the hazard ratio for CVD death was 2.90 (1.36-6.19) 
comparing high risk to low risk among men without CVD at baseline. The hazard ratio for 
CVD death was 2.39 (1.294.44) comparing medium risk to low risk among men without CVD at 
baseline. The p-value for trend was 0.004. Considering people with CVD at baseline, the 
hazard ratio for CVD death was 1.91 (1.12-3.27) comparing high risk levels of CRP to low risk, 
and the hazard ratio for CVD death was 1.15 (0.69-1.93) when comparing medium risk to low 
risk. The p-value for trend for this analysis was 0.010. Hazard ratios were also estimated for 
comparisons between tertiles of CRP. Including only subjects without CVD at baseline in the 
analysis, the hazard ratio for CVD death was 3.88 (1.72-8.73) comparing the top tertile of CRP to 
the bottom tertile, and the hazard ratio for CVD death was 3.65 (1.65-8.05) comparing the 
middle tertile of CRP with the bottom tertile. The p-value for trend was 0.002. Considering 
men with CVD at baseline, the hazard ratio for CVD death was 1.73 (0.99-3.04) comparing the 
top tertile of CRP to the bottom tertile. Comparing the middle tertile of CRP to the bottom 
tertile gave a hazard ratio for CVD death of 1.23 (0.69-2.20). The p-value for trend was 0.032. 
Data from the CHS was used by Cushman, Arnold, Psaty et al. 183 to investigate the association 
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without vascular diseases at baseline and aged 65 or over at baseline. Levels of CRP were 
defined as high risk (> 3.0 mg/L), medium risk (1.0-3.0 mg/L) or low risk (< 1.0 mg/L). 
Analyses were adjusted for age, sex, race, field centre, hypertension, diabetes, smoking, log 
pack-years, BMI, waist circumference, total cholesterol, HDL cholesterol, regular aspirin use, 
and measures of subclinical vascular disease. The hazard ratio for CHD was 1.37 (1.06-1.78) 
comparing high risk CRP levels with low risk, and the hazard ratio for CHD was 1.04 (0.82-1.31) 
comparing medium risk CRP levels with low risk. 
As well as the cross-sectional analysis described above in Section 6.2.1, Lawlor et al-153 
investigated the effect of doubling CRP on time to incident CHD among women without 
prevalent CHD at baseline. Data for 2,723 women were used in the analysis. Uponadjustment 
for age, life course socio-econon-dc position score, behavioural and physiological risk factors, 
adult anthropometry and FEVI, the hazard ratio for incident CHD for a doubling of CRP was 
1.03 (0-94-1.13). 
The estimated associations between CRP and CHD or CVD described in this section are 
summarised in Table 6.4. 
6.2.5. Meta-analyses 
A meta-analysis of prospective studies to estimate the effect of blood levels of CRP on risk of 
CHD was performed by Danesh, Collins, Appleby et al. 184 Seven prospective studies were 
identified and included in the meta-analysis. The risk ratio for CHID was found to be 1.7 (1.4- 
2.1), and corresponded to a difference in CRP of 1.4 mg/L. This meta-analysis was updated in 
2000 by Danesh, Whincup, Walker et al. 160 to include an additional seven prospective studies. 
The overall risk ratio for CHD was found to be 1.9 (1.5-2.3) when comparing the top third with 
the bottom third of CRP, and corresponded to a difference of CRP of 1.4 mg/L. A further 
update was carried out in 2004 and included 22 prospective studies. 165 The OR for CHD, 
comparing the top with the bottom tertile of the CRP distribution, was 1.58 (1.48-1.68). 
6.3. Summary 
Many studies have shown a positive association between CRP and CHD. There was, however, 
very little consideration of possible bias due to measurement error in the exposure, residual 
confounding or unmeasured confounding in these studies. Only one observational study was 
identified which investigated the effects of measurement error, and this study only considered 
measurement error in CRP. 175 Their conclusion was that the estimated association between CRP 
and CHD, based on a single CRP measurement, would be an underestimate of the true 
association. Their analysis only adjusted for confounding by age and BMI, both of which were 
considered to be perfectly measured. It seems likely that their estimated association is biased 
by unmeasured confounding. NaYve estimates of the association between CRP and CHD, in 
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which there is no correction for the effects of measurement error, may not underestimate the 
association if the effects of any residual and unmeasured confounding act to bias the estimated 
association away from the null value. It is also possible that the observed associations are a 
result of reverse causation, where elevated CRP levels are a result of pre-clinical disease rather 
than a cause. It therefore remains open to discussion whether the estimated associations 
between CRP and CHD from observational epiden-dological studies are causal. 
Davey Smith, Harbord and Ebrahim'85 suggested that Mendelian randon-dsation could address 
these questions. In parent-offspring designs, the genetic variant associated with raised CRP 
levels does not suffer from confounding, as a person's genetic status is determined by 
segregation of genes, which is a random process. Mendelian randomisation in other designs for 
genetic association studies will be approximate. 186 Additionally, the genes are determined 
before birth, which elin-tinates the possibility of reverse causation. One drawback of this 
method is that large sample sizes are required to give a sufficiently precise estimate. In the 
study by Zee and Ridker, 187 no association was found between the genetic variant associated 
with elevated CRP levels and CHD. A similar lack of association was found in a genetic study 
by Casas, Shah, Cooper et aL, 188 which suggests that the estimated associations from 
observational epidemiological studies may not be causal. 
A further hypothesis is that confounding by factors acting across the lifecourse could explain 
the observed CRP/CHD association. 153 In a study using data from the BWHHS, Lawlor, Davey 
Smith, Run-dey et al. 153 showed that the inclusion of variables describing socio-economic status 
across the lifecourse, behavioural and physiological risk factors, adult anthropometry and lung 
function attenuated the observed association between CRP and both prevalent CHD at baseline 
and incident CHD. 
The effects of exposure measurement error and residual confounding on the estimated 
association between CRP and CHD are investigated in Chapter 7. 
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Chapter 7. 
Case study: Allowing for measurement error in confounders in 
estimating the association between C-reactive protein and 
coronary heart disease 
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Introduction 
In this chapter the impact of residual confounding and exposure measurement error on the 
estimated association between C-reactive protein (CRP) and coronary heart disease (CHD) is 
investigated, using data from the British Women's Heart and Health Study (BWHHS). The 
effects of residual confounding by forced expiratory volume in one second (FEVi) and 
triglycerides are investigated. These were chosen based on their crude and multivariable 
estimated associations with CHD. A Monte Carlo sensitivity analysis, described in Section 
4.4.3, is used as the BWHHS data do not contain validation or replication data on CRP, FEVI or 
triglycerides. This Monte Carlo sensitivity analysis involves repeatedly choosing measurement 
error variances for the two confounders and the exposure from three probability distributions. 
Repeatability measures obtained from the literature, such as intra-class correlation coefficients 
(ICCs) and coefficients of variation (CVs), are used to define these probability distributions. 
Regression calibration is then used to correct estimated associations for measurement error in 
the confounders and exposure. The analysis is carried out for three CHD outcomes; prevalent 
CHD, incident CHD, and time to CHD. 
7.2. Methods 
Notation and terminology 
The notation introduced in Chapter 5 (Section 52-1) will also be used in this chapter. 
Throughout this chapter the term naive analysis will refer to the analysis in which no adjustment 
is made for measurement error, and the term crude analysis will refer to any analysis in which no 
control for confounders is made. 
7.2.2. The British Women's Heart and Health Study 
The BWHHS is a prospective cohort study. The selection of participants and measurements 
used have been described previously by Lawlor, Ebrahim and Davey Sn-dth'89 and Lawlor, 
Bedford, Taylor, et aL, 190 so will be only briefly reviewed here. Between 1999 and 2001,4,286 
women aged 60 to 79 years, who were randomly selected from 23 British towns, were 
interviewed, exan-tined, completed medical questionnaires and had detailed reviews of their 
medical records. These women have been followed up by flagging with the NHS central 
register for mortality data, two yearly review of their medical records and a 3-year follow-up 
questionnaire sent to aU surviving participants between March and September 2003. Local 
ethics comn-dttees' approvals were obtained for the study. 
The MMHS data contain information on prevalent CHD at baseline, incidence of CHD, and 
time to incident CHD. Prevalent CHD at baseline was defined as a woman with either a 
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medical record of myocardial infarction, angina, coronary artery bypass or angioplasty, or self- 
report that a doctor had ever diagnosed a heart attack or angina. Incident cases of CHD in 
women who were free of prevalent CHD at baseline were defined as death with an underlying 
cause of CHD, a new myocardial infarction, a new diagnosis of angina or a new coronary artery 
bypass or angioplasty identified by medical record review, or self-report of a new heart attack 
or new diagnosis of angina. The analyses in this chapter will investigate each outcome 
(prevalent CHD, incident CHD and time to incident CHD), using a logistic regression model for 
presence of prevalent and incident CHD, and a Cox proportional hazards model for time to 
incident CHD. The confounders that will be adjusted for in all analyses are age, smoking status 
(never smoked, ex-smoker, or current smoker), systolic blood pressure, total cholesterol, 
triglycerides (logged), body mass index, FEV,, presence of diabetes, and socio-economic status 
in six categories (class L class II, class III non-manual, class III manual, class IV, and class V). 
These confounders are commonly adjusted for in other published analyses. 
Measurement error in two confounders, log triglycerides and FEVi, and in CRP will be 
considered. The reasons for choosing these confounders will be presented later (see Section 
7.3.1). In order to correct for measurement error in continuous explanatory variables, the 
relevant measurement error variance should be estimated from repeated measures or an 
internal or external validation study. This information is not available in the BWHHS data, and 
therefore repeatability measures for CRP, FEVI and triglycerides, such as ICCs or CVs, were 
extracted from the literature. To find articles on FEVi, Medline was searched for articles 
including the terms FEVI, spirometry, spirometric, or forced expiratory in the title. In the case 
of triglycerides, articles were searched for the terms triglyceride or lipid in the title. For CRP, 
titles were searched for the terms C-reactive protein, CRP, inflammation or inflammatory. 
These were combined with searches on the terms measurement error, reliability, 
reproducibility, repeatability, variability or variation. Only articles in English were considered. 
After the searches, titles and abstracts were reviewed and any relevant articles obtained. Only 
papers which measured repeatability on a healthy population, or on a randon-dy selected 
population were included. Additionally, papers in which repeated measures were obtained on 
the same day were excluded. The reference lists of the extracted articles were also reviewed, 
and any additional relevant papers obtained. 
7.2.3. Sensitivity analysis method 
To investigate the impact of residual confounding by FEVi and triglycerides and measurement 
error in CRP on the estimated association between CRP and CHD, a Monte Carlo risk analysis 
method will be used (see Section 4.4.3). Most of the applications of Monte Carlo risk analysis to 
measurement error in the literature consider only n-dsclassification of categorical variables (e. g. 
Fox et al., 134 Phillips, 136 Lash et al., 61 Lash et al. 135). As the analysis of interest in this chapter 
investigates the effect of measurement errors in continuous variables, the exact methods used in 
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these papers cannot be used for this analysis. A Monte Carlo risk analysis was therefore 
developed to investigate the effect of measurement error in continuous variables. 
The first step in the Monte Carlo method is to independently choose values of the error 
variances for each of the variables (FEVi, log triglycerides and CRP) from probability 
distributions. The method for choosing the probability distributions for each of the variables is 
described in detail below. 
7.2.3.1 Choosing a probability distribution for the error variance of FEVi 
First, the method of choosing a probability distribution for the error variance of FEVi is 
described. This probability distribution will be informed by repeatability measures found in the 
literature, such as ICCs or CVs. As FEVi is approximately normally distributed in the BWHHS 
data, a classical measurement error structure in the confounders is assumed, where the 
measurement error is additive and independent of the true values. Values of 
(a 22 
u +6e) and g 
can therefore be observed from the data. The formulae for deriving the measurement error 
variances for the BWHHS from the ICC or CV values in the literature are therefore 
2 cr, 2= (02 + CF2 , ý, 
)_jCC(C; 2 +Cre2), Equation 7.1: ICC = 
cy 2+ cl 2 
C; e UU 
Ue 
Equation 7.2: CV (Cvg)' . 
A normal probability distribution is then chosen so that 95% of error variances chosen will be in 
the range found in the literature. The mean of the normal distribution is defined to be the mid- 
2 point between the largest and smallest derived error variance. If C; e2, max and cFe, min are the 
largest and smallest derived error variances respectively, the mean of the normal distribution is 




max -Ge, rni 
C, min +2 
The variance for the normal distribution is also defined using the largest and smallest derived 
error variances. From the properties of a normal distribution, values 1.96 standard deviations 
either side of the mean occur with probability 0.95. The variance of the probability distribution 
is therefore defined so that the values between the smallest and largest derived error variances 
are chosen with probability 0.95. This is equivalent to setting the range between the smallest 
and largest derived error variances equal to 3.92 standard deviations of the required normal 
distribution. The variance is therefore equal to 
2 Cle2, max -Cle, min 
3.92 
As error variances cannot be negative, this normal distribution is truncated at zero. In practice, 
truncating the chosen distribution at zero makes very little difference to the coverage 
probabilities. The probability of choosing negative error variances, and therefore the impact of 
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truncating the distributions at zero, for the normal distributions used in this analysis are 
provided in Section 7.3.2. 
7.2.3.2 Choosing a probability distribution for the error variance of log triglycerides 
The method used to choose the probability distribution for the error variance of logged 
triglycerides; is slightly different to that described for FEVi in Section 7.2.3.1. This difference 
arises because the triglyceride variable is skewed in the BWHHS data, and the logged value will 
be used in the regression analyses presented later (Section 7.3). The repeatability measures 
found in the literature in general are for the skewed triglyceride variable, and therefore the 
following transformation was developed to derive error variances for logged triglycerides. For 
these transformations, it is assumed that triglycerides have a log-normal distribution, and hence 
that log triglycerides; has a normal distribution. 
To calculate an error variance for log triglycerides from an ICC of triglycerides, it is first 
assumed that the ICC is the ratio of the variance of the true variable to the observed variance. 
The variance of a log-normal variable is given by 
(eO2 
_ 1ý 21,1*' , where cY2 and g are the 
variance and mean of the normally distributed variable respectively. The ICC of a log-normal 
variable is therefore given by 
I 2px+cr 2 
, CC 
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0'+6.2 (e x 
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70.2 
2 
X+ Cye2 As lix and 
(a the mean and variance of the observed log triglycerides variable, are 
observable from the data, e02- can be calculated from the above formula. 
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As the above expression for ex must be positive, the second half of the formula cannot be 
subtracted from the first. The error variance of log triglycerides is therefore given by 
X +Cr2 
ý02+02 







To calculate the error variance of log triglycerides from a CV, the CV is first converted to an ICC 







where crz and p are the observed variance and mean of the untransformed triglyceride variable 
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respectively. This expression is derived by equating Equation 7.1 and Equation 7.2. 
The CV is converted to an ICC because the CV does not place any restriction on the size of the 
error variance compared with the observed variance. It would therefore be possible to estimate 
an error variance for log triglycerides that is larger than the observed variance. This problem 
does not occur when an ICC is used. Following conversion of the CV to an ICC, the method 
described previously for estimating the error variance of log triglycerides from an ICC is used. 
Once error variances for log triglycerides have been derived from the repeatability measures in 
the literature, a normal probability distribution is defined so that 95% of the possible error 
variances are within the range defined by the values in the literature. The method for deriving 
the parameters of this distribution has been described in Section 7.2.3.1. 
7.2.3.3 Choosing a probability distribution for the error variance of CRP 
The CRP variable in the BWHHS data is skewed. Using a logarithmic transformation improves 
the normality of the variable. In the analyses, the effect of a doubling of CRP on the CHD 
outcome is investigated, and therefore log CRP is also divided by log 2. Dividing by a constant 
has no effect on ICCs or CVs. The procedure described in Section 7.2.3.2 can therefore be used 
to derive the error variance from ICC or CV values based on skewed CRP measurements 
obtained from the literature. If ICC or CV values for CRP from the literature use a logged CRP 
variable, the method described in Section 7.2.3.1 for deriving an error variance for FEVI can be 
used. Following derivation of the measurement error variance, a normal distribution is defined 
so that 95% of the error variances are in the range described by the literature. The parameters of 
this distribution are derived using the method described in Section 7.2.3.1. 
7.2.3.4 Regression calibration 
An error variance for each variable assumed to be measured with error is chosen from the 
relevant probability distributions. Once the error variance for each variable has been chosen, 
regression calibration is used to correct the na*fve analyses for residual confounding in the 
continuous confounders and for measurement error in the exposure. The regression calibration 
method has been described previously in Chapter 5 and will not be repeated here. For all 
analyses in which errors in more than one variable are considered, the errors are assumed to be 
independent. This implies that the off-diagonal elements of iuu, the estimated covariance 
matrix_of the errors, will be zero. 
The regression calibration estimate is saved, and the process of selecting a measurement error 
variance and using the regression calibration method to obtain a parameter estimate is repeated 
until a sufficiently large number of repetitions are reached. The occurs when the widths of the 
95% confidence intervals (Cls) around the 2.5th, 50th and 97.5th percentiles of the cumulative 
probability distribution of the parameter estimate are less than 0.01. If the stopping criteria 
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have not been satisfied once 100,000 repetitions have been performed, the analysis is stopped. 
These occurrences will be marked in the results section. The cumulative probability 
distribution is summarized using the 2.5th, 50th and 97.5th percentiles. The cumulative 
probability distribution of the estimate can also be plotted. 
In the Monte Carlo sensitivity analysis described so far, the variability due to uncertainty in the 
true error variance is included, but sampling variation in the estimated parameter is ignored. 
This will be known as sensitivity analysis A. In sensitivity analysis B, sampling variation is 
reintroduced by taking a bootstrap sample of the full dataset. The method described for 
sensitivity analysis A is then followed, using the bootstrapped dataset, to obtain a cumulative 
probability distribution. Figure 7.1 shows a flowchart of the method. 
The results from sensitivity analysis A include only variability due to differences in the 
repeatability measures extracted from the literature. If there is little variation in the measures 
found in the literature there will be very little variability in the cumulative probability 
distribution obtained from sensitivity analysis A. The results from sensitivity analysis B can be 
thought of as combining the sources of variation from the na*fve analysis and sensitivity analysis 
A; sampling variation and uncertainty over the measurement error variance. 
Figure Zl: Methodfor sensitivity analysis. 
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Throughout this chapter, the results will be presented in terms of the median estimates, which 
is defined as the 50th percentile of the cumulative probability distribution from each sensitivity 
analysis, and a 95% simulation interval, which is defined as the interval between the 2.5th and 
97.5th percentiles of the cumulative probability distribution for each sensitivity analysis. The 
results of a Monte Carlo sensitivity analysis do not have a frequentist interpretation, and "the 
only fomal statistical interpretation" is Bayesian. 133 As such, the median estimate and 95% 
simulation interval provide summaries of a probability distribution for the effect estimate of 
interest, given the assumed distributions for the measurement error variances and the observed 
data. 
7.3. Results 
7.3.1. Nalive analysis 
Table 7.1 and Table 7.2 show the crude and multivariable analyses respectively for the effects of 
each explanatory variable on prevalent and incident CHD and time to incident CHD. The 
confounders that will be investigated for the effects of measurement error are those continuous 
confounders for which the p-value for the estimated association between the confounder and 
CHD is less than or equal to 0.05 for all CHD outcomes, and in both the crude (Table 7.1) and 
multivariable (Table 7.2) analyses. Only one of the continuous confounders, FEVI, meets these 
criteria. Triglycerides, however, are very close to meeting the criteria, with p-values in all 
analyses of 0.06 or less. The effect of measurement error in FEVi and triglycerides on the 
estimated association between CRP and CHD will therefore be investigated. 
All analyses will be performed using data from participants with complete information on all 
confounders. From the original dataset with 4,286 observations, this resulted in the loss of 666 
(15.5%) of the observations. The time to incident CHD analysis includes 13,089 person-years of 
observation, and a mean follow-up per person of 4.3 years. The shortest follow-up for this 
analysis was 2 days, while the longest was 5.5 years. Table 7.3: shows basic descriptions of the 
three variables of interest (FEVi, triglycerides and CRP) for each of the analysis methods 
(prevalent CHD, incident CHD and time to incident CHD). 
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7.3.2. Repeatability measures for FEV1, triglycerides and CRP 
The values of the repeatability measures found in the literature for FEVi, triglycerides and CRP 
are shown in Table 7.4. In order to estimate the long-term repeatability of FEVi, triglycerides 
and CRP, all of the repeatability measures shown in Table 7.4 are derived from repeated 
measures that were not obtained on the same day. For FEVi, titles and abstracts of 65 articles 
were reviewed. Two of these were considered relevant to this analysis, and a further two 
articles were obtained by reviewing their reference lists. For triglycerides, titles and abstracts of 
283 articles were reviewed. Six of these were considered relevant to this analysis. No 
additional articles were found by reviewing the reference lists of these six articles. For CRP, 
titles and abstracts of 168 articles were reviewed. Five of these were considered relevant to this 
analysis. A further five results were obtained by reviewing the reference lists of these five 
articles. 
Table 7.4: Repeatability measures offorced expiratory volume in one second, triglycerides and C-reactive 
protein, extracted from the literature, and the derived measurement error variances. In the British 
Women's Heart and Health Study, forced expiratory volume in one second is measured in litres, 
triglycerides is measured in millimoles per litre, and C-reactive protein is measured in log milligrams per 
litre. 
2 Variable Reference Retest period CV ICC Derived ae_ 
Lebowitz et al. 191 
FEVI Rozas et al. 192 
Groth et al. 193 













Jacobs et al. 195 1 week-1 year -25 0.0247 
Godsland'96 Weekly for 11-27 weeks 20.9 0.0171 
Triglycerides Bookstein et al. 197 
Monday, Wednesday 
and Friday of the same week 
21.5 0.0181 
Brenner et al. 198 1 week-1 year 0.78a 0.0455 
Marcovina, et al. 199 Fortnightly for 8 weeks 28.3 0.0320 
Egger et al. 200 Average 1 year OA6 0.0967 
Clark et al. 2m Fortnightly for 10 weeks 63.0 0.0721 
de Maat et al. 202 Every 3 weeks for 6 months 0.86b 0.360 
de Maat et al. 203 Every 4 weeks for 20 weeks 82b 0.526 
Schuit et al. 204 1 year 32b 0.0801 
CRP Macy et al. 
205 Every 3 weeks for 24 weeks 42.2 0.0311 
Sakkinen et al. 206 Every 3 weeks for 24 weeks 0.77 0.125 
Riese2O7 5 days 18b, c 0.0253 
Ockene et al. 208 Every 90 days for a year 0.78b 0.565 
Koenig et al. 209 3 years 0.54b 1.18 
BroekmanSd 6 months 37b, c 0.107 
Abbreviations: CV, coefficient of variation; ICCý intra-class correlation coefficient; FEV1, forced 
a2 expiratory volume in one second; CRP, C-reactive protein; e, measurement error variance. 
a ICCfor log triglycerides 
b ICC or CVfor log CRP 
c Value obtainedftom Kluft et al. 210 
d No reference available. 77w dataset was obtainedfrom Broekmans and analysed by Kluft et al. 210 
The derived values of a. 2 for FEVI are all very small. This is due to the high repeatability of 
168 
CRP and CHD 
FEVI, indicated by low CVs. The method described in Section 7.2.3.1 is used to define the 
parameters of the normal distributions for the error variances. For FEVI, the probability 
distribution chosen for the error variance is N(O. 00588,2.04xlO-6). The variance in this 
distribution is small due to the low variance between the repeatability measures values found 
in the literature. The probability of choosing negative error variances from this distribution is 
1.9xlO-5. For triglycerides, the chosen probability distribution for the measurement error 
variance for triglycerides is N(O. 0569,4AN104), where the parameters are derived using the 
method in Section 7.2.3.1. The probability of choosing negative error variances from this 
distribution is 0.0026. The chosen probability distribution for the measurement error variance 
in CRP is N(O. 603,0.0868). The probability of choosing negative error variances from this 
distribution is 0.020. For all of these distributions, therefore, the coverage probabilities are not 
greatly affected by truncating the distribution at zero. 
7.3.3. Crude analysis 
First, results from the crude analyses are presented, where univariable models for the 
association between FEVI, triglycerides, or CRP and three CHD outcomes (prevalent CHD at 
baseline, incident CHD, and time to incident CHD) are fitted. The nafve analyses give a crude 
OR for the effect of a unit increase in FEVi on prevalent CHD of 0.44 (0.37-0.53), for a unit 
increase in log triglycerides of 1.55 (1.28-1.87), and for a doubling of CRP of 1.17 (1.10-1.24). The 
crude OR for the effect of a unit increase in FEVI on incident CHD is 0.49 (0.36-0.67), for a unit 
increase in log triglycerides is 1.69 (1.21-2.35), and for a doubling of CRP is 1.16 (1.05-1.28). For 
time to incident CHD, the crude hazard ratio for the effect of a unit increase in FEVI on time to 
incident CHD is 0.52 (0.37-0.73), for a unit increase in log triglycerides is 1.66 (1.20-2-30), and for 
a doubling of CRP is 1.14 (1.03-1.26). 
Table 7.5 shows the results of the crude analyses on prevalent CHD, incident CHD and time to 
CHID, allowing for measurement error in FEVi, triglycerides or CRP. In the descriptions that 
follow, the width of the 95% CI or simulation interval is defined to be the difference between 
the logged values of the upper and lower limits for the intervals. This corresponds to the width 
of the 95% CI or simulation interval around the log OR or log hazard ratio. 
For all results presented in this table, the 95% simulation interval from sensitivity analysis B is 
wider than the naYve 95% Cl. This is a general result that does not apply only to the analyses 
considered in this section. Sensitivity analysis B incorporates both variation due to uncertainty 
over the true value of the measurement error variance, and sampling variation in the estimated 
parameter. As the variation due to uncertainty in the measurement error variance will always 
be greater than zero (for a sensitivity analysis), it follows that the 95% simulation interval will 
be wider than the 95% Cl which includes only sampling variation. 
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The 95% simulation intervals from sensitivity analysis A are always narrower than the nal've 
95% Cl. This is not a general result, and may not apply to other analyses. It is possible for the 
variation due to uncertainty over the true value of the measurement error variance to be greater 
than the sampling variation. In this situation, the 95% simulation interval from sensitivity 
analysis A would be wider than the naYve 95% Cl. 
Table 7.5: Summary of effect estimates for a unit increase of FEVi, a unit increase of log triglycerides, or 
a doubling of CRP on prevalent CHD, incident CHD or time to incident CHD ftom the cumulative 
probability distributions yielded by sensitivity analyses in which the amount of measurement error in 
FEVI, triglvcerides or CRP respectively is varied. 
Outcome Variable measured Analysis 
Median 95% simulation 
with error estimate interval 
NaYve analysis 0.44 (0.37-0.53) 
FEVi Sensitivity analysis A, 0.44 (0.43-0.44) 
Sensitivity analysis Bb 0.44 (0.36-0.53) 
Nave analysis 1.55 (1.28-1.87) 
Prevalent CHD Triglycerides Sensitivity analysis Aa 1.83 (1.61-2.27) 
Sensitivity analysis Bb 1.83 (1.39-2.654) 
Nave analysis 1.17 (1.10-1.24) 
CRP Sensitivity analysis Aa 1.23 (1.18-1.33) 
Sensitivity analysis Bb 1.23 (1.13-1.39) 
Nave analysis 0.49 (0.36-0.67) 
FEVi Sensitivity analysis Aa 0.48 (0.47-0.49) 
Sensitivity analysis Bb 0.48 (0.35-0.65) 
Na7fve analysis 1.69 (1.21-2.35) 
Incident CHD Triglycerides Sensitivity analysis Aa 2.06 (1.78-2.69+) 
Sensitivity analysis Bb 2.06 (1.32-3.59+) 
Nave analysis 1.16 (1.05-1.28) 
CRP Sensitivity analysis A& 1.22 (1.17-1.32) 
Sensitivity analysis Bb 1.22 (1.06-1.44) 
NaYve analysis 0.52 (0.37-0.73) 
FEVi Sensitivity analysis Aa 0.51 (0.51-0.51) 
Sensitivity analysis Bb 0.51 (0.36-0.72) 
Time to 
Na*fve analysis 1.66 (1.20-2.30) 
incident CHD Triglycerides Sensitivity analysis Aa 2.02 (1.74-2.60+) 
Sensitivity analysis Bb 2.02 (1.30-3.45+) 
NaYve analysis 1.14 (1.03-1.26) 
CRP Sensitivity analysis Aa 1.19 (1.15-1.28) 
Sensitivitv analvsis Bb 1.19 (1.04-1.41) 
Abbreviations: FEVi, forced expiratory volume in one second; CRP, C-reactive protein, CHD, coronary 
heart disease. 
11 Analysis allowing onlyfor variability due to uncertainty about the true measurement error variance. 
b Analysis allowing for both variability due to uncertainty about the true measurement error variance 
and sampling variation. 
* Width of 95% confidence interval around the 97.5th percentile of the cumulative probability 
distribution>0.01. 
For analyses estimating the association between FEVi and CHD, there is little variability in the 
cumulative probability distribution when only variation due to uncertainty over the true value 
of the measurement error variance is considered. This is shown by the small width of the 95% 
simulation interval for sensitivity analysis A. This is due to the small variance between the 
derived measurement error variances for FEVi from repeatability measures found in the 
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literature (see Table 7.4), and the correspondingly small variance in the probability distribution 
for the measurement error variance. This implies a small amount of uncertainty over the true 
value of this measurement error variance, and results in the narrow 95% simulation interval 
from sensitivity analysis A. 
Allowing for measurement error in FEVi has little or no effect on the point estimates for all 
analyses. When the outcome is prevalent CHD, there is no difference between the nayve OR 
and the median estimates from either sensitivity analysis. For incident CHD and time to 
incident CHD, allowing for measurement error in FEVi has decreased the point estimate by 
0.01. This small effect is due to the small measurement error variances derived from the 
repeatability measures found in the literature, and the correspondingly small mean in the 
probability distribution for the measurement error variance. 
When allowing for measurement error in triglycerides or CRP, the sensitivity analyses have 
moved the point estimate away from the nallve estimated OR. Throughout this chapter, 
measurement error in all variables is assumed to be non-differential and random. Under this 
type of measurement error, the nawe estimates would be attenuated towards the null value. 
Allowing for measurement error therefore moves the point estimates away from the null value. 
Figure 7.2 gives a graphical representation of the cumulative probability distribution for the 
association between FEVj, triglycerides or CRP and prevalent CHD allowing for measurement 
error. A lateral shift of the sensitivity analysis results away from the naive analysis results 
corresponds to a change in the median estimate. The amount of lateral shift is due to the size of 
the mean in the probability distribution from which the error variance is drawn. A change in 
slope of the sensitivity analysis results compared with the nali've analysis changes the width of 
the 95% simulation interval for the log OR when compared with the naYve analysis. A steeper 
slope corresponds to a narrower 95% simulation interval for the log OR, and a shallower slope 
corresponds to a wider 95% simulation interval. The change in slope is due to the variance in 
the probability distribution from which the measurement error is drawn. 
Considering the analysis of the effect of FEVi on prevalent CHD, there is very little lateral shift 
of the sensitivity analysis results from the na7i*ve analysis. This can be seen in Table 7.5, as there 
is no change in the median estimate from the sensitivity analyses compared with the nayve 
point estimate. This is caused by the small amount of measurement error (small mean) in FEVI. 
The cumulative probability distribution from sensitivity analysis A is an almost vertical line, 
which corresponds to the narrow 95% simulation interval seen in Table 7.5. The slope of the 
cumulative probability distribution for sensitivity analysis B is similar to that of the nallve 
analysis, which corresponds to the 95% simulation interval for sensitivity analysis B having a 
similar width to the 95% CI from the nal*ve analysis. The sensitivity analyses have shifted the 
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Figure 7.2: Graphical representation of sensitivity analysis results for the effect of a unit increase in 
FEV,, a unit increase in log triglycerides, or a doubling of CRP on prevalent CHID, allowing for 
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cumulative probability distribution for the estimated association between triglycerides and 
prevalent CHD away from the na*fve results, and away from the null value. This shift away 
from the null value is expected, as measurement error in triglycerides would attenuate the 
estimated association with CHD towards the null. Correspondingly, Table 7.5 shows an 
increase in the median estimates for both sensitivity analyses. The slope of the cumulative 
probability distribution of sensitivity analysis A is slightly steeper than the naive analysis, 
which results in a narrower 95% simulation interval for the log OR. The slope of the cumulative 
probability distribution for sensitivity analysis B is shallower than that of the naYve analysis, 
and Table 7.5 shows a correspondingly wider 95% simulation interval compared with the width 
of the nSfve 95% CL The slopes of the cumulative probability distributions for the sensitivity 
analyses of triglycerides are shallower than those of FEVi because of the larger variance used in 
the probability distribution for the measurement error in triglycerides. The wide 95% CI 
around the upper limit of the 95% simulation interval for sensitivity analysis B, shown in Table 
7.5, is due to the shallow slope of the cumulative probability distribution at this point. The 
patterns observed for the crude analysis of the effect of CRP on prevalent CHD are the same as 
those described for triglycerides. 
The graphs for the other analyses in this section, and for all remaining analyses in this chapter, 
are not presented here, as the interpretation of the plots and relationship with the results 
presented in the tables are the same as described above. The graphs for the other analyses 
described in this section, and the analyses that are presented in Section 7.3.4, are available in 
Appendix 2. 
7.3.4. Multivariable analysis 
The multivariable sensitivity analysis for the effect of measurement error in FEVI, triglycerides, 
CRP or a combination of these on the estimated association between CRP and the three CHD 
outcomes (prevalent CHID, incident CHD and time to incident CHD) will now be considered. 
The estimated associations from the nalive multivariable analyses, with no correction for error, 
give an OR for prevalent CHD of 1.05 (0.99-1.12) for a doubling of CRP, an OR for incident CHD 
of 1.07 (0.96-1.20) for a doubling of CRP, and a hazard ratio for time to incident CHD of 1.06 
(0.95-1.18) for a doubling of CRP. 
Table 7.6 surnmarises the sensitivity analysis results for prevalent CHD, incident CHD and time 
to incident CHD. As observed for the results of the crude analyses in Section 7.3.3, the 95% 
simulation intervals from sensitivity analysis A are all narrower than the corresponding nayve 
95% Cl, and the 95% simulation intervals from sensitivity analysis B are all at least as wide as 
the na*fve 95% CL When allowing for measurement error in FEVi only, the 95% simulation 
intervals for sensitivity analysis A are once again very narrow. 
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Allowing for measurement error in FEVI only has no effect on the point estimate for any of the 
analyses. This is once again due to the small derived measurement error variances from the 
repeatability measures found in the literature, and the correspondingly small mean in the 
probability distribution for the measurement error variance. The only differences observed 
between the naive analysis results and the results of sensitivity analysis B occur when the 
outcomes are prevalent CHD or time to incident CHD, where the lower limit of the 95% 
simulation interval for sensitivity analysis B is slightly smaller than the lower limit of the nawe 
95% CL 
For analyses with incident CHD or time to incident CHD as the outcome, allowing for 
measurement error in triglycerides only moves the point estimate slightly towards the null 
value. When the outcome is prevalent CHD, this effect is not observed, and allowing for 
measurement error in triglycerides has no effect on the point estimate. 
Allowing for measurement error in triglycerides and FEVi generally produces results that are 
no different to the results obtained when allowing for measurement error in triglycerides alone. 
This is due to the lack of effect of allowing for measurement error in FEVi alone. The only 
difference between the results obtained when allowing for measurement error in triglycerides 
alone, and allowing for measurement error in triglycerides and FEV, occurs when the outcome 
is time to incident CHD. The upper limits for the 95% simulation intervals for sensitivity 
analysis A in these two cases are slightly different. 
As expected, allowing for measurement error in CRP moves the point estimate away from the 
null value. Random and non-differential measurement error in the exposure will attenuate the 
nSfve point estimate towards the null value, and therefore allowing for this error will move the 
point estimate away from the null value. 
Allowing for measurement error in all three variables simultaneously moves the point estimate 
away from the null value, but not to the same extent as when allowing for measurement error in 
CRP alone. This demonstrates that the effects of measurement errors in the exposure and 
confounders can act in different directions, and that allowing for measurement error in the 
exposure variable only may produce too large a correction away from the null value. It is 
interesting to note that, although no attenuation of the point estimate is observed when the 
outcome is prevalent CHD and allowing for measurement error in triglycerides, the point 
estimate obtained when allowing for measurement error in all three variables is not as large as 
that observed when allowing for measurement error in CRP only. This suggests that allowing 
for measurement error in triglycerides; does attenuate the effect estimate, but the attenuation 
effect is too small to be observed when allowing for measurement error in triglycerides only (or 
in triglycerides and Mi together). 
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Table Z6: Summary of estimated effects of doubling CRP on prevalent CHD, incident CHD or time to 
incident CHD from the cumulative probability distributions yielded by sensitivity analyses in which the 
amount of measurement error in FEVI, triglycerides, CRP or a combination of these is varied. 
Outcome Variable measured Analysis 
Median 95% simulation 




Prevalent CHD CRP 
FEVi and triglycerides 
CRP, FEV, and 
triglycerides 
Na*fve analysis 
Sensitivity analysis As 
Sensitivity analysis Bb 
Sensitivity analysis As 
Sensitivity analysis Bb 
Sensitivity analysis As 
Sensitivity analysis Bb 
Sensitivity analysis A& 
Sensitivity analysis Bb 
Sensitivity analysis As 























None NaYve analysis 1.07 (0.96-1.20) 
Sensitivity analysis As 1.07 (1.07-1.07) FEVI Sensitivity analysis Bb 1.07 (0.96-1.20) 
Triglycerides Sensitivity analysis As 
1.06 (1.04-1.07) 
Sensitivity analysis Bb 1.06 (0.94-1.19) 
Incident CHD Sensitivity analysis As 1.10 (1.07-1.17) CRP Sensitivity analysis Bb 1.10 (0.94-1.35) 
FEVi and triglycerides 
Sensitivity analysis A& 1.06 (1.04-1.07) 
Sensitivity analysis Bb 1.06 (0.94-1.19) 
CRP, FEV, and Sensitivity analysis As 1.08 (1.05-1.15) 
triglycerides Sensitivity analysis Bb 1.08 (0.91-1.33) 
None NaTve analysis 1.06 (0.95-1.18) 
Sensitivity analysis As 1.06 (1.06-1.06) FEVi Sensitivity analysis Bb 1.06 (0.94-1.18) 
Sensitivity analysis As 1.05 (1.03-1.06) Triglycerides Sensitivity analysis Bb 1.05 (0.93-1.18) Time to Sensitivity analysis As 1.08 (1.06-1.14) incident CHD CRP Sensitivity analysis Bb 1.08 (0.92-1.32) 
FEVI and triglycerides 
Sensitivity analysis A& 1.05 (1.03-1.05) 
Sensitivity analysis Bb 1.05 (0.93-1.18) 
CRP, FEVi and Sensitivity analysis As 1.07 (1.04-1.11) 
triglycerides Sensitivity analysis Bb 1.07 (0.90-1.29) 
Abbreviations: FEVI, forced expiratory volume in one second, CRP, C-reactive protein; CHD, coronary 
heart disease. 
a Analysis allowing onlyfor variability due to uncertainty about the true m easurement error variance. 
b Analysis allowing for both variability due to uncertainty about the true measurement error variance 
and sampling variation. 
7.4. Discussion 
Summary of results 
A method to allow for measurement error in continuous exposures and confounders has been 
developed, and the impact of measurement errors in two confounders and exposure on the 
estimated exposure-outcome association has been investigated. Although the effects of 
measurement error were small, it is preferable to investigate them rather than to ignore them 
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and report the results of a nave analysis. The main findings in this chapter are that 
measurement error in FEVI is small and does not bias the estimated association between CRP 
and CHD, that measurement error in CRP attenuates the nalive estimate towards the null, but 
that the effect of residual confounding by triglycerides acts in the opposite direction and results 
in a smaller attenuation due to exposure measurement error. 
7.4.2. Strengths and weaknesses 
It was not possible to estimate error variances for FEVI, triglycerides or CRP directly from the 
BWHHS data, as no repeated measures were made. External estimates, extracted from the 
literature from reported CVs or ICCs, were therefore used. These estimates are not necessarily 
transportable to the BWHHS data. This problem has been reduced by choosing an error 
variance from a probability distribution for which 95% of the choices will be in the range found 
in the literature, and not relying on a single external estimate. Nevertheless, the results 
presented in this chapter should not be interpreted as being perfectly corrected for 
measurement error, and should only be viewed as a sensitivity analysis of the possible effects of 
residual confounding by FEVi and triglycerides and measurement error in CRP. 
Error variances for CRP, FEVI and triglycerides were drawn from normal distributions, based 
on repeatability values found in the literature. Other probability distributions are possible. 
Lash and FinIC, 61 for example, drew values of sensitivity and specificity for their n-dsclassified 
variable from triangular probability distributions. The choice of probability distribution is 
somewhat arbitrary. To investigate the impact of using different probability distributions, 
further analyses could be carried out in which the probability distribution is varied. 
To derive the measurement error variances for the skewed variables (CRP and triglycerides), it 
was assumed that the skewed variable had a log-normal distribution, and that the log variable 
had a normal distribution. These assumptions are likely not to hold exactly, and there will 
therefore be some error in the derivation of the error variances for log triglycerides; and CRP. 
There are many assumptions required when a sensitivity analysis is undertaken. For example, 
in this chapter, classical and non-differential measurement error have been assumed, as well as 
assuming that the true measurement error variances for CRP, FEVI and triglycerides are taken 
from a normal distribution with parameters defined by the values found in the literature. While 
all assumptions may be validly criticised, this should not deter investigators from using 
sensitivity analysis methods. Considering measurement error, and attempting to quantify the 
effects through sensitivity analysis, is preferable to considering only sampling variation and 
reporting the results of a naTve analysis. 
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7.4.3. Implications 
The results presented in this chapter have shown that allowing for measurement error in CRP 
consistently moves the median estimates from the sensitivity analyses away from the null value 
when compared with the naYve point estimates, and therefore that it is possible that the nal*ve 
estimates presented by previous studies into the association between CRP and CHD may be 
attenuated towards the null value. Residual confounding caused by errors in confounders, 
however, may act in the opposite direction, as was the case in this study with error in 
triglycerides. Residual confounding may therefore reduce any under-estimation of the 
exposure-outcome effect caused by measurement error in the exposure. In the case study 
presented in this chapter, accounting for residual confounding by triglycerides as well as 
measurement error in CRP resulted in a smaller change in the median estimate than was seen 
when accounting for the measurement error in CRP alone. As measurement errors in only two 
confounders were considered in this chapter, it is possible that considering measurement errors 
in other confounders could entirely cancel out the effects of exposure measurement error, or 
attenuate the na*fve estimates towards the null. It therefore appears possible that the association 
between CRP and CHD may have been over-estimated in previous publications. As both 
under- and over-estimation of the association appears possible, the effects of measurement 
errors and misclassification of explanatory variables should be quantitatively assessed, as the 
combined effects of measurement errors in the exposure and confounders may be complex. 
Allowing for measurement error in all variables included in an analysis is likely to be a time- 
consuming process. In this case-study, measurement error in FEV, had no effect on the 
estimated association between CRP and CHD. It would therefore appear unnecessary to allow 
for measurement error in all variables, but instead to restrict attention to the variables measured 
with moderate or large amounts of error. 
Ideally, measurements should be free from error. This is often not possible in epidemiological 
studies. Internal or external validation studies, or repeated measurements should therefore be 
used to estimate measurement error variances, and these estimates used to correct the results of 
na*fve analyses. The results from this chapter show that allowing for measurement error may 
have little or no effect on the naYve estimates. It is, however, better to consider measurement 
error in the exposure and confounders than to ignore it by using only a naive analysis. 
7.4.4. Future research 
An extension to the analysis carried out in this chapter could include investigating the impact of 
measurement error or inisclassification in all confounders simultaneously. This would require a 
further adaptation of the Lash and Fink sensitivity analysis method6l to account for 
n-dsclassification in polytomous confounders. 
177 
BLANK IN ORIGINAL 
Part C. 
Estimating treatment efficacy in the presence of departures from 
randomly allocated treatment in randomised controlled trials 
179 
BLANK IN ORIGINAL 
Literature: Analysing compliance in RCTs 
Chapter 8. 
Background literature: Methods for estimating treatment efficacy 
in the presence of departures from allocated treatment in 
randomised controlled trials 
181 
Uterature. Analysing compliance in RCTs 
Introduction 
The primary method of analysis for randon-tised controlled trials (RCrs) is the intention-to-treat 
(ITI) analysis. Participants are analysed based on the treatment arm to which they were 
assigned, rather than treatment actually received. This method of analysis has the advantage 
that the groups compared should be similar with respect to both known and unknown 
prognostic factors providing sufficiently many participants are randon-dsed, and therefore the, 
effect estimate will not be biased by residual or unmeasured confounding. If there *are 
departures from the allocated treatment the effect estimate is a mixture of the effect of treatment 
on compliers, and the lack of effect of treatment on non-compliers, and does not provide an 
estimate of treatment efficacy. Instead, it is an estimate of the effectiveness of treatment 
allocation. If the aim of the trial is to investigate the effect of treatment in a coinmunity 
intervention programme this effectiveness estimate may be the required parameter, assuming 
compliance rates in the community do not differ from those in the original trial. If the primary 
interest is instead on the efficacy of treatment, the rIT estimate will be biased when there are' 
departures from the allocated treatment. If trial participants switch between treatment arms, 
but participants in the intervention arm receive more treatment than those in the control arm, 
the ITT analysis produces effect estimates that are biased towards the nulL If trial participants 
switch to non-trial treatments, the nr estimate for efficacy may be biased in either direction. - 
Alternative methods of analysis can be used in trials in which information on treatment actually 
received is recorded. An as-treated analysis analyses the effect of treatment received on 
outcome ignoring the randomisation. This is essentially an analysis of observational data and 
therefore suffers the same problems of residual and unmeasured confounding as observational 
studies. An alternative method of analysis is per-protocol analysis. In this method subjects are 
censored at the first time they depart from their randomised treatment. Per-protocol analysis 
therefore requires a binary definition of compliance, in order to specify the time at which the 
departure occurred. An underlying assumption of per-protocol analysis is that the two groups 
of subjects in each treatment arm that have not departed from their allocated treatment are 
comparable. 211 If this assumption does not hold, the per-protocol estimate will be subject to 
selection bias. 
Statistical methods have been developed to estimate treatment efficacy in the presence of non- 
compliance while respecting the randomisation. These methods are all applications of 
instrumental variables methods, which are commonly used in economics. In epidemiological_ 
terminology, an instrumental variable is a variable that is independent of all confounders of the 
exposure-outcome association, is associated with exposure, but is independent of outcome 
given exposure and confounders. 212 This relationship is shown in Figure 8.1. In the context of 
RCTs, the randomisation is an instrumental variable, and can be used as such in analyses of the 
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effect of treatment actually received on outcome. 




Exposure I ýl Outcome 
I Confounders I 
A key concept in causal modelling is that of counterfactual (or potential) outcomes. Causal 
models aim to compare the outcome that would have been observed for a particu lar person 
under different treatment regimes. For example, the motivating example for this chapter is an 
analysis of the effect of sunscreen use on time to first basal cell carcinoma (BCC). The causal 
effect of sunscreen is obtained by comparing the time to BCC that would be observed if 
sunscreen was used every day with the time to BCC that would be observed if sunscreen was 
never used, with both outcomes relating to the same person. Only one outcome is observed for 
each person in a study, and all other outcomes are therefore contrary to fact and are termed 
counterfactual outcomes. This idea of defining causal effects by counterfactual outcomes has 
been called RubWs Causal Mode1213 following publications by Rubin. 214-217 The number of 
counterfactual outcomes for each individual in a study is potentially very large. This number is 
often limited by using the stable unit-treatment value assumption (SUTVA). 216 This states that the 
causal effect of treatment for an individual in the study is not affected by the treatment received 
by other individuals. In studies where treatment is binary (i. e. an individual either receives 
treatment or not) there are only two counterfactual outcomes for each person. 
Background literature on methods which respect the randomisation and estimate treatment 
efficacy in the presence of non-compliance in RCTs are now described. Three specific methods 
are described in detail; estimation of complier average causal effects, rank preserving structural 
failure time models, and structural nested mean models. 
8.2. Methods for estimating treatment efficacy in the presence 
of departures from allocated treatment in RCTs 
Binary Compliance 
8.2.1.1 Estimation of complier average causal effects 
In many of the methods for analysing departures from allocated treatment in RCTs, it is 
assumed that compliance is all-or-nothing, i. e. that subjects either always take their allocated 
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treatment for the duration of the trial, or never take it. In these methods, participants are often 
divided into strata based on the treatment they would take if they were allocated to either the 
intervention or the control arm. Compliers are participants that would take the intervention 
treatment if and only if they were randomised to the intervention arn-L Always-takers will 
always receive the intervention treatment, and never-takers will never receive the intervention 
treatment, regardless of the trial arm they are randon-dsed to. Defiers will take treatment if and 
only if they are randon-dsed not to receive it. These classifications have been called compliance- 
types'12 or principal strata. 218 Table 8.1 shows the principal strata in terms of randon-tised status 
and treatment received, and demonstrates that, without further assumptions, the principal 
strata are not observable. For example, people in the intervention arm who take the allocated 
treatment are either compliers or always-takers. If subjects in the intervention arm do not take 
the intervention treatment, they are either defiers or never-takers. 
Table 8.1: Principal strata according to randomised status and treatment received. 
Randomised Treatment received 
group Yes No 
Intervention Always-taker Never-taker Complier Defier 
Control Always-taker Never-taker Defier Complier 
Methods using the principal stratification framework often assume that there are no defiers, (the 
monotonicity assumption). This allows identification of never-takers in the intervention arm and 
always-takers in the control arm (see Table 8.1). Using the fact that compliance-type is a pre- 
randomisation variable, and should therefore be independent of the Tandon-tised groups, the 
prevalence of never-takers (p,, ) and the prevalence of always-takers (p. ) in the population can 
be estimated using the observed proportions in each trial arm. The prevalence of compliers (pc) 
in the population can then be estimated as pc=1-pn-p.. 
Another common assumption is that if the randomisation does not affect the treatment actually 
received (as in the case of always and never-takers), then the randon-tisation does not affect the 
outcome. This is referred to as the exclusion restriction assumption. If interest lies in estimating 
an additive treatment effect on a continuous outcome, the exclusion restriction assumption 
states that the mean outcome for always-takers is the same in the intervention arm as in the 
control arm. The same argument applies to mean outcomes for never-takers. The only group, 
therefore, that has a different mean outcome in the intervention arm to the control arm is the 
group of compliers (assuming there are no defiers). 
Estimation is usually of the efficacy of treatment among the compliers, and has been called the 
complier average causal effect (CACE). In the case of an additive treatment effect on mean 
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outcome, CACE estimation is intuitively simple. If the mean outcomes in the intervention and 
control groups are respectively denoted by 71 and TC, the ITT estimate in this situation equals 
Yj -YC. In terms of mean outcomes in the principal strata, the ITT estimate equals 
pc ýt, j -g, O), where pc, and gco are the mean outcomes among the compliers in the 
intervention and control groups respectively. There is no contribution to the ITT estimate from 
the always-takers and the never-takers because of the exclusion-restriction assumption of no 
difference in mean outcomes in the two randomised groups for always-takers and never-takers. 
The CACE estimate is therefore simply the ITT estimate divided by the estimate of pc. A similar 
argument can be followed to obtain CACE estimates for binary or time-to-event outcomes and 
other measures of treatment efficacy, such as risk ratios. 211 
The description above shows an intuitively simple method to estimate the CACE point 
estimate. It is not clear, however, how to estimate confidence intervals (Cls) for the CACE 
estimate. A simple method, which ignores any uncertainty in estimation of additional 
parameters (such as p, ), is to follow the same method, but to use the ITT confidence limits 
where the IT17 estimate would be used. Other possibilities are estimation via the delta method, 
using resampling techniques, such as the bootstrap or jackknife, or using Bayesian methods to 
obtain credible intervals from posterior distributions. 
Some of the literature describing methods for obtaining CACE estimates is now described. 
8ZII Background literature on CACE estimation 
Sommer and Zeger219 proposed a method to estimate the efficacy of vitamin A supplementation 
on mortality in a RCT with non-compliance. Children living in 225 randomly selected villages 
received vitamin A supplementation and were compared with children living in the remaining 
225 viHages that were not selected to receive supplementation. Their method was based on a 
comparison of compliant subjects in each arm of the trial. As there was no placebo control in 
the trial considered, compliance in the control arm was not observed. Four probabilities based 
on compliance type and outcome were therefore inferred for the control arm from data from the 
intervention arm; the probability of being a complier and alive, the probability of being a 
complier and dead, the probability for being a non-complier and alive, and the probability of 
being a non-complier and dead. To infer these probabilities, it was assumed that the expected 
rate of compliance was the same in both trial arms, and the expected mortality rate was the 
same in non-compliers; in both arms. The number people in each of the four classifications in 
the control arm could then be derived from the probabilities. The estimate of efficacy was a 
ratio of the risk ratios among compliers; in the intervention and control arms. As there was no 
placebo control, the estimated efficacy was a combination of the biologic efficacy of vitamin A 
and a placebo effect. The method applies only to all-or-nothing compliance and dichotomous 
outcome variables. Further assumptions are required to allow analysis of polytomous or 
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continuous compliance variables. The delta method was used to estimate the variance of the 
efficacy estimate. This method also does not allow for clustered responses, and therefore 
produces 95% CIs that are too precise. An extension to adjust variance estimates for clustering 
was proposed by Albertý2" 
Another method that estimates treatment efficacy among compliers; where outcome is binary 
was described by Cuzick, Edwards and Segnan. 2n Their method incorporated non-compliance 
in both treatment arras, so that participants in the control arm were able receive the intervention 
treatment. The method was described in terms of the principal strata, although efficacy could 
only be estimated in the group of compliers with further assumptions such as equality of 
treatment effects in all principal strata, or the absence of defiers. Time to event outcomes may 
be incorporated into the method by dividing the follow-up period into several intervals and 
using a method similar to that described for binary outcomes. This method is a generalization 
of the method described by Sommer and Zeger, 219 and also used the delta method to estimate 
the variance of the efficacy estimate. Branson and Whitehead222 developed a score test for the 
mode1221 assuming all-or-nothing compliance and binary outcome data. 
The principal stratification framework was also used by Angrist, Imbens and Rubin. 143 They 
described the application of instrumental variables to the problem of compliance in a 
randon-tised setting. They defined a Local Average Treatment Effect (LATE), which is the 
average causal effect for compliers, assuming that there are no defiers. The exclusion restriction 
and monotonicity assumptions were used to allow LATE estimation. Further assumptions, 
such as full compliance in the control arm were required for the LATE estimate to be an 
estimate of the treatment effect in a subpopulation identifiable from the observed data. 
Standard errors for the IV estimates were obtained using a normal approximation to the 
sampling distribution of the ratio of the difference in estimated probability of outcome between 
the intervention and control groups, and the difference in probability of treatment received 
between the intervention and control groups. This model was extended by Baker223 to account 
for survival outcomes, and used the delta method to estimate standard errors of efficacy 
estimates. 
A Bayesian method of analysis which also used the principal stratification framework was 
described by Imbens and Rubin. 224 A major advantage of Bayesian methods in this setting is 
that the monotonicity assumption and exclusion restriction assumption are not required. The 
focus was on estimating the CACF, which is the same as the LATE estimate defined by Angrist, 
Imbens and Rubin. 143 The posterior distributions of the efficacy estimates were used to define 
the credible intervals. The method can be applied to both binary and continuous outcomes, and 
was illustrated using the vitamin A data of Sommer and Zeger. Z19 
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Hirano, Imbens, Rubin et al. 225 extended the Bayesian CACE estimation method224 to allow for 
baseline covariates, and the exclusion restriction was divided into two components; an 
exclusion restriction assumption for always-takers, and one for never-takers. This contrasts 
with previous methods in which the exclusion restriction was applied to both always- and 
never-takers together. This allows a sensitivity analysis of the impact of violation of the 
exclusion restriction assumption. The plausibility of violations of the exclusion restriction in 
always-takers and never-takers should be assessed in the context of the analysis in question. 
Credible intervals were again derived from the posterior distributions of the estimates. 
A further extension to the Bayesian CACE estimation methodS224,225 was provided by Frangakis, 
Rubin and ZhoU218 to allow for clustered randomisation where non-compliance can occur at the 
individual level. This can occur in clustered encouragement designs, in which, for example, GP 
practices are randomised to either offer a treatment or not, and patients within each practise 
may or may not actually receive the treatment. The method was demonstrated with a binary 
outcome, and credible intervals for the efficacy estimates were obtained from the posterior 
distributions. 
The issue of all-or-nothing compliance and non-ignorable missing outcomes in RCrs was 
considered by Frangakis and Rubin. 226 In this setting, ITT analysis is often based on the 
responders only and may therefore be biased. The authors proposed a method to obtain an ITT 
estimate that is unbiased in the presence of non-ignorable missing outcome data, based on a 
CACE estimate that can be obtained from the observed data. The delta method was used to 
estimate the variance of the efficacy estimate. The setting considered allows only for non- 
compliance in the intervention arm of the trial, although extensions to allow non-compliance in 
both trial arms are possible. 
Levy, O'Malley and Normand= extended the method of Frangakis and Rubin226 to allow 
adjustment for a continuous covariate in situations with all-or-nothing compliance. The model 
allows analysis of both continuous and binary outcomes, and CIs for the estimates were 
obtained using bootstrap resampling techniques. Simulation studies showed that the proposed 
estimators were unbiased when there were departures from the randon-dsed treatment, with 
non-ignorable missing outcomes, and where there was a true effect of a continuous covariate on 
the outcome. 
An all-or-nothing definition of compliance was used by Loeys and Goetghebeur228 in the 
complier proportional hazards effect of treatment (C-PROPHET) model. This model allows for 
compliance in RCTs using a proportional hazards model, and non-compliance is assumed to 
only be possible in the intervention arm. Variance estimates for the estimated parameters are 
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varying treatment, and partial compliance. A Stata command, written by Kim and White, 229 is 
available to implement this method. 
8Z1.3 Other methods 
Ten Have, Joffe and Cary230 proposed a method to obtain an estimate of the causal OR when 
there is treatment non-compliance. Rather than estimating a treatment effect among compliers, 
which is a common strategy in methods with binary compliance, the causal OR that would have 
been observed if everyone had received treatment was estimated. This approach does not 
require the monotonicity assumption, although it does require an assumption that treatment 
effects are the same in those who received treatment as those who did not. Simulation studies 
showed the parameter estimates were less biased than ITT or as-treated estimates, and the 
estimates had less bias than estimates obtained from a related method231 (described later) when 
there was a strong relationship between compliance type and outcome. 
The assumption of all-or-nothing compliance in principal stratification methods is often 
unrealistic. If it is possible for participants to switch treatment part way through a trial, and 
some participants do so, they cannot be classified into a principal stratum. Other analysis 
methods will be required under these circumstances. 
8.2.2. Partial Compliance 
Rather than assun-dng that compliance is all-or-nothing, methods have been proposed that will 
allow for a situation in which participants receive some, but possibly not all, of their allocated 
treatment. 
Efron and Feldman, 232 described a method for estimating a dose-response curve with partial 
compliance in a clinical trial of the effect of cholestyramine on cholesterol level. A model 
relating the outcome to the amount of treatment and the placebo response (the outcome that 
would be observed if the placebo were taken) was defined and used in the estimation of the 
dose-response curve. In general, the dose-response curve is not fully identified and therefore 
cannot be fully estimated, although a family of dose-response curves to which it belongs can be 
found. The curve can be fully estimated if either an assumption is made that there is no 
interaction between dose and placebo response, or if it is assumed that the dose-response curve 
is linear. Estimation of the dose-response curve also assumes that the placebo response and 
compliance are independent of the allocated treatment. In the example provided, however, 
compliance was better in the control group. This was accounted for by applying a simple 
adjustment to the compliance in the control group, and using this adjusted compliance when 
estimating the dose-response curve. The variance of the dose-response curve was estimated by 
a linear function of compliance separately in each treatment group. The coefficients for this 
linear function were obtained first by regressing outcome on compliance in the treatment and 
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control groups separately, and then regressing the squared residuals on compliance. 
Zeger and LiangB3 extended Efron and FeldmanW32 method for cases in which compliance in 
the placebo and intervention groups is not comparable. In particular, they considered 
situations in which either the trial was not placebo controlled, or compliance with placebo was 
assumed to be irrelevant. They found that, under these circumstances, the dose-response curve 
could be estimated if a personýs response to treatment does not depend on their tendency to 
comply, and if the compliance-response curve is linear. No consideration was given to variance 
estimation for the effect estimates. 
The effect of errors in compliance measures in the model proposed by Zeger and Liang2m was 
considered by Dunn. 234 Using simulation studies, measurement errors were shown to bias the. 
required treatment-outcome effect estimates. A method for correcting for errors in compliance 
measures was proposed, using factor analysis. He concluded that measurement errors should 
be explicitly considered in compliance analyses, and that analysis models should be modified to 
account for sucli errors. 
Data from the Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT), 
previously analysed by Efron and Feldman, = were again used by Goetghebeur and 
Molenberghs. 2-15 In their method, compliance was a polytomous variable, with categories for 
less than 20%, between 20% and 60%, and greater than 60% compliance. Outcome was 
dichotomised, so that in the example a positive outcome corresponded to lowering cholesterol 
by at least 20 units. The dose-response curve was estimated in the different compliance subsets. 
It would be possible to extend the method to allow analysis of continuous outcomes with 
categorical compliance. The variance of the dose-response curve was estimated using solutions 
to the score equations. 
The relationship between a continuous compliance variable and a continuous outcome variable 
was considered by Albert, 236 with a focus on determining a threshold dose beyond which 
treatment has no further effect. The dose response was defined as the difference between the 
outcome at a specific dose and zero dose, and was related linearly to dose less than a threshold 
value, with no further effect of dose above the threshold. Bootstrapping was used to estimate 
Cls for the threshold dose. 
8.2.3. Repeated Compliance Measures 
Another possible framework for data on compliance in RCrs Is that there may be repeated 
measures over time. In this section, methods that allow repeated binary compliance measures 
are described. 
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8.2.3.1 Rank preserving structural failure time models 
The rank preserving structural failure time model (RPSFTM) was originally proposed by Robins 
and TsiatiS. 237 Treatment received is related to failure time by an acceleration parameter that 
describes the amount lifetime is lengthened (or shortened) by treatment. A simple RPSFTM is 
-T 
Equation 8.1: Uj = 
jexp(pXj(t))dt 
where Ui is the possibly counterfactual treatment-free failure time (i. e. the failure time that 
would be observed if no treatment was received), Ti is the observed lifetime, P is the 
acceleration parameter to be estimated, and Xi(t) is treatment at time t. Using a binary variable 
to denote treatment received, the simple model assumes that the total time on (or off) treatment 
affects the causal treatment effect estimate, and therefore allows for repeated measures of 
treatment received. If Xi(t) is a binary variable, Equation 8.1 reduces to 
Equation 8.2: U, =TOj +e'Tli, 
where Toi is the time that X#) equals 0, and Tii is the time that Xi(t) equals 1. The quantity eP is 
known as the acceleration factor, and can be interpreted as the amount by which lifetime is 
accelerated by treatment. If eO <1 (equivalently, P <0) treatment is protective and extends 
lifetime. If eP>1 (equivalently, P>0) treatment is harmful and reduces lifetime, and if J-1 
(P =0) there is no effect of treatment. 
RPSFTMs respect the randomisation. If the ITT estimate has a 95% CI including the null value, 
the estimated parameter from the RPSFrM will also have a 95% Cl including the null value. 
The RPSFTM parameter estimate will show an effect in the same direction as but further from 
the null than the ITT estimate. 
The estimate of 0 from Equation 8. Z is found by searching for the value of 0 for which the 
distributions of the treatment-free failure times, U, are equal between treatment arms. This 
process uses the randon-tisation as an instrumental variable to find the causal treatment effect 
estimate. The treatment-free failure times are calculated for various values of P using Equation 
8.1 (or Equation 8.2 if the measures of treatment received are binary), and a log-rank test is used 
to test for the equality of the distributions between the randomised arms of the trial for each 
value of P. An interval bisection method or a grid search method can be used to find 
ý. For 
both methods, a range of values of 0 to search for the solution must be defined. The interval 
bisection method calculates the value of the log-rank statistic for the two values of 0 at either 
end of the search range. If the two log-rank statistics have opposite signs, there must be a 
solution between the two values of P. The interval is then bisected, and the process repeats 
until a value of P at which the log-rank statistic equals zero is found. If the initial two values of 
the log-rank statistic have the same sign the search range must be modified to find an interval 
which contains a solution. Alternatively, a grid search is possible. This evaluates the value of 
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the log-rank statistic at one end of the search range, and then increases the size of P in small 
steps until the other end of the search range is reached. The same methods can used to find the 
95% CI for 0, using the points at which the log-rank statistic is 1.96 and -1.96. Although the 
grid search method is more computationally intensive than the interval bisection method, one 
major advantage of the grid search method is that multiple solutions can be identified. This 
occurs when the log-rank statistic is equal to, for example, 0 for different values of P. White, 
Babiker, Walker et al. 238 propose a method to deal with this problem. If the log-rank statistic 
crosses the required values (-1.96,0 or 1.96) at the points ao, ai, ..., a,,, 
for even n, the estimate is 
n 
taken to be E(-l)'ai . This corresponds to an average of the 
first and last crossing points, 
1-0 
weighted by the total length of the interval between ao and a. for which the log-rank statistic is 
positive and negative. 
A further issue is that of censoring. Suppose, due to non-informative censoring such as 
adn-dnistrative end of follow-up or random loss to follow-up, follow-up for subject i ends at 
time Q. Then the censoring time for Ui, using Equation 8.1, is 
expoXi(t))dt. 
Clearly, Di is dependent on X,, and therefore censoring of the treatment-free failure time is 
informative. For unbiased estimation, this dependence between D and X must be removed. 
This is achieved by recensoring U at the earliest censoring time possible over all treatment 
scenarios. If it is possible for X to always be 0 or always be 1, the recensoring time is given by 
Dj(p)=n-dn(Cj, eOCj). 
Using this recensoring time, events occurring close to the end of follow up will not be used. 
This loss of events can be viewed as follows. Participants with a particular treatment history, 
and an event occurring close to the end of follow-up, would not have had an event observed 
had their treatment history been more favourable. A different method, such as inverse- 
probability-of-censoring weighting, is required if censoring of the observed failure time is 
informative (see the appendix in HernAn, Cole, Margolick et al. 231. Walker, White and 
Babiker240 proposed a method to avoid recensoring, and therefore loss of information, when 
using a RPSFrM by specifying a bivariate frailty model for the association between treatment 
received and the latent failure time. As the proposed method is parametric, model 
misspecification may bias effect estimates. 
RPSFTMs have also been described by White, Babiker, Walker et al., 238 and White, Walker and 
Babiker241 described a Stata command that allows implementation of the model. There was. 
some work on bivariate models by White et al., 238 although they concluded that the models 
proposed have little power or robustness for estimating more than one parameter. Further 
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examples of the use of RPSFrMs were provided by Mark and Robins, 242 and Wmte, Walker, 
Babiker et al. 243 
While the acceleration factor has a simple interpretation, effect estimates for time to event 
analyses are more commonly presented as hazard ratios. White, Babiker, Walker et al. 238 
proposed a method to obtain hazard ratios by correcting the event times using Equation &Z so 
that Tj' =TOj +eOTjj if the participant is randon-dsed to the control arm, and Tj* =e-OTO, +Tj if 
the participant is randon-dsed to the intervention arm. These corrected event times are the times 
that would have been observed had the subject remained on their randon-dy allocated 
treatment. The corrected event times are recensored in an analogous way to the recensoring 
described above, at the minimum censoring time of T' over all possible treatment histories. For 
participants who do not change from their randomly allocated treatment, censoring of T' 
therefore occurs at Ci. For participants who do change from their randomly allocated treatment, 
censoring of r occurs at n-dn(Ci, CieO) in the control arm, and at n-dn(Ci, Cie-0) in the intervention 
arm. The corrected times are then used in a proportional hazards model to obtain hazard ratios. 
This hazard ratio does not account for error in the acceleration parameter White et al. 238 
suggested that two 95% Cls should be presented for these hazard ratios. The first is a Cl 
symmetric around the log hazard ratio, and with the same p-value as the ITT analysis. The 
second Cl is the one obtained by taking 1,000 bootstrapped samples from each arm of the trial 
separately and estimating the hazard ratio in each bootstrap sample. It is possible that an 
estimate for the acceleration parameter will not be found in all bootstrapped datasets. In this 
situation, White et al. 2m calculated the corrected event time r using an extreme value of the 
acceleration parameter, and censored the resulting hazard ratio. 
Problems may arise when estimating the causal parameter and 95% Cl from a RPSFTM. For 
example, it may be impossible to find the 95% confidence limits, or there may be multiple 
possible values for the point estimate. These problems arise due to an inability of the model to 
distinguish true values of the causal parameter from other values. Mark and RobinS244 used 
simulation studies to investigate these problems. They found that the problems were a function 
of compliance, so that as compliance worsened the 95% Cls increased until the limits became 
infinite and the graph of the test statistic against the acceleration parameter became non- 
monotonic. If the probability of actually receiving the intervention treatment is equal in both 
randomised arms, the trial data cannot provide any information about the true effect of 
receiving treatment, as the survival curves in each arm will be equal in expectation. 
The simulation studies presented by Mark and Robins244 were extended by Korhonen, Laird 
and Palmgren, 245 with particular emphasis on situations in which there are unmeasured 
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confounders of the association between treatment received and outcome. They found that 
RPSFTMs can deal with unmeasured confounders at baseline, because the distribution of the 
confounders should be equal between the randon-dsed arms. 
RPSFTMs were extended to allow for clustering of outcomes in cluster randomised trials by 
Korhonen, Loeys, Goetghebeur et al. 246 and Loeys, Vansteelandt, and Goetghebeur. 247. In the 
first method, the treatment-free survival time was assumed to follow a proportional hazards 
model conditional on another covariate (age in their example), and then a robust covariance 
estimator was used to allow for the effect of clustering. The second method additionally allows 
for a cluster-specific frailty in the assumed proportional hazards model for treatment-free, 
survival. The treatment effect was estimated as the value at which the treatment-free survival 
time is independent of the randornisation. 
Loeys and Goetghebeurm extended the RPSFTM method to include baseline information. In 
the extension, a proportional hazards model related the baseline covariates to the treatment-free 
failure time. A RPSFTM was then used to estimate the effect of treatment on failure time. This 
method can lead to more precise estimates of the acceleration parameter than using log-rank 
tests, which is a common method of estimating the acceleration parameter in RPSFTMs. 
RPSFTMs were extended by MatsuI249 to analyse time to repeated failure events in RCTs with 
non-compliance and informative censoring. An accelerated failure time model was defined for 
the time to each repeated outcome, and a separate model for the dependent censoring time. The 
method requires estimation of two parameters from the two accelerated failure time models. 
Vandebosch, Goetghebeur and Van Damme2m also extended RPSFTMs to account for multiple 
failure events. They combined the RPSFTM proposed by Robins and TsiatiSM7 with the method 
proposed by Wei, Lin and Weissfeld2s' to deal with multiple failure events. Only non-_ 
informative censoring was considered. 
8.2.3.2 Other methods 
A model to analyse the effect of compliance in a trial with repeated binary outcomes was 
proposed by Sato. 252 In the method, exposure to the intervention treatment was binary and was, 
measured on several different occasions. The focus was on estimating the causal risk difference, 
and estimation used the Mantel trend statistic. An estimator of the risk ratio was also 
presented, which is a generalisation of the estimator described by Cuzick, Edwards and 
Segnan. 2m The method calculates the predicted number of participants in the intervention 
group that would have had a certain number of events if they had taken the control treatment, 
for each possible compliance pattern and each possible number of events. In situations where 
there are more than three repeated measures of compliance the method therefore becomes 
difficult to use, as the number of possible compliance patterns increases exponentially. The 
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authors suggested only calculating the predicted numbers for the compliance patterns observed 
in the data. 
A different method for analysing data with repeated compliance measures was proposed by 
Robins and Finkelstein. 253 In this method, a subject was regarded as censored the first time they 
stop their randomised treatment, switch treatments, or drop out of the study. Inverse- 
probability-of-censoring weights were then used to weight a log-rank test of the equality of 
survival distributions between the randomised arms. Repeated measures of compliance with 
the allocated treatment are therefore used in the model, but a binary definition of compliance is 
required to identify the first time a subject is non-compliant. This analysis method could result 
in loss of information, due to observed failures being artificially censored in those subjects that 
did not adhere to their randon-dsed treatment. As loss of information increases, the widths of 
95% CIs around the point estimates will also increase. 
8.2.4. Repeated Measures and Partial Compliance 
In the most general setting, trial data will contain repeated measures of partial compliance. 
Some methods have been developed to analyse such data. 
8.2.4.1 Structural nested mean models 
Robins254,255 proposed structural nested mean models (SNMMs) to correct for non-compliance 
in randon-dsed trials. The model allows for mean treatment to be measured at several time 
points, and therefore uses repeated measures of partial compliance. The models were originally 
developed for continuous outcomes, which may be repeated, and can be applied in a fairly 
general RCT setting. 
For continuous outcomes, the basic principle of SNMMs compares the observed outcome to the 
outcome that would have been observed if no treatment was received. The description of the 
method provided by Robins254 is complex, but a more accessible description has been provided 
by Goetghebeur and Vansteelandt. 256 The aim is to estimate 
Equation 8.3: E(Y - YO ID, X, R= 1), 
where Y is the observed outcome, Yo is the outcome that would have been observed if no 
treatment had been received, D is the treatment received, X is a vector of baseline covariates, 
and R is the randon-dsation indicator. Several assumptions are required to estimate Equation 
8.3. 
The first assumption is the consistency assumption. This states that, for both treatment arms and 
for given baseline covariates, the observed outcome when no treatment is received corresponds 
to Yo, the possibly counterfactual treatment-free outcome. 
The second assumption is the randomisation assumption. This states that YO is independent of the 
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randomisation. This assumption is particularly useful when the control group cannot receive 
treatment, but is also useful when all trial participants can receive treatment. When subjects in 
the control arm cannot receive treatment the observed outcomes Y in the control arm will equal 
the treatment-free outcomes Yo. The distribution of Yo can then be estimated in this arm and, 
using the randomisation assumption, the same distribution of counterfactual outcomes applies 
in the treatment arm. 
Third, a causal model relating treatment received to the difference between Y and Yo must be 
assumed. This may be generally written as 
E(Y - YO ID, X, R) = DVj (p 
where VR is a vector function of the baseline covariates, and may be different in the different 
randomised arms, and (p is a vector of causal parameters to be estimated. Estimation is 
complex, as Y-Yo is only observed when no treatment is received and equals zero, and is 
achieved via the estimating equations: 
n 
I: w(XiXRi -P(Ri =11XI&j -DjVj(Xjp-q(Xj)j=0 
i-I 
where w(X) is a vector function and q(X) is a scalar function of baseline covariates. Robins254 
provided optimal choices for these functions. It is not clear how to estimate the variance of ý. 
Goetghebeur and Lapp, 2v Lapp and Goetghebeurm and Loeys, Vansteelandt and 
Goetghebeur247 have provided expressions for variance estimation in the specific settings 
considered in their papers. 
The use of SNMMs in a more restricted setting of a placebo controlled trial was demonstrated 
by Goetghebeur and Lapp. 257 Fischer-Lapp and Goetghebeur2w compared estimated 
parameters from SNMMs and ordinary least squares in situations in which the compliance 
measures were continuous. They found that the SNMM estimator was preferable, particularly 
where the treatment-outcome relationship suffered from unmeasured confounding. 
The method proposed by Matsuyama, 259 which allows for repeated compliance and outcome 
measures, is a special case of a SNMM when outcome at time t is assumed to depend only on 
treatment at time t-1. Compliance and outcome were both binary variables, and estimation of 
both the causal risk difference and causal risk ratio were discussed. 
SNMMs were extended by Loeys, Vansteelandt and Goetghebeur247 to allow for different effects 
of treatment between clusters in cluster randon-dsed trials. A cluster-specific parameter was 
included in the model which quantified how different the effect of treatment was in a specific. 
cluster compared with the general population. The population treatment effect was estimated 
using a test of no difference in treatment effects between randon-ised arms. The variance of the, 
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cluster-specific treatment parameter was estimated by testing for equal means of the square of 
the treatment-free outcomes between each randon-dsed arm. These treatment-free outcomes 
may be counterfactuals, and were therefore estimated from the observed outcomes using the 
estimate of the population treatment effect. 
Joffe and Bresinger260 extended SNMMs to allow weights in analyses of the efficacy of treatment 
in RCrs. Tluoughout, outcome was a continuous variable, and compliance was a fixed 
proportion between one and zero. It was hypothesized that compliers provide more 
information about treatment efficacy, and therefore weighting by the compliance score (the 
effect of randomisation on treatment received) was used to increase the precision of efficacy 
estimates. 
The impact of measurement error in treatment received when using linear SNMMS was 
investigated by Goetghebeur and Vansteelandt. 2% They found that parameter estimates were 
asymptotically unbiased in the presence of random treatment measurement error. Similarly, 
differential measurement error causes no bias in the SNMM parameter estimates. This contrasts 
with results from standard linear regression, in which random treatment measurement error 
will bias parameter estimates towards the null value, and differential measurement error may 
bias estimates in either direction (see Section 2.3). A classical measurement error model causes 
an increase in the variance of parameter estimates from SNMMs. Neither random nor 
systematic treatment measurement errors affect the a-level of hypothesis tests of no causal 
effect of treatment, but there may be a loss of power. If the treatment measurement error is 
systematic, with the bias known, a simple transformation is required in the treatment variable 
to enable unbiased estimation of the causal parameter of the SNMM. These results provide 
some reassurance that errors in compliance measures will not impact greatly on parameter 
estimates for analyses of this type. 
8.2.4.2 Other methods 
Participants in a RCT may often switch between the intervention and control arms, especially if 
the trial is placebo controlled. The method proposed by Nagelkerke, Fidler, Bemsen et al. 231 can 
account for such treatment crossover. They suggested that there is a variable, uncorrelated with 
randomised status, that when used in a regression analysis along with the variable describing 
treatment received removes all confounding that would arise from an as-treated analyses. This 
variable is equal to the residual of the regression of treatment received on randomised status. 
Their method may also apply to measures of partial compliance, if the treatment effect is 
assumed to be monotonically increasing with the amount of treatment received, and to time- 
varying treatments. 
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8.3. Summary 
There are many methods available for analysing the effect of departures from allocated 
treatment in RCTs. Of all of the methods described in this chapter, CACE estimation, 
estimation using RPSFTMs and estimation using SNMMs appear to be the most well developed. 
The choice of model to use depends on the available compliance data and the outcome of 
interest. For example, in situations in which treatment is either received or not, such as for 
surgical interventions, CACE estimation methods can be used. These methods can be applied 
to a wide variety of outcomes. For more complex measures of compliance, for example 
repeated measures, or a single partial compliance measure, CACE estimation could still be used 
if the compliance data could be summarised as a single binary measure. In this situation, 
however, other methods to estimate treatment efficacy may be more appropriate. Rank 
preserving structural failure time models can be used with more complex compliance data 
where the total time using treatment can be calculated, but only allow for failure time outcomes. 
Structural nested mean models are also applicable to situations with complex compliance data, 
and may be used for continuous or binary outcomes. 
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Chapter 9. 
Background literature: The association between sunlight and 
basal cell carcinoma 
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Introduction 
The literature reviewed in this chapter is motivated by an analysis of the effect of sunscreen use 
on basal cell carcinoma (BCC), allowing for departures from allocated treatment in an RC`r, that 
will be presented in Chapter 10. Basal cell carcinoma is the most common form of skin cancer, 
and is locally invasive but very rarely metastasizes. 261 The other two main types of skin cancer, 
squamous cell carcinoma (SCC) and melanoma, are not considered here. 
In 2004, a review of environmental risk factors leading to the development of BCC was 
published. 262 Included among the numerous risk factors were ultraviolet (UV) radiation, 
smoking, occupational exposure to risk factors such as asphalt, mineral oils and 
organophosphate compounds, ingestion of arsenic containing medicines or arsenic 
contaminated water, and ionising radiation. 
The risk factor of interest in this chapter is UV radiation or, more generally, exposure to 
sunlight. Evidence for the relationship between sunlight and BCC has been reviewed, 263 and 
BCCs were found to be more frequent in people residing closer to the equator, in those with 
sun-sensitive skin, in those with high levels of sun exposure, and in people with benign sun, 
related skin lesions such as actinic keratoses. BCCs also occurred more frequently on sun- 
exposed sites, and were reduced by sun protection behaviour, such as wearing a hat. These six 
areas of evidence are reviewed below. 
Papers were identified by searching Medline for articles under the medical subject headings of 
basal cell carcinoma and ultraviolet rays or sunlight. Titles and abstracts were reviewed and 
the relevant articles obtained. Additional articles were obtained by reviewing the reference lists, 
of these papers. 
9.2. The association between sunlight and BCC 
Area of residence 
There is some evidence that the risk of BCC increases as the distance of the region of residence 
from the equator decreases. For example, in a study conducted in the United StateO4 residents 
of California and Florida had an increased risk of BCC when compared with residents of the 
north eastern states of Massachusetts, Connecticut, New York, New Jersey, Pennsylvania and 
Maryland. The hazard ratio for BCC for residents of California was 1.51 (1.25-1.83), while that 
for residents of Florida was 2.03 (1.46-2.83). TI-ds evidence of an increased risk was not found 
when comparing residents of Texas with residents of the north eastern states, however, where 
the hazard ratio was 1.05 (0.75-lA7). 
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A cross-sectional prevalence study conducted in Australia investigated the effect of latitude of 
residence on prevalent BCC. 265 There was evidence that living closer to the equator increased 
the risk of BCC. Among men, the rate ratio for BCC when comparing those who lived at 
latitudes less than 29" south with those who lived at latitudes greater than 37* south was 3.2 
(2.3-4.5). Among women, the rate ratio for BCC when comparing those who lived at latitudes 
less than 29* south with those who lived at latitudes greater than 37* south was 4.3 (2.9-6.5). 
Rate ratios and confidence intervals (Cls) comparing the intermediate category of between 29" 
south and 37* south with greater than 37* south were not provided. 
A case-control study in Western Australia investigated the effect of ambient solar radiance at 
the place of residence on BCC266 There was some evidence that the risk of BCC increased as the 
accumulated global radiance over the whole year increased. Accumulated global radiance was 
measured in n-dlliwatt hours per centimetre squared (mWh crn-2). When compared with people 
with 8.8x10-5 mWh crn-2 or less, between 8.8x10-5 mWh crn-2 and 10.140-5 mWh Cm-2 gave an 
odds ratio (OR) for BCC of 1.32 (0.69-2.55), between 10.1x10-5 mWh cm-2 and 11.440-5 mWh Cm-2 
gave an OR of 1.72 (0.72-4.09), and 11.4404 mWh crn-2 or more gave an OR of 2.18 (0.82-5.82). 
The p-value for trend was 0.11. There was stronger evidence that the risk of BCC increased 
with accumulated global radiance over the warmer months. When compared with 5.8xI0-5 
mWh cm-2 or less, between 5.8x10-5 mWh crn-2 and 6.740-5 mWh cnr2 gave an OR of 1.40 (0.69- 
2.85), between 6.740-5 mWh cm-2 and 7.540-5 mWh cnr2 gave an OR of 2.45 (0.94-6.40), and 
7.5x10-5 mWh cm-2 or more gave an OR of 3.44 (1.15-10.31). The p-value for trend was 0.02. 
Analyses from the Health Professionals Follow-Up Study found evidence of an association 
between living in a region with high levels of sunlight and risk of BCC. 267 The hazard ratio for 
BCC was 1.48 (1.36-1.60) when compared with residents of areas with low levels of sunlight. 
There was little evidence that living in areas with medium levels of sunlight increased the risk 
of BCC when compared with areas with low levels of sunlight, as the hazard ratio for BCC was 
1.01 (0.92-1.11). The p-value for trend, however, was less than 0.0001, providing strong 
evidence that the risk of BCC increases with increasing amounts of sunlight in the region of 
residence. There was also evidence that the risk of BCC was increased for people who had 
always lived in areas with high levels of sunlight (hazard ratio=1.46 (1.29-1.66)), and for people 
who only lived in an area with high levels of sunlight at the time of the study (hazard ratio-1.60 
(1.40-1.83)) when compared with people who had always lived in areas with low levels of 
sunlight. There was little evidence that living in an area with high levels of sunlight as a child 
increased the risk of BCC, as the hazard ratio for BCC was 1.08 (0.80-1.45) when compared with 
people who had always lived in areas with low levels of sunlight. There was some evidence 
that the risk of BCC was increased for people who did not fit into any of the categories above 
(e. g. always living in areas with medium levels of sunlight) when compared with people who 
had always lived in areas with low levels of sun exposure, as the hazard ratio 
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for BCC was 1.09 (0.99-1.20). 
The results described above are summarised in Table 9.1, and appear to suggest that living in 
areas closer to the equator and with higher levels of ambient solar irradiance increases the risk 
of BCC. There are several hypotheses for this relationship. Kricker, Armstrong, English et al. 266 
suggested that the association between area of residence and BCC could be due to increased 
intensity of exposure at areas of higher ambient solar irradiance, or that there is greater 
opportunity for outdoor activity in sunnier areas. Hunter, Colditz, Stampfer et al. 264 suggested 
that there n-dght be increased exposure to ultraviolet-B (UVB) radiation in areas closer to the 
equator. The lack of evidence of an association between residence in Texas and BCC may be 
due to differences in sun exposure. Residents of Texas reported spending the least amount of 
time outside in summer of all of the states studied. 264 A further possible explanation for the 
apparent higher risk of BCC in sunnier areas is that the rates of detection of BCC in these areas 
are higher. 267 
9.2.2. Skin sensitivity to sun exposure 
People with skin that tends to bum rather than tan have been shown to be at increased risk of 
BCC. For example, a study in Australia268 found a rate ratio of 2.1 (p value=0.006) when 
comparing people who burned without tanning on their first sun exposure of the year with 
those who tanned only. There was, however, no control for confounding when estimating this 
association. 
Evidence of an increased risk of BCC with skin that bums rather than tans was found in a cross- 
sectional study in the United States. 269 Comparing skin that burns with skin that tans, the OR 
for BCC was 2.72 (1.13-6.55). 
In a case-control study in Western Australia, there was some evidence that the risk of BCC 
increased with increasing severity of skin reaction to sun exposure. 270 When compared with 
people who brown without burning, people who bum and then tan had an OR for BCC of 1.38 
(0.81-2.34), people who have pain and peeling had an OR for BCC of 1.69 (0.98-2.91), and people 
who bum with blistering had an OR for BCC of 1.53 (0.79-2.99). The p-value for trend was 0.09. 
A Canadian case-control study, however, found little evidence of an association between skin 
reaction to sun exposure and BCC. 2n Considering skin reaction to first sun exposure and when 
compared with people who never bum, people who bum after long exposure had an OR for 
BCC of 0.7 (0.4-1.3), people who burn after short exposure had an OR of 0.8 (0.4-1.5), and people 
who usually bum had an OR of 0.9 (0.4-1.9). There was also little evidence of an association 
between skin reaction to one week of sun exposure and BCC. When compared with people 
who tan without burning, people who tan when using sun protection had an OR of 1.1 (0.4-3.3), 
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people who bum then tan had an OR of 0.9 (0-6-1.5), and people who bum and never tan had an 
OR of 1.6 (0.8-3.2). 
The Helios study in Southern Europe found evidence of an association between skin reaction to 
sun exposure and BCC. 272 The OR for BCC was 2.70 (2.10-3.47) when comparing people who 
burned without tanning with those who did not bum. Evidence of increased risk of BCC was 
also found among people who had a less severe skin reaction to sun exposure. Compared with 
people who did not bum, those who burned and then tanned had an OR for BCC of 1.49 (1.26- 
1.78). 
The effect of skin reaction to two or more hours of sunlight as a child or adolescent was 
considered in a cohort study in the United States. 264 A hazard ratio for BCC of 2.41 (1.72-3.37) 
was found when comparing women who experienced painful sunburn with blisters with those 
who did not bum. Evidence of a ham-dul effect was also seen for less severe skin reactions to 
sun exposure as a child or adolescent. When compared with women who had no reaction to 
two hours or more of sun exposure, those who experienced painful burns had a hazard ratio for 
BCC of 1.70 (1.23-2.33), those who experienced burning had a hazard ratio of 1.87 (lA3-2.45), 
and those who experienced some redness had a hazard ratio of 1AO (1.09-1.80). The p-value for 
trend was less than 0.001, providing strong evidence that the risk of BCC increases with 
increasing severity of skin reaction in childhood or adolescence. 
Analysis of data from the Health Professionals Follow-Up Study found evidence that skin 
reaction to sun as an adolescent increased the risk of BCC267 When compared with people who 
tanned without burning in adolescence, those who burned than tanned had a hazard ratio for 
BCC of 1.51 (1.37-1.67), while those who burned painfuny then peeled had a hazard ratio for 
BCC of 2.13 (1.90-2.38). The p-value for trend was less than 0.0001, providing strong evidence - 
that the risk of BCC increases with increasing severity of skin reaction to sun exposure in 
adolescence. 
An Italian case-control study also found evidence of an association between skin reaction to sun 
exposure and BCC. M The OR for BCC was 2.4 (1.7-3.8) for skin that bums frequently or always 
when first exposed to sun compared with skin that never bums. There was little evidence of an 
association between skin that burns occasionally when first exposed to sunlight, where the OR 
was 1.1 (0.8-1.4) when compared with skin that never bums. The p-value for trend was less 
than 0.001, providing strong evidence that the risk of BCC increases with increasing severity of 
skin sensitivity to sun exposure. 
Strong evidence of a harmful association between skin sensitivity to sunlight and BCC was. 
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usually bums with little or no tanning, although the reference group for this analysis was 
unclear. 
Additional evidence for an association between skin sensitivity to sun exposure and BCC comes 
from a Spanish case-control study. 2n The OR for non-melanoma skin cancer (NMSC) (i. e. SCC 
and BCC) was 1.4 (1.0-2.2) when comparing men with a tendency to bum without tanning with 
those with a tendency to tan. Little evidence of an association between skin sensitivity and 
NMSC in women was found, however, as the OR comparing women who tend to burn without 
tanning with those who tan without burning was 0.7 (0.4-1.3). As analyses included SCCs the 
association between skin sensitivity to sun exposure and BCC alone is not clear. 
The results described above are summarised in Table 9.2. The evidence does not indicate a clear 
association between skin sensitivity to sun exposure and BCC, although it does seem to suggest 
that, if there is an association between skin sensitivity to sun exposure and BCC, that it is not 
protective. One possibility for the mixed results is that residual and unmeasured confounding 
is a problem in many of the estimated associations. 
9.2.3. Location of skin cancer 
The most common areas of the body for BCC to occur are the areas usually exposed to sunlight, 
such as the head, and least common are rarely exposed areas such as the abdomen. 
In a cross-sectional prevalence study in Australia, 276 92% of prevalent BCCs occurred on the 
head and neck. When this population was followed up for incident cases of NMSC 94% of 
incident BCCs occurred on the head and neck, with 6% occurring on the hands and forearMS. 268 
Only BCCs occurring on the head, neck, forearms and hands were considered in these studies. 
A further cross-sectional prevalence study was conducted in Australia in 1990.265 BCCS were 
most common on the head and neck, accounting for 66% of prevalent BCCs among men and 
69% of prevalent BCCs among women. The next most common site was the trunk, with 21% 
and 14% of prevalent BCCs in men and women respectively. The upper limbs accounted for 8% 
of the BCCs occurring in men and 9% of the BCCs occurring in women, while the lower limbs 
accounted for 4% and 6% in men and women respectively. The locat ion of the BCC was not 
determined for 1% of cases in men and 2% of cases in women. 
In a cross-sectional prevalence survey of 808 white male fishermen residing in Maryland in the 
United States, 78.3% of prevalent BCCs occurred on the face, head or neck. 269 The next most 
common location was the trunk with 13.3% of prevalent BCCs, followed by the upper 
extremities with 8.4% of prevalent BCCs. No BCCs were found on the lower extremities. 
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Basal cell carcinomas were shown to be most common on the head in a case-control study in 
Southern Europe, 272 accounting for 78.1% and 76.9% of cases in men and women respectively. 
The next most common site was the trunk, with 14.1% of cases in men and 10.1% of cases in 
women. BCCs on the neck, abdomen, upper limbs and lower limbs were less common, with 
each site accounting for less than 3% of cases in men, and 4.2% of cases in women. 
In a case-contrql study in SpainP NMSC was most common on the head, with 94.2% of the 
cases occurring there. The hunk was the next most common location and accounted for 2.9% of 
the cases. The neck, upper extremities and lower extremities accounted for 1.1%, 11% and 0.7% 
of the cases respectively. These results include both SCC and BCC 
In a case-control study in Italy, 2m 63.3% of cases had a BCC on the head or neck. The trunk was 
the next most common site with 27.7% of cases. Fewer BCCs were found on the limbs (7.2%), or 
at multiple sites (1.9%). 
Similar results were reported for a case-control study in Southern Germany, 277 where 58.2% of 
the BCCs in the cases were on the head. Acral BCCs (i. e. BCCs occurring on peripheral parts of 
the body, such as the ears or fingers) were the next most common, comprising 31.0% of all 
BCCs. BCCs on the trunk, lower extremities and upper extremities were much less common, 
comprising 6.6%, 2.8% and 1.4% of all cases respectively. 
These results are summarised in Table 93. The hypothesis that exposure to sunlight is a major 
cause of BCC is supported by the fact that, in every study described, the majority of BCCS 
occurred on the head and neck, which are commonly exposed to sunlighL That a higher 
proportion of BCCs occur on the hunk, an area less commonly exposed to sunlight, appears to 
contradict this hypothesis. Several reasons have been advanced for this. Marks et al. 265 
suggested that an increase in the proportion of BCCs observed on the trunk and upper limbs is 
due to a change in fashions, and less clothing being worn on these areas. Squamous cell 
carcinomas do not display the same distribution on the body as BCC Green et al. = suggested 
that the difference may be due to the fact that a lower amount of exposure to UV radiation is 
required for BCCs to develop than for SCCs. The pattern of sun exposure may also be 
important. Intermittency of exposure has been proposed as an explanation for the high 
proportions of BCCs seen on the trunk, an area that is infrequently exposed to sunlight. v9,280 
This idea was extended by Rosso et al., 281 who suggested that risk of BCC may be affected by 
how directly UV radiation reaches the basal layers. In intermittently exposed sites, such as the 
trunk, the skin protection against sunlight does not develop as quickly, and therefore the UV 
radiation enters the basal layer more directly. Once skin protection has developed, SCCs tend 
to form instead of BCCs. Of course, there may be a simple dose-response relationship between 
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develop. The lack of BCCs on the lower limbs, including the hands, may then be due to the skin 
on the hands providing more protection against BCC2w 
9.2.4. Level of sun exposure 
9.2.4.1 Sunbum 
Sunburn can be considered a marker of sun exposure, and evidence has been found for a 
harmful association between sunburn and BCC In a cohort study in the United States 1 264 
evidence of an increased risk of BCC was found when comparing six or more painful sunburns 
on the face and arms with none, with a hazard ratio of 1.90 (1.50-2.40). There was also evidence 
of increased hazard ratios for smaller numbers of lifetime sunburns. Compared with no severe 
or painful sunburns on the face and arms, women with three to five sunburns had a hazard 
ratio of 1.34 (1.05-1.71), and those with one or two sunburns had a hazard ratio of 1.18 (0.94- 
1.48). The p-value for trend was less than 0.001, providing strong evidence that the risk of BCC 
increases with increasing numbers of lifetime sunburns. 
There was, however, little evidence of an association between painful sunburn and BCC in a 
cohort study in Queensland, Australia. m When compared with people with no painful 
sunburns, people with one had an OR for BCC of 0.5 (0.2-1.4), people with between two and 
five painful sunburns had and OR for BCC of 0.6 (0.3-1.5), and people with six or more painful 
sunbums had an OR for BCC of 1.0 (0.4-2.5). 
There was similarly little evidence of an association between lifetime sunburn pain and BCC in 
a Canadian case-control study. 2n When comparing people who had ever experienced two days 
or more of sunburn pain over their lifetime with people who had never experience such 
sunburn pain, the OR for BCC was 0.9 (0.6-13). There was some evidence that sunburn pain 
over the last decade had a harmful association with BCC. Comparing people who had 
experienced two days or more of sunburn pain over the last decade with people who had not, 
the OR for BCC was 2.3 (0.8-6.6). 
A case-control study in Western Australia279 found evidence of an increased risk of BCC when 
comparing people with between three and ten sunburns to people with none with an OR of 1.75 
(1.08-2.85). There was also some evidence of an association when people with eleven or more 
sunburns were compared with those with none, with an OR for BCC of 1.50 (0.99-2.26). There 
was little evidence of an association between having one or two sunburns and BCC, where the 
OR was 1.09 (0.67-1.79). There was some evidence of a harmful association between blistering 
sunburns and BCC. When comparing people with one or two blistering sunburns to people 
with no sunburn, the OR for BCC was 1.60 (0.92-2.79). There was, however, little evidence of an 
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1.55)), or when comparing three or more blistering sunburns with no sunburn (OR - 1.24 (0.69- 
2.24)). 
In a case-control study in Southern Europe, some evidence was found of an association between 
number of lifetime sunburns and BCC-272 Compared with people with no sunburns, people 
with one sunburn had an OR for BCC of 1.13 (0.94-1.36), those with two sunburns had an OR of 
1.30 (0.92-1.84), and those with three or more sunburns had an OR of 1.30 (0.95-1.78). The p- 
value for trend was 0.031, providing some evidence that the risk of BCC increases with an 
increasing number of lifetime sunburns. 
Analyses from the Health Professionals Follow-Up Study found evidence of an association 
between lifetime number of blistering sunburns and risk of BCC. 267 When compared with 
people with no blistering sunburns in their lifetime, people with one or two had a hazard ratio 
for BCC of 1.14 (1.00-1.30), people with between three and five had a hazard ratio for BCC of 
1.20 (1.05-1.38), people with between six and nine had a hazard ratio for BCC of 1.33 (1.14-1.54), 
and people with ten or more had a hazard ratio for BCC of 1.49 (1.30-1.71). The p-value for 
trend was less than 0.0001, providing strong evidence that the risk of BCC increases with 
increasing numbers of lifetime blistering sunburns. 
Evidence of an association between sunburn 20 years before the diagnosis of BCC and BCC was 
found in a German case-control study. 277 The OR for BCC was 3.6 (1.9-6.8) when comparing 
people who experienced sunburn with those who did not. 
The estimated associations between sunburn and BCC described above are summarised in 
TabIe 9.4. 
9.2.4.2 Occupational sun exposure 
There is some evidence that occupational sun exposure is associated with BCC. A cohort study 
in Australia268 found a rate ratio for BCC of 1.6 (p value=0.030) when comparing people who 
work outdoors with those who work indoors. No control for confounding was made when 
estimating this association. 
A cohort study in Queensland, Australia, 282 found some evidence of an association between 
occupational exposure to sunlight and BCC when comparing people who work indoors and 
outdoors to people who work mainly indoors (OR=1.5 (0.9-2.9)). There was little evidence of an 
association between working mainly outdoors and BCC, where the OR for BCC was 1.3 (0.6-2.8) 
when compared with people who work mainly indoors. 
Sin-dlarly, little evidence of an association between occupational sun exposure and BCC was 
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found in a Canadian case-control study. 271 When compared with less than 3.5 hours per week 
of occupational sun exposure in summer, between 3.5 and 13.9 hours per week of exposure had 
an OR for BCC of 1.0 (0.6-1.8), between 14 and 24.9 hours per week of exposure had an OR for 
BCC of 1.3 (0.8-Z3), and 25 hours per week or more had an OR for BCC of 1A (0.8-2.4). The p- 
value for trend was greater than 0.05. 
There was littleevidence of an association between occupational exposure to sunlight and BCC 
in a case-control study in Western Australia. 266 When compared with 14,700 hours of 
accumulated sun exposure on working days since the age of 15, between 14,800 hours and 
27,700 hours had an OR for BCC of 1.25 (0.79-1.97), between 27,800 hours and 49,300 hours had 
an OR for BCC of 1.17 (0.72-1.90), and 49,400 hours or more had an OR for BCC of 0.86 (0.50- 
1.51). The p-value for trend was 0.46. 
Little evidence of an association between occupational sun exposure and BCC was found in a 
European case-control study. 281 When compared with people with less than 7,200 hours of sun 
exposure during outdoor work, between 7,200 hours and 54,720 hours of exposure gave an OR 
for BCC of 1.02 (0.84-1.24), and more than 54,720 hours gave an OR for BCC of 1.00 (0.78-130). 
Some evidence of a harmful association between occupational sun exposure and BCC was 
found by an Italian case-control study. 2" When comparing intermediate levels of occupational 
sun exposure with low levels, the OR for BCC was 1.4 (0.9-2.0). There was, however, little 
evidence of an association when comparing high levels of occupational sun exposure with low 
levels, where the OR for BCC was 0.9 (0.6-13). There was little evidence of an increasing risk of 
BCC with increasing levels of occupational sun exposure, as the p-value for trend was 0.69. . 
Evidence of an association between outdoor work in summer and BCC was found in a 
Yugoslavian case-control study, 274 with an OR for BCC of 3.95 (1.62-9.66). The reference 
category for this analysis was unclear. 
A German case-control study also found evidence of a harmful association between 
occupational sun exposure and BCC277 The OR for BCC was 2.4 (134.7) when comparing 
frequent or occasional occupational UV exposure with rare or no UV exposure. 
Evidence of an association between occupational sun exposure and NMSC was found am ong 
men in a Spanish case-control study. 275 The OR for BCC was 5.3 (3.1-92) when comparing, 
chronic occupational sun exposure of more than 4.8 hours per day with less than 1.7 hours per 
day. Comparing men with between 3.6 and 4.8 hours per day of occupational sun exposure 
with those with less than 1.7 hours per day, the OR for NMSC was 2.5 (1-5-43). There was little 
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men with exposure of between 1.7 and 3.6 hours per day with men with less than 1.7 hours per 
day of exposure (OR=1.2 (0.6-2.2)). Little evidence of an association between occupational sun 
exposure and NMSC was found for women, however, for any of the categories of occupational 
sun exposure. When compared with less than 1.7 hours per day of chronic occupational 
exposure, women with between 1.7 and 3.6 hours per day of exposure had an OR for BCC of 2.1 
(0.8-5.6), women with between 3.6 and 4.8 hours per day of exposure had an OR for BCC of 0.8 
'(0.24.2), and women with more than 4.8 hours per day of exposure had an OR for BCC of 0.8 
(0.1-8.2). These results include both SCCs and BCCs and therefore the effect of sun exposure on 
BCCs alone cannot be established. 
The estimated associations between occupational sun exposure and BCC described above are 
summarised in Table 9.5. 
9.2.4.3 Recreational sun exposure 
Some evidence has been found that recreational sun exposure, such as at weekends or while on 
holiday, is also associated with BCC. However, little evidence of an association between sun 
exposure during leisure was found in a cohort study in Queensland, Australia. 282 When 
compared with people who spend their leisure time mainly indoors, people who spend their 
leisure time indoors and outdoors had an OR for BCC of 1.0 (0.4-2.2), and people who spend 
their leisure time mainly outdoors had an OR for BCC of 0.6 (0.3-1.3). 
In a case-control study in Western AuStralia, 279 there was evidence that the risk of BCC was 
increased for all categories of lifetime hours of sun exposure while on holiday when compared 
with less than 602 hours of exposure. Comparing people with between 602 and Z268 hours of 
sun exposure with those with less than 602 hours of exposure, the OR for BCC was 1.65 (1.01- 
2.70). Comparing people with between Z268 and 3,794 hours of sun exposure to those with less 
than 602 hours of exposure gave an OR for BCC of 1.68 (1.00-2.80). The greatest risk occurred in 
the group with greater than 3,794 hours of sun exposure, with an OR of 1.85 (1.09-3.13) when 
compared with people with less than 602 hours of sun exposure on holidays. The p-value for 
trend was 0.04, providing some evidence that the risk of BCC increases with increasing number 
of hours of sunlight exposure while on holiday. There was some evidence of an association 
between sunbathing and BCC. Comparing people who had sunbathed between one and 200 
times during their lifetime with people who had never sunbathed, the OR for BCC was 1.57 
(0.98-2.51). There was, however, little evidence of an association between more frequent 
sunbathing and BCC. Comparing people with between 201 and 700 occasions of sunbathing in 
their lifetime with those with none, the OR for BCC was 1.08 (0.68-1.72), while for people with 
between 700 and 9,000 lifetime instances of sunbathing the OR for BCC was 1.02 (0.63-1.64). 
Interrnittency of sun exposure was also investigated in this study. 279 Intermittency was 
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measured as the proportion of days exposed to sunlight on non-working days compared with 
the total number of days exposed. There was little evidence of an association between 
intermittency of sun exposure and BCC among people between 20 and 24 years old. When 
compared with intermittency of 20% or less, between 21% and 44% intermittency gave an OR 
for BCC of 1.35 (0.83-2.18), between 45% and 89% intermittency gave an OR for BCC of 1.06 
(0.59-1.90), and between 90% and 100% intern-dttency gave an OR for BCC of 1.71 (0.88-3.34ý. 
The p-value for trend was 0.2. There was also little evidence of an association between 
intermittency and BCC in people between 25 and 39 years old. Compared with intermittency of 
19% or less, between 20% and 39% intermittency gave an OR for BCC of 131 (0.82-2.11),, 
between 40% and 89% intermittency gave an OR for BCC of 1.40 (OW-2.35), and between 90% 
and 100% intermittency gave an OR for BCC of 1.13 (0.57-2.22). The p-value for trend was 0.45. 
There was weak evidence of an association between intermittency of sun exposure in the 10, 
years prior to diagnosis and BCC. When compared with 24% intermittency or less, between 
25% and 49% intermittency had an OR for BCC of 1.75 (1.15-2.66), between 50% and 99% 
intermittency had an OR for BCC of 2.10 (1.25-3.54), and 100% intermittency had an OR for BCC 
of 1.22 (0.65-2.31). The p-value for trend was 0.10. The evidence of an association between 
intermittency between 11 and 30 years prior to diagnosis and BCC was also weak. When 
compared with 29% or less intern-tittency, between 30% and 56% intermittency had an OR for 
BCC of 1.58 (0.96-2.61), between 57% and 99% intermittency had an OR for BCC of 1.42 (0.77- 
2.64), and 100% intermittency had an OR for BCC of 1.75 (0.89-3.45). The p-value for trend was 
0.14. 
Data from the same study showed evidence of an increased risk of BCC with increased hours of 
sun exposure on non-working days since the age of 15.266 An OR for BCC of 1.74 (1.03-2.95) was 
found when comparing more than 16,300 hours of exposure with less than 6,700 hours. When 
compared with less then 6,700 hours of exposure, between 11,200 hours and 16,200 hours of, 
exposure had an OR of 1.76 (1.07-2.90), and between 6,700 hours and 11,100 hours of exposure 
had an OR of 1.72 (1.05-2.79). The p-value for trend was 0.04, providing some evidence that the 
risk of BCC increases with increasing hours of sun exposure on non-working days since the age 
of 15. 
The Helios study also found evidence of a harmful association between recreational sun 
exposure and BCC. 281 Comparing people with more than 3,398 hours of lifetime sun exposure 
during holidays with people with no holiday sun exposure produced an OR for BCC of 1.47 
(1.18-1.83). When compared with people with no holiday sun exposure, people with between 
1,324 hours and 3,398 hours of exposure had an OR for BCC of 1.10 (0.88-1.39), people with 
between 280 hours and 1,323 hours of exposure had an OR for BCC of 1.26 (1.01-1.56), and 
people with less than 280 hours of exposure had an OR of 1.20 (0.97-1.48). The p-value for trend 
was 0.036, providing evidence that the risk of BCC increases with increasing sun exposure on 
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holidays. 
Sun exposure at the beach on holidays showed some evidence of a harmful association with 
BCC. When compared with people with no sun exposure at the beach, less than Z464 hours of 
exposure had an OR for BCC of 1.12 (0.95-1.32), and more than Z464 hours of exposure had an 
OR for BCC of 1A7 (1.18-1.84). 
There was strong evidence that the risk of BCC increased with increasing time doing water 
sports. An OR for BCC of 1.47 (1.04-2.07) was found when comparing more than Z112 hours of 
sun exposure during water sports with no exposure. When compared with no sun exposure 
during water sports, less than Z112 hours of exposure gave an OR for BCC of 1.45 (1.18-1.79). 
For sun exposure during outdoor sports in general, the OR for BCC when comparing less than 
288 hours of exposure with none was 1.22 (0.99-1.51). There was, however, little evidence of an 
association with BCC for higher levels of sun exposure during outdoor sports. When compared 
with no sun exposure during outdoor sports, between 288 and 1,008 hours of exposure had an 
OR for BCC of 1.10 (0.89-1.51), between 1,009 and 3,420 hours of exposure had an OR for BCC of 
1.07 (0.86-1.32), and more than 3,420 hours of exposure had an OR for BCC of 1.01 (0.84-1.28). 
The p-value for trend was 0.552, providing little evidence that the risk of BCC increases with 
increasing sun exposure during outdoor sports. 
There was also little evidence of an association between sun exposure during sports that take 
place in the mountains or in air (i. e. skiing, climbing, hiking, flying, hang-gliding and 
parachuting) and BCC. Compared with people with no sun exposure during sports in the 
mountains or air, people with less than 140 hours of exposure had an OR for BCC of 1.22 (0.85- 
1.77), people with between 140 and 504 hours of exposure had an OR for BCC of 1.14 (0.79-1.66), 
people with between 505 and 1,887 hours of exposure had an OR for BCC of 1.06 (0.72-1.54), 
and people with more than 1,887 hours of exposure had an OR for BCC of 1.04 (0.72-1.52). The 
p-value for trend was 0.438, providing little evidence that the risk of BCC increases with 
increasing amounts of sun exposure during sports in the mountains or air. 
A Yugoslavian case-control study274 found evidence of a harmful association between an 
average of seven or more weeks per year of seaside holidays and BCC, with an OR of 1.81 (1.24- 
2.64). The reference category for this analysis was unclear. 
In an Italian case-control study273 intermediate amounts of lifetime recreational sun exposure 
gave an OR for BCC of 1.8 (1.3-2.6), and high lifetime recreational sun exposure gave an OR of 
1.6 (1.1-2.3), when compared with low lifetime levels of sun exposure. The p-value for trend 
was less than 0.001, providing strong evidence that the risk of BCC increases with increasing 
lifetime recreational sun exposure. 
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Some additional evidence of a harmful effect of recreational sun exposure on BCC is provided 
by a Spanish case-control study of NMSC. 275 In men, high levels of sun exposure (>0.12 hours 
per day) during open air activities had an OR for BCC of 1.7 (1.1-2.8) when compared with low 
levels of exposure (<0.005 hours per day), although there was little evidence of an association 
between sun exposure during open air activities and NMSC for an intermediate amount of sun 
exposure (0.005-0.12 hours per day) (OR=0.7 (0.5-1.3)). An OR of 2.1 (1.2-3.9) was found when 
comparing more than 0.4 hours per day of sun exposure during holidays with less than 0.16 
hours per day. Again there was little evidence of an association between sun exposure and 
NMSC for lower levels of sun exposure. Compared with less than 0.16 hours per day of sun 
exposure during holidays, between 0.16 and 0.26 hours per day of sun exposure had an OR for 
BCC of 0.8 (0.5-1.6), and between 0.26 and 0.40 hours per day of exposure had an OR for BCC of 
1.3 (0.7-2.6). 
There was some evidence of an association between high levels of sun exposure during outdoor 
activities and NMSC among women, as the OR for BCC was 2.1 (0.9-4.7) when comparing more 
than 0.12 hours per day of exposure with less than 0.005 hours per day of exposure. There was, 
however, little evidence of an association between intermediate levels of sun exposure during 
outdoor activities (0.005-0.12 hours per day), with an OR for BCC of 1A (0.5-3.8) when 
compared with less than 0.005 hours per day of exposure. There was also little evidence of an 
association between sun exposure during holidays and NMSC for women. When compared 
with less than 0.16 hours per day of exposure, between 0.16 and 0.26 hours per day of exposure 
had an OR for BCC of 1.7 (0.7-4.3), between 0.26 and 0.40 hours per day of exposure had an OR 
for BCC of 1.2 (0.6-2.5), and more than 0.40 hours per day of exposure had an OR for BCC of 1.4 
(0-6-3.2). These analyses included both SCCs and BCCs, and therefore the effect of recreational 
sun exposure on BCCs alone cannot be established. 
In contrast to the results described above, a case-control study of Canadian men found evidence 
of a protective association between recreational sun exposure and BCC. 2n Comparing a 
lifetime mean of 8.5 hours per week or more of recreational sun exposure in summer with a 
mean of less than 2.8 hours per week gave an OR for BCC of 0.4 (0.2-1.0). When compared with 
less than 2.8 hours per week of recreational sun exposure in summer, between 2.8 and 5.5 hours 
per week of exposure had an OR for BCC of 0.9 (0.5-1.7), and between 5.6 and 8.4 hours per 
week of exposure had an OR for BCC of 0.6 (0.3-13). The p-value for trend was 0.03, providing 
evidence that the risk of BCC decreases with decreasing amounts of lifetime recreational sun 
exposure. 
The estimated associations between recreational sun exposure and BCC described above are 
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Literature: The association between sunlight and BCC 
9.2.4.4 Total sun exposure 
In some studies no distinction has been made between occupational and recreational sun 
exposure, and the effect of total sun exposure on BCC has been investigated. In a cohort study 
in the United StateS, 264 there was evidence that the risk of BCC was increased when comparing 
women who spent more than eight hours per week outside in summer and used sunscreen with 
those who did not spend more than eight hours per week outside, with a hazard ratio of 1.37 
(1.11-1.69). 
There was little evidence of an association between cumulative exposure to UVB radiation and 
BCC in a cross-sectional study in the United States. 20 Comparing men with above median 
exposure with those with below median exposure, the OR for BCC was 0.69 (0.31-1.53). 
Comparing men in the upper quartile of UVB radiation exposure with men in the lower three 
quartiles resulted in an OR for BCC of 1.11 (0.50-2.44). 
Little evidence of an association between lifetime total sun exposure and BCC was found in a 
case-control study in Canada. 271 When compared with a mean value of less than 11.5 hours per 
week of sun exposure in summer, between 11.5 and 18.9 hours per week of summer exposure 
had an OR for BCC of 1.3 (0.8-2.2), between 19 and 27.9 hours per week of summer exposure 
had an OR of 1.2 (0.7-2.2), and 28 hours per week or more of summer exposure had an OR of 1.3 
(0.7-2.4). The p-value for trend was greater than 0.05. 
Data from a case-control study in Western Australia was used to investigate the association 
between total sun exposure and BCC-266 There was some evidence that the risk of BCC on the 
head and neck decreased with increasing sun exposure to the site. When compared with 28,600 
hours or less of sun exposure to the head and neck, between 28,600 hours and 44,500 hours of 
exposure gave an OR for BCC of 0.95 (0.45-1.97), between 44,500 hours and 65,000 hours of 
exposure gave an OR for BCC of 0.90 (0.42-1.89), and 65,000 hours of exposure or more gave an 
OR for BCC of 0.38 (0.15-0.97). The p-value for trend was 0.07. In contrast, there was evidence 
that the risk of BCC on the trunk increased with increasing sun exposure to the site. When 
compared with no sun exposure to the trunk, between 100 and 5,200 hours of exposure gave an 
OR for BCC of 0.62 (0.24-1.59), between 5,200 hours and 13,000 hours of exposure gave an OR 
for BCC of 1.03 (0.51-2.09), and 13,000 hours or more of exposure gave an OR for BCC of 2.39 
(1.184.83). The p-value for trend was 0.01. There was weak evidence that the risk of BCC on 
the limbs was decreased by increasing sun exposure to the site. When compared with 19,200 
hours of exposure or less, between 19,200 hours and 28,600 hours of exposure had an OR for 
BCC of 1.21 (0.41-3.62), between 28,600 hours and 43,700 hours of exposure had an OR for BCC 
of 0.78 (0.25-2.37), and 43,700 hours or more of exposure had an OR for BCC of 0.43 (0.13-1.44). 
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measure, quadratic models showed that risk of BCC increased up to a total exposure of 
approximately 35,000 hours, and then fell. 
Table 9.7 summarises the estimated associations between total sun exposure and BCC described 
above. 
9.2.4.5 Sun exposure before the age of 20 
Evidence of an association between intermittency of sun exposure between the ages of 15 and 
19 and BCC has been found in a case-control study in Western Australia. 279 Intern-dttency was 
measured as the proportion of days exposed to sunlight on non-working days compared with 
the total number of days exposed. Between the ages of 15 and 19, comparing 100% 
intermittency with less than 40% gave an OR for BCC of 3.86 (1.93-7.75). Comparing between 
59% and 99% intermittency with less than 40% gave an OR for BCC of 1.82 (1.01-3.28), while 
comparing between 41% and 58% intem-dttency with less than 40% gave an OR for BCC of 1.49 
(0.88-2.52). The p-value for trend was less than 0.001, providing strong evidence that the risk of 
BCC increases with increasing intermittency of sun exposure between the ages of 15 and 19. 
In a case-control study of Canadian men, 271 some evidence of a harmful association between 
sunburns between the ages of 5 and 15 and BCC was found. When comparing frequent or 
severe burns with no burns, the OR for BCC was 1.6 (1.0-2.7). There was little evidence of an 
association with less severe burning and BCC, however. When compared with no bums 
between the ages of 5 and 15, moderate bums had an OR for BCC of 1.3 (0.8-2.1) and rare or 
mild bums had an OR for BCC of 0.8 (0.5-1.4). Having sunburn pain for two days or more, 
twice a year or more between the ages of 5 and 15 when compared with no pain gave an OR for 
BCC of 4.5 (1.7-12.3), while having sunburn pain for two days or more once a year had an OR 
for BCC of 1.7 (0.9-3.4) when compared with no pain. Mean recreational sun exposure of more 
than 12.5 hours per week in summer before the age of 19 years showed evidence of a harmful 
association with BCC when compared with less than 3.8 hours per week, with an OR for BCC of 
2.6 (1.1-6.5). There was little evidence of an association between lower categories of sun 
exposure at under 19 years of age and BCC. When compared with less than 3.8 hours per week 
in summer, between 3.8 and 7.4 hours per week had an OR for BCC of 1.1 (0.6-2.0), and between 
7.5 and 12.4 hours per week had an OR for BCC of 1.4 (0.7-3.0). There was, however, evidence 
that increasing hours of sun exposure per week in summer before the age of 19 increased the 
risk of BCC, as the p-value for trend was 0.03. 
A case-control study in Southern Europe272 found evidence of an increased risk of BCC among 
people who experienced a first sunburn before the age of 15. Compared with people whose 
first sunburn was after the age of 15, the OR for BCC was 1.65 (1.10-2.36). In a separate 
publication, 281 there was evidence of a harmful association between sun exposure at the beach 
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during childhood holidays and BCC. When compared with no sun exposure at the beach in 
childhood, less than 197 hours of exposure gave an OR for BCC of 1.05 (0.78-1.41), between 197 
and 714 hours of exposure gave an OR for BCC of 1.23 (0.93-1.64), between 715 and 2,079 hours 
of exposure gave an OR for BCC of 1.10 (0.82-1.48), and more than 2,079 hours of exposure gave 
an OR for BCC of 1.43 (1.09-1.89). The p-value for trend was 0.005, providing strong evidence 
that the risk of BCC increases as the amount of sun exposure at the beach in childhood 
increases. 
Analyses from the Health Professionals Follow-Up Study found evidence of an association 
between time spent outdoors in a swimming costume as a teenager in summer and BCC-117 
Compared with people who were outdoors less than once a week in summer in a swimming 
costume, people who were outdoors once a week had a hazard ratio for BCC of 1.30 (1.14-1.47), 
people who were outdoors twice a week had a hazard ratio for BCC of 1.34 (1.19-1.52), people 
who were outdoors several times a week had a hazard ratio for BCC of 1.36 (1.22-1.52), and 
people who were outdoors in a swimming costume every day had a hazard ratio for BCC of 
1.42 (1.24-1.63). The p-value for trend was less than 0.0001, providing strong evidence that the 
risk of BCC increases as the amount of time spent outdoors in a swimming costume in summer 
as a teenager increases. 
An Italian case-control studyn found evidence of an association between intermediate amounts 
of recreational sun exposure before the age of 20 and BCC, with an OR for BCC of 1.9 (1.2-3.1) 
when compared with low amounts of exposure. There was little evidence of an effect of high 
levels of sun exposure as the OR for BCC was 1.0 (0.6-1.6) when compared with low levels of 
sun exposure. Evidence was found of a harmful association between severe sunburns before 
the age of 15 and BCC. When compared with no severe sunburns, one severe sunburn gave an 
OR of 2.8 (1.94.1), while two or more gave an OR of 3.9 (1.6-9.2). The p-value for trend was less 
than 0.001, which provides strong evidence of an increasing risk of BCC with increasing 
numbers of sunburns before the age of 15. 
The estimated associations between sun exposure before age 20 and BCC described above are 
summarised in Table 9.8. 
9.2.4.6 Summary 
The evidence for an association between sun exposure and BCC is mixed. There is some 
evidence that sunburn is related to BCC, and that the risk of BCC increases as the frequency of 
sunburns increases. The evidence for an effect of occupational or total sun exposure is less 
convincing. There is little evidence that increasing occupational exposure increases the risk of 
BCC, and in fact increasing total sun exposure to the head or limbs may protect against BCC at 
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increasing recreational exposure, but this association has not been found consistently. Sunburn 
and recreational sun exposure before the age of 20 also appear to be risk factors for BCC. The 
evidence suggests that the risk of BCC increases with increasing frequency of sunburn before 
the age of 15 and increasing recreational sun exposure in childhood. 
Several reasons have been proposed for this observed association between recreational sun 
exposure, sunburn and BCC, but a lack of association with occupational or total sun exposure. 
It has been suggested that a dose-response relationship exists between sun exposure and BCC, 
where at higher levels of exposure the risk of BCC levels out, and possibly even dropS. 266,20 
Occupational sun exposure may therefore not show an association with BCC, as sun exposure is 
high. Kricker et al. 266 suggested two explanations for this dose-response relationship. 
Mutations due to exposure to UV radiation may be very common in sun exposed skin. 283,284 As 
sun exposure increases, these mutations may lead to cells that would become BCCs to become 
non-viable. The second hypothesis proposed was that the mutations caused by sun exposure 
could increase the immunogenicity of the basal cells (the degree to which the cells induce an 
immune response), and therefore make them more susceptible to destruction by the immune 
system. On the other hand, this dose-response relationship may not truly exist and may be due 
to people who are aware of their high risk of developing BCCs (because of previous skin 
cancers or benign skin lesions) reducing their sun exposure. People with high levels of 
exposure would then be at lower risk of BCC. 266 
The pattern of sun exposure may also be important in determining the risk of BCC. 266 
Recreational sun exposure and sunburn are both indicators of intermittent sun exposure, and 
this intermittency may be important, particularly in childhood. 279 Rosso et al. 281 suggested that 
outdoor work, which indicates more consistent sun exposure, allows the skin to develop sun 
protection by tanning and thickening of the external layers. This protection does not develop to 
the same extent with recreational exposure, and therefore BCC is caused when UV radiation 
reaches the basal cells as directly as possible, in the absence of any natural skin protection. This 
hypothesis also supports the dose-response curve with a levelling of risk at high levels of sun 
exposure. 
Finally, it has been suggested that sun exposure in childhood is an important risk factor for 
BCC, 2n, 7n, 281 and that the skin in childhood is more sensitive to the effects of sun exposure that 
lead to BCCs developing in later life. 2n Armstrong et al. 210 suggested that the potential for skin 
cancer is determined by sun exposure in childhood. Adult sun exposure then determines how 
much of this potential is realised. 
9.2.5. Previous benign sun-related skin conditions 
Associations between BCC and benign sun-related skin conditions, such as actinic keratoses, 
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actinic cheilitis, solar lentigines, melanocytic naevi and actinic elastosis have been found. 
Actinic keratoses are skin lesions that begin as flat scaly areas, but later develop a hard, wart- 
like surface. 285 If an actinic keratosis occurs on the lip, it is called actinic cheilitis. 286 Solar 
lentigines, also known as age spots or liver spots, are flat spots with increased pigmentation. 287 
Melanocytic naevi are also known as moles and are clusters of pigmented skin cells. 2m Actinic 
elastosis is premature aging of the skin due to sun exposure. Some of the characteristics of 
actinic elastosis are inelasticity and wrinkling of the skin and skin dryness with fine scaling. 289 
Telangiectasias are abnormally dilated blood vessels. Facial telangiectasia is associated with 
age, sun exposure and alcohol consumption. 290 
A cohort study in Queensland, Australia found evidence of a harmful association between 
actinic keratoses and BCC. 282 When compared with people with no actinic keratoses on the 
face, people with between one and five had an OR for BCC of 3.9 (1.9-8.0), people with between 
six and 20 had an OR for BCC of 5.6 (2.3-13.3), and people with more than 20 had an OR for 
BCC of 10.0 (3.5-28.2). There was also evidence that facial telangiectasia had a harmful 
association with BCC. Compared with people with no facial telangiectasia, people with mild 
telangiectasia had an OR for BCC of 2.3 (1.1-4.7), people with moderate telangiectasia had an 
OR for BCC of 2.9 (1.2-7.1), and people with severe telangiectasia had an OR for BCC of 7.3 (2.1- 
26.0). There was evidence of a harmful association between actinic elastosis of the neck and 
BCC. Compared with people with no elastosis of the neck, people with mild to moderate 
actinic elastosis had and OR for BCC of 3.7 (1.6-8.3) and people with severe actinic elastosis of 
the neck had an OR for BCC of 3.6 (1.3-9.8). There was also evidence of a harmful association 
between the number of solar lentigines on the hands and BCC. Compared with people with no 
solar lentigines on the hands, people with between one and 10 had an OR for BCC of 1.5 (0-8- 
2.5), people with between 11 and 20 had an OR for BCC of 2.9 (1.2-7.0), and people with more 
than 20 had an OR for BCC of 3.7 (1.2-11.7). 
Evidence of a harmful association between childhood freckling and BCC was found in a cross- 
sectional study in the United States. 269 Comparing men who experienced freckling during 
childhood with men who did not, the OR for BCC was 3.66 (1.51-8.84). 
Some evidence of associations between benign sun related skin conditions and BCC was found 
in a case-control study in Western Australia. 270 The majority of analyses adjusted for age, sex, 
age of arrival in Australia and Southern European ethnicity. Evidence of an increased risk of 
BCC with increased density of freckling in childhood on the arms was found. Comparing 
people who had scattered freckling on the arms during childhood with people who had no 
freckling on the arms, the OR for BCC was 1.37 (0.93-2.02). Comparing people with moderate to 
heavy freckling on the arms during childhood with people with none gave an OR for BCC of 
1.63 (1.06-2.51). The p-value for trend was 0.02. There was also evidence of an increased risk of 
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BCC for people with four or more melanocytic naevi on the back. Comparing people with four 
or more melanocytic naevi on the back with people with three or less, the OR for BCC was 1.80 
(1.22-2.65). Strong evidence was found for an increasing risk of BCC with increasing severity of 
actinic elastosis on the neck. Comparing people with mild solar elastosis on the neck with 
people with none, the OR for BCC was 1.85 (0.804.26). When compared with people with no 
actinic elastosis on the neck, people with moderate actinic elastosis had an OR for BCC of 2.75 
(1.16-6.50), and people with severe actinic elastosis of the neck had an OR for BCC of 3.96 (1.58- 
9.93). The p-value for trend was less than 0.001. 
A Canadian case-control study found evidence of a harmful association between freckling 
between the ages of five and 15 and BCC. 2n When compared with people who did not freckle 
between those ages, people who did had an OR for BCC of 1.8 (1.2-2.5). 
Analyses from the Health Professionals Follow-Up Study found evidence of an association 
between the number of melanocytic naevi on the forearms and risk of BCC. 267 Compared with 
people with no melanocytic naevi on the forearms, people with one or two had a hazard ratio 
for BCC of 1.27 (1.14-1.41), people with between three and five had a hazard ratio for BCC of 
1.29 (1.11-1.50), and people with six or more had a hazard ratio for BCC of 1.20 (1.00-1.45). The 
p-value for trend was less than 0.0001, providing strong evidence that the risk of BCC increases 
with increasing numbers of melanocytic naevi on the forearms. 
In an Italian case-control study, 273 an OR for BCC from many solar lentigines compared with 
none of 1.6 (1.1-2.1) was found, although there was little evidence of an association when 
comparing few solar lentigines with none (OR=1.1 (0-8-1.4)). The p-value for trend was 0.002, 
providing strong evidence of an increasing risk of BCC with increasing numbers of solar 
lentigines. There was evidence of a harmful association between actinic keratoses and BCC. 
Comparing people with actinic keratoses with those with none, the OR for BCC was 2.8 (2.0- 
4.0). There was little evidence of an association between freckles and BCQ, with an OR for BCC 
of 0.8 (0.6-1.1) when comparing people with freckles with people without freckles. There was 
evidence of a harmful association between melanocytic naevi on the upper limbs and BCC. 
Comparing people with between one and five melanocytic naevi on the upper limbs with those 
with none, the OR for BCC was 1.7 (1.2-2.3), while comparing those with six or more with those 
with none gave an OR of 1.6 (1.1-2.4). The p-value for trend was 0.002, providing strong 
evidence for an increase in risk for BCC with increasing numbers of melanocytic naevi on the 
upper limbs. 
In a Yugoslavian case-control study, the OR for BCC for people who freckled before the age of 
15 was 2.65 (1.29-5.46), 274 which provides evidence for a hamiful effect. The reference category 
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A German case-control study277 comparing people with actinic cheilitis with people without 
gave an OR for BCC 7.1 (2.7-18.4). Comparing people with actinic keratosis to those without 
gave an OR for BCC of 2.7 (1.3-5.9), and comparing people with solar lentigo to people without 
gave an OR for BCC of 2.5 (1.2-5.3). The presence of actinic elastosis, appeared to be protective 
against BCC, with an OR for BCC of 0.1 (0.05-0.42) when comparing people with actinic 
elastosis to people without. 
The results described above are summarised in Table 9.9. Actinic keratoses appear to be 
associated with BCC, and may suggest that BCC is related to total sun exposure. 280 
Telangiectasia also appears to have an association with BCC, although it was only considered in 
two studies. There is some evidence that solar lentigines are associated with BCC, although one 
study found little evidence of an association. 279 The evidence for an association between actinic 
elastosis and BCC is contradictory, with two studies reporting harmful effects270,282 and one 
study reporting a protective effect. 277 Freckling and the presence of melanocytic naevi appear to 
be associated with BCC, although the observed associations for melanocytic naevi may be due 
to n-dsclassification of solar lentigines. 267,270 It has been suggested that BCC and malignant 
melanoma are aetiologically similar, as freckles and melanocytic naevi are well known risk 
factors for malignant melanoma. 270,2n, 2", 274,2n 
9.2.6. Sun protection 
92.6.1 Hat use 
Use of a hat to protect against skin cancer was investigated by in a case-control study in 
Western Australia. 279 Evidence of an increased risk of BCC was found for people using hats 
more than half the time for between 10 and 19 years when compared with people who reported 
using hats less than half the time, with an OR for BCC of 2.90 (1.12-7.50). For use more than half 
the time for between one and nine years, and more than 20 years, the ORs for BCC were 2.46 
(0-96-6.26) and 1.55 (0.69-3.47) respectively when compared with people who use a hat for less 
than half the time. Little evidence of an association between wearing a broad brimmed hat and 
BCC was found. When compared with people using a broad brimmed hat less than half the 
time, those using a broad brimmed hat more than half the time for between one and nine years 
had an OR for BCC of 1.15 (0.51-2.59), for between 10 and 19 years had an OR for BCC of 1.30 
(0.50-3.41), and for 20 years or more had an OR for BCC of 0.77 (0.32-1.84). Considenng hat use 
in the 10 years prior to diagnosis, using a hat for between one and nine years when compared 
with never using a hat gave an OR for BCC of 2.45 (1.10-5.45). Using a hat for the full 10 years 
showed little evidence of an association with BCC, with an OR for BCC of 1.43 (0.74-2.79) when 
compared with never wearing a hat. Little evidence of an association between hat use between 
11 and 30 years prior to diagnosis and BCC was found. Compared with people who never wore 
a hat, those who wore a hat for between one and nine years had an OR for BCC of 1.39 (0.61- 
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3.16), for between 10 and 19 years had an OR for BCC of 0.82 (0.37-1.83), and for 20 or more 
years had an OR for BCC of 1.07 (0.52-2.22). There was similarly little evidence of an association 
between broad brimmed hat use and BCC. Comparing people who ever used a broad brimmed 
hat in the 10 years before diagnosis with those who never used a broad brimmed hat gave an 
OR for BCC of 1.23 (0.63-2.38). Comparing people who ever used a broad brimmed hat 
between 11 and 30 years prior to diagnosis with people who never wore a broad brimmed hat 
in this time period gave an OR for BCC of 1.05 (0.53-2.10). 
Some evidence of a protective effect of using a hat during occupational sun exposure on NMSC 
was found among men in a Spanish case-control study. 275 Using a hat between May and 
September for occupational exposure gave an OR for NMSC of 0.5 (0.3-0.7), while between 
October and April the OR for NMSC was 0.5 (0.3-0.8), both when compared with not using a 
hat. There was, however, evidence of a harmful effect of hat use during holidays on NMSC 
among men. When compared with men who did not wear a hat, men who wore a hat during 
holidays between October and April had an OR for NMSC of 2.0 (1.3-3.3). Little evidence of an 
effect of hat use during outdoor activities on NMSC was found. Comparing men who used a 
hat during outdoor activities between May and September with men who did not gave an OR 
for NMSC of 1.4 (0.8-2.5), and comparing men who wore a hat during outdoor activities 
between October and April with those who did not gave an OR for NMSC of 1.3 (0.7-2.0). There 
was weak evidence of an effect of hat use during holidays between May and September among 
men with an OR for NMSC of 0.7 (0.4-13). 
There was little evidence of any effect of hat use on NMSC among women. The ORs for NMSC 
were 0.8 (0.4-1.7) for hat use during occupational exposure between May and September, and 
0.91 (0.3-2.5) for hat use during occupational exposure between October and April, both when 
compared with not wearing a hat. The ORs for NMSC were 0.7 (0.2-3.3) for hat use during 
outdoor activities between May and September, and 0.7 (0.2-2.5) for hat use during outdoor 
activities between October and April, both when compared with not wearing a hat. The ORs 
for NMSC were 0.8 (0.3-1.7) for hat use during holidays between May and September, and 1.1 
(0.6-2.0) for hat use during holidays between October and April, both when compared with not 
using a hat. The effect of hat use on BCC alone cannot be established from these analyses, as 
they include both SCC and BCC. 
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9.2.6.2 Sunscreen use 
There is little evidence that sunscreen protects against skin cancer. A review of the evidence in 
2000m identified four studies which investigated the relationship between BCC and sunscreen 
use. 264,275,278,279 
A cohort study among women in the United States264 found evidence that, among women who 
spent more than eight hours outdoors in summer, the risk of BCC was increased for women 
who used sunscreen than for those that did not use it. The hazard ratio for BCC in this situation 
was 1.43 (1.22-1.67). 
A case-control study in Western Australia279 found evidence that using sunscreen half the time 
or more for between one and nine years when compared with using sunscreen less than half the 
time increased the risk of a BCC, with an OR of 1.92 (1.17-3.13). When using sunscreen for half 
the time or more for ten years or more was compared with less than half the time there was 
little evidence of an association as the OR for BCC was 1.25 (0.82-1.90). There was little 
evidence of an effect of sunscreen use on BCC when used between 11 and 30 years prior to 
diagnosis. When comparing use for half the time or more for between one and nine years with 
use less than half the time, the OR for BCC was 1.20 (0.69-2.08). Using sunscreen for more than 
half the time for ten years or more gave an OR for BCC of 0.72 (0.40-1.28) when compared with 
sunscreen use less than half the time. Considering sunscreen use in the ten years prior to 
diagnosis, using sunscreen more than half the time for less than 10 years produced an OR for 
BCC of 1.77 (1.09-2.87) when compared with no sunscreen use in the 10 years prior to diagnosis. 
Using sunscreen half the time or more for the full 10 years gave an OR for BCC of 1.07 (0.69- 
1.67). 
There was some evidence of an harmful association between sunscreen use and NMSC among 
men in a case-control study in Spain. 275 Comparing men who used sunscreen with those who 
did not, the OR for NMSC was 1.7 (0.91-3.3). Little evidence of an association between NMSC 
and sunscreen use was found in women. Comparing women who used sunscreen with those 
who did not, the OR for NMSC was 1.4 (0.7-2.5). The analyses included both SCC and BCC, and 
therefore the effect of sunscreen on BCC alone cannot be determined. 
The Nambour Skin Cancer and Actinic Eye Disease Trial was an RCT investigating the effect of 
sunscreen use and beta-carotene supplementation on NMSCs in a population from Queensland, 
Australia. 278 In this RCT, subjects were allocated to daily sunscreen use, or discretionary 
sunscreen use. Little evidence of effect of sunscreen use on BCC was found. The rate ratio for 
the number of people with new BCCs was 1.03 (0.73-1.46) when comparing the sunscreen 
intervention group with the control group, while the rate ratio for the total number of new 
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BCCs was 1.05 (0.82-1.34) when comparing the sunscreen intervention group with the control 
group. 
Data from the Nambour Trial was also used to investigate the effect of sunscreen use on 
repeated occurrence of BCC-292 Using a Cox proportional hazards model for a survival analysis 
of the time to first BCC, the hazard ratio for BCC when comparing the intervention group with 
the control group was 1.03 (0.77-1.38). Three different models were used for the multiple failure 
time survival analysis; the Andersen-Gill model, 293 the Wei-Lin-Weissfeld model, 251 and the 
Prentice-Williams-Peterson model. 2% When all failures were analysed simultaneously, the 
Andersen-Gill model gave a hazard ratio for BCC of 0.90 (0.66-1.23), the Wei-Lin-Weissfeld 
model gave a hazard ratio for BCC! of 0.89 (0.65-1.24), and the Prentice-Williams-Peterson model 
gave a hazard ratio for BCC! of 0.91 (0.72-1.15), all when comparing the intervention group with 
the. control group. When the analysis was stratified by event episodes, the estimated hazard 
ratio for the second occurrence of BCC from the Wei-Lin-Weissfeld model was 0.70 (0.43-1.16) 
when comparing the intervention arm with the control arm, and from the Prentice-Williams- 
Peterson model the estimated hazard ratio for the second occurrence of BCC was 0.71 (0.43-1.17) 
when comparing the intervention arm with the control arm. For the third occurrence of BCC' 
the estimated hazard ratio from the Wei-Lin-Weissfeld model was 0.59 (0.27-1.28) when 
comparing the intervention arm with the control arm, and the estimated hazard ratio from the 
Prentice-Williarns-Peterson model was 0.67 (0.31-1.44) when comparing the intervention arm 
with the control arm.. 
The estimated associations between sunscreen use and BCC described above are summarised in 
Table 9.11. 
Some evidence for a protective effect of sunscreen use comes from studies and trials for the 
prevention of actinic keratoses. In a trial in Australia, 588 subjects with between one and thirty 
actinic keratoses at baseline were randomised to daily sunscreen, or daily use of a cream 
without the sun protective active agents. 295 The trial found evidence that the risk of new actinic 
keratoses; in the sunscreen group was reduced, compared with the control group, with a risk 
ratio for actinic keratosis of 0.62 (0.54-0.71). 
Evidence of a protective effect of sunscreen use on actinic keratoses was found in an RCr 
conducted in the United StateS. 2% In total, 53 individuals joined the trial, with 26 randonlised to 
the control group and 27 randon-dsed to the sunscreen group. The participants were followed 
up for two years. Over that time, the rate of actinic keratosis formation per year in tile 
sunscreen group was 51 % (p=0.023) of the rate per year in the control group. 
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Data from the Nambour Trial were used to assess the effect of sunscreen use on actinic 
keratoses. 297 Although actinic keratoses increased over the period of the trial in both 
randon-dsed groups, between 1992 and 1994 the increase in the number of actinic keratoses on 
the whole body in the sunscreen group was 76% (62%-94%) of the increase in actinic keratoses 
on the whole body in the control group. Similar results were found for actinic keratoses 
occurring on the sites of sunscreen application (head, neck, arms and back of hands), with the 
increase in actinic keratoses in the intervention group being 78% (64%-96%) of the increase in 
the control group. Little evidence of an effect of sunscreen use on the number of actinic 
keratoses was found between 1994 and 1996. The increase in the number of actinic keratoses on 
the whole body in the sunscreen group was 95% (75%-119%) of the increase in actinic keratoses 
on the whole body in the control group. The increase in actinic keratoses occurring on the sites 
of sunscreen application in the intervention group was 94% (75%-119%) of the increase in 
actinic keratoses on the sunscreen application sites in the control group. This lack of evidence 
of an association between 1994 and 1996 may be due to an increase in the amount of sunscreen 
used by subjects in the control arm. 
9.2.63 Summary 
There is very little evidence that sun protection behaviours such as wearing a hat or using 
sunscreen protects against BCC. For hat use, the only protective associations found were in a 
study which included both BCC and SCC as the outcome. 275 Squamous cell carcinoma may 
have a very different relationship with sun exposure than BCC, and this observed protective 
effect may be due to protection against SCC. In the study considering only BCC as the outcome, 
there was some evidence that hat use was harmful. 279 The effect of sunscreen on BCC was also 
unclear. In the observational studies, sunscreen appeared to have a harmful effect on BCC. 
Results from the Nambour trial showed little evidence of an effect of sunscreen on first BCC, 
but there may a protective effect of sunscreen on repeated occurrences of BCC. A review of the 
evidence for the effect of sunscreen on skin cancer conducted in 2000 "concluded that there is 
inadequate evidence in humans for a cancer-preventive effect of topical use of sunscreen formulations 
against cutaneous malignant melanoma and basal-cell carcinoma of the skin ". 291 and little evidence has 
been found to suggest that this conclusion should be changed in relation to BCC. 
One possible explanation for the harmful associations seen in the observational studies is that 
people who are aware of a higher risk status for BCC (because of a previous skin cancer or 
benign skin lesion) start protecting themselves against sun exposure by using hats and applying 
sunscreen. 264,2n This change of behaviour in high risk people would then lead to an apparent 
harmful effect of hat use or sunscreen on BCC. Any specific harmful effect of applying 
sunscreen seems unlikely because similar harmful effects are seen for hat use. 279 
The estimated associations reported in the observational studies are likely to be subject to 
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unmeasured confounding. 264,280,291 For example, people who use sunscreen may be more likely 
to have light hair and eye colour, or to have skin that is more sensitive to sun exposure. The use 
of sunscreen may lead to longer sun exposure, and to wearing less clothing for protection from 
sunlight. 
9.3. Summary 
The literature described above shows some evidence that UV radiation is a cause of BCC, 
although the relationship may not be straightforward. Some methodological issues should also 
be considered when evaluating the evidence. 
For all observational studies described in this chapter, exposure measurement error is likely. It 
is very difficult to accurately measure a participant's sun exposure history, and many of the 
studies required participants to estimate their exposure many years in the past. In addition, 
recall bias in the case-control studies may have caused cases to report higher levels of sun 
exposure than controls. In this situation, associations between sun exposure and BCC may be 
overestimated. 
A further possibility for all studies is outcome misclassification, especially in studies in which 
outcomes were classified according to subject self-report or clinical diagnosis, rather than 
histological diagnosis. Many of the studies, however, classified outcomes based on histological 
data to minimise this problem. 
The lack of effect of sunscreens in protecting against BCC is an area that requires further 
research. The data of the Nambour Trial278,298 provide an opportunity for further analysis. In 
randomised controlled trials, while patients are allocated to receive treatment or not, they often 
do not comply with their assignation. The Nambour Trial Group started collecting data on 
sunscreen compliance in 1996, and these data are useful in estimating the efficacy of sunscreen 
on BCC. This analysis is presented in Chapter 10. 
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Chapter 10. 
Estimating treatment efficacy in randomised controlled trials with 
departures from randomly allocated treatment: the effect of 
sunscreen use on time to first basal cell carcinoma 
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Introduction 
In this chapter, the association between sunscreen use and time to first basal cell carcinoma 
(BCC) is investigated allowing for departures from the randon-dy assigned treatment regime. 
Data from the Nambour Skin Cancer and Actinic Eye Disease Trial (Nambour Trial) are used, 
which contain repeated measures of sunscreen use over almost six years. A rank preserving 
structural failure time model (RPSFTM) is used to relate the total time using sunscreen 
throughout the trial to the possibly counterfactual failure time that would have been observed 
had the subject used no sunscreen. The estimated acceleration parameter from the RPSFTM, 
which describes how fast lifetime is used up by using sunscreen, is converted into a hazard 
ratio, which is a more commonly used parameter in survival analyses. The analysis is carried 
out for two groups, the complete cases, which includes all subjects who did not drop out of the 
study before October 2002, and the complete cohort, which includes all subjects who entered 
the trial in 1992. 
10.2. Methods 
10.2.1. The Nambour Trial 
The design of the Nambour Trial has been described in detail by Green, Battistutta, Hart et al., 2" 
and so will be described more briefly here. It is aW factorial trial, aimed at assessing the effect 
of sunscreen use and beta-carotene supplementation on the incidence of squamous cell 
carcinoma (SCC) and BCC in a community in Queensland. The baseline survey for the trial was 
carried out in 1992. The trial included 1,621 subjects, who were randomised to one of four 
different treatment groups; daily sunscreen and beta-carotene, daily sunscreen and placebo, 
usual sunscreen use and beta-carotene, and usual sunscreen use and placebo. The sunscreen 
intervention was not placebo-controlled for ethical reasons. Firstly, it was thought that an 
emulsion with no active ingredients may cause increased damage from ultraviolet radiation 
when the water in the emulsion evaporated, and secondly use of a placebo sunscreen in a 
population with such high levels of exposure to ultraviolet radiation would lead to sunburn. 291 
In this chapter only the sunscreen intervention is considered, and the term intervention arrn will 
refer to the arm in which participants were asked to use sunscreen daily, and the term control 
arm will refer to the arm in which participants were asked to use their usual amount of 
sunscreen. 
Follow-up clinics in 1994 and 1996 were used to diagnose new BCCs, and clinically diagnosed 
BCCs were examined histologically. Participants were also asked at three monthly intervals 
whether any new BCCs had occurred. Medical records were reviewed for all new BCCs 
reported in this way. Self-reported BCCs were not included if they were not confirmed by 
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review of the medical record. Histological reports for self-reported BCCs were obtained where 
possible. The analysis here includes histologically confirmed BCCs on the head and neck. In 
order to obtain information on participants' sunscreen use, questionnaires were sent to the 
participants between August 1996 and March 2002 in approximately six-month intervals. 
Information on sunscreen use is not available before August 1996. 
10.2.2. Analysis method 
The purpose of the analyses presented in this chapter is to estimate the effect of sunscreen use 
on time to first BCC. In Chapter 8, five methods were identified that allowed for departures 
from randomly allocated treatment in RC7rs and survival outcomes. 2M, 226,228,237,253 Of these 
methods, four require a binary definition of compliance, either to estimate a complier average 
causal effect, 223, =6,2n or to identify the first time at which a participant is non-compliant. 253 
In the Nambour Trial, questionnaires were used to detern-dne participants' use of sunscreen in 
approximately six-month intervals between August 1996 and March 2002. They were asked to 
report how many days per week they were using sunscreen on their face, head or neck. The 
responses available were never, 1-2 days per week, 3-4 days per week, 5-6 days per week, and 
every day. Using a method that requires a binary definition of compliance, e. g. defining 
participants as compliant if they use sunscreen every day, and non-compliant otherwise, does 
not make full use of the available data. RPSFTMs, described in Section 8.2.3.1 and originally 
proposed by Robins and Tsiatis, 237 will therefore be used to estimate the effect of sunscreen use 
on time to first BCC in this chapter. 
For this analysis, BCCs occurring within one year of a participant's entry to the study are not 
included, as these may be due to underlying latent disease at the time of entry. Participants 
enter the analysis at their date of entry to the study, and are censored at the time of their first 
BCC more than one year post-randomisation, date of drop-out, or 30th September 20OZ 
whichever comes first. 
Table 10.1: Conversion of self-revorted sunscreen use into a proportion of time using sunscreen. 
Self-reported sunscreen use Proportion of time using sunscreen 
Never 0 
1-2 days per week 1.5/7=0.214 
3-4 days per week 3.5/7=0.5 
5-6 days per week 5.5/7=0.786 
Every day 1 
The analysis in this chapter will compare sunscreen use with no sunscreen use. In the notation 
of Equation 8.1, Toi will be the total time not using sunscreen, and Tii will be the total time using 
sunscreen. These times can be calculated using each subject's self-reported sunscreen use. This 
requires converting the self-reported sunscreen use to a proportion of time using sunscreen. 
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The values used for this conversion are shown in Table 10.1. 
Missing data on sunscreen use is a large problem in this dataset (see Table 10.5). Three 
alternative methods are used to deal with this problem, and the results from each compared. 
The first method will be referred to as last value carriedforward. For all missing values, other 
than the response to the first questionnaire in August 1996, the missing value will be replaced 
by the most recent non-n-dssing value. If information on sunscreen use from the first 
questionnaire in August 1996 is missing, participants in the intervention arm are assumed to 
use sunscreen every day, while those in the intervention arm are assumed to never use 
sunscreen. There was no information on sunscreen use before August 1996, and so it is 
assumed that throughout this period participants allocated to the intervention arm used 
sunscreen every day, and those in the control arm never used sunscreen. The reported 
sunscreen use is assumed to be constant until the date of the next questionnaire. For example, if 
a participant reports using sunscreen one or two days per week in the August 1996 
questionnaire, that subject is assumed to use sunscreen one or two days per week between 31st 
August 1996 and 31st March 1997, the date of the next questionnaire. Sunscreen use is then 
converted to a proportion using the values give in Table 10.1, and multiplied by the length of 
time (in years) between the two questionnaires. This provides an estimate of the total time 
using sunscreen in the various periods of follow-up, which are then summed to give an 
estimate of the total time using sunscreen throughout follow-up. 
Table 10.2 provides an example of this calculation for subject 10236. Follow-up for this subject 
started on 15th March 1992 and ended on 14th January 2002, when the subject dropped out of 
the study. As the subject was randomised to the intervention arm it was assumed that 
sunscreen was used every day between 15th March 1992 and 31st August 1996. The missing 
information on sunscreen use for the questionnaires on 31st March 1997 and 30th September 
1997 were replaced by the information provided in the August 1996 questionnaire. All other 
missing values were replaced in a similar way. The information on sunscreen use was 
converted to a proportion of time using sunscreen, defined by the values in Table 10.1. This 
proportion was multiplied by the total time of the interval to which it relates to give the total 
time using sunscreen in that interval (the final column in Table 10.2). Summing this column 
gives the total time using sunscreen throughout follow-up. 
The second method to deal with missing data on sunscreen use will be referred to as average 
value post 1996. For this, the average value of all available responses to the sunscreen use 
questionnaire is taken and applied to the entire period between August 1996, the date of the 
first sunscreen questionnaire, and September 2002, the end of the analysis time. For the period 
between entry to the study and August 1996 people randon-dsed to the intervention arm are 
assumed to use sunscreen every day, and people randomised to the control arm are assumed to 
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never use sunscreen. If there are no responses to the sunscreen use questionnaires, and 
therefore no values to take an average of, the subject is assumed to use sunscreen every day if 
they were randomised to the intervention arm, and to never use sunscreen if they were 
randon-dsed to the control arm. There were only four subjects who had not dropped out or had 
a BCC before 31st August 1996, and who had no information about sunscreen use. 
Table 10.3 illustrates this method with data from subject 10236. For this subject, follow-up 
started on 15th March 1992 and ended on 14th January 2002 when the subject dropped out of 
the study. The average value was calculated by summing the proportions of time using 
sunscreen as defined in Table 10.1 (equal to 1.21 for this subject) and dividing by the number of 
available responses (equal to five for this subject). This average proportion (0.24) is then 
applied to all intervals after 31st August 1996, while before 31st August 1996 this subject was 
assumed to use sunscreen every day because they were randomised to the intervention arm. 
The total time using sunscreen in each interval was obtained by multiplying the proportion of 
time using sunscreen by the length of the interval, and the total time using sunscreen 
throughout follow-up was calculated by summing the times using sunscreen in each interval of 
follow-up. 
These first two methods for dealing with the missing information both make implausible 
assumptions about sunscreen use between entry to the study and August 1996. It is extremely 
unlikely that all subjects in the intervention arm were using sunscreen every day, and all 
subjects in the control arm were never using sunscreen throughout this time. For the third 
method, therefore, missing information about sunscreen use will be will be dealt with by taking 
an average of all available responses to the sunscreen questionnaires, and applying this average 
to the entire analysis time between entry to the study in 1992 and September 2002. This will be 
referred to as the average value. There were 232 people with no information on sunscreen use. 
For these people, it was assumed that they used sunscreen every day if they were randomised 
to the intervention arm, and that they never used sunscreen if they were randomised to the 
control arm. Although this means that sunscreen use is likely to be overestimated in the 
intervention arm, and underestimated in the control arm for people with no information on 
sunscreen use, this method may more accurately capture the amount of time that sunscreen was 
used in both arms of the trial. 
Table 10.4 illustrates this method with data from subject IOM For this subject follow-up 
started on 15th March 1992 and ended on 14th January 20OZ when the subject dropped out of 
the study. The average value is calculated by summing the proportions of time using sunscreen 
(defined in Table 10.1) from the available responsm and dividing by the total number of 
responses (in this case, five). This average proportion is then applied to all intervals between 
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Summing these times using sunscreen provides the total time using sunscreen throughout 
follow-up. 
Non-compliance will be used to describe participants in the control arm using sunscreen, and 
participants in the intervention arm not using sunscreen. The analyses in this chapter will 
consider non-compliance in both arms simultaneously. It is possible to use RPSFIMs to analyse 
the effect of non-compliance in each arm separately. This was done, but the results are not 
provided as they required implausible assumptions about sunscreen use in the randon-dsed arm 
of the trial in which self-reported sunscreen use was not being used. For example, if non- 
compliance in the intervention arm only was considered, the subjects in the control arm would 
be assumed to never use sunscreen, which is extremely implausible. 
Two methods to allow for censoring will be used. In the first, censoring will only be due to the 
administrative end of follow-up, and data for subjects who dropped out before this will not be 
analysed. This will be called the complete case analysis. For the complete case analysis only 
participants who did not leave the study before 30th September 2002 are included. Between the 
date of entry into the study and 30th September 2002,523 participants dropped out, leaving 
1,098 subjects for the analysis. Figure 10.1 shows the numbers remaining in each treatment arm, 
and the number of first BCCs occurring between one year post-randomisation and 30th 
September 2002. 
Figure 10.1: Participants included in the complete case analys 
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In the second analysis, it is assumed that loss to follow-up is non-informative and subjects 
censored before the end of follow-up will be included. This will be called the complete cohort 
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analysis. Figure 10.2 shows the numbers in each treatment arm, and the number of first BCCs 
occurring between one year post-randomisation and 30th September 2002. 
Figure 10.2: Participants included in the complete cohort analysis. 
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Inverse probability of censoring weights, as discussed in Section 8.2.3.1, are not used for 
censoring in the analysis in this chapter, as the dataset provided for the analysis contained no 
information on covariates that predict censoring. A grid search, described in Section 8.2.3.1, 
was used to obtain the point estimates and 95% Cls for the acceleration parameter from the 
RPSFFM. 
Hazard ratios, and two corresponding 95% confidence intervals (Cls), are calculated for each 
analysis using the method described in Section 8.2.3.1. The CI based on the p-value of the 
intention-to-treat (ITI) analysis will be referred to as the test-based Cl. The second CI, based on 
1,000 bootstrapped samples, will be referred to as the bootstrapped C3. This 95% CI will be 
calculated using the bias-corrected and accelerated (BCý) method, 2" which is a percentile 
method for estimating CIs from bootstrap samples. To reduce computation time for the 
bootstrapped 95% Cl, ý is estimated using an interval bisection method (described in Section 
8.2.3.1), rather than a grid search. 
10.2. ZI The bias-corrected and accelerated method 
Using the same notation as Efron and Tibshirani, 2" a bootstrapped (100-2cc)% Cl is calculated 
using the BC. method as 
(6*(aj), 6*(a2)), where 0") is the ath percentile of the bootstrap 
replications of the parameter of interest, 
io +z(l-a) 
a) , and =c+. -1-iioFzo -+(lz-(,,, 
) 
9) 




In the equations above, (D(x) is the standard normal cumulative distribution function, and z(a) 
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is the ccth percentile point of a standard normal distribution. The bias-correction, io, is 
calculated using the formula 
io 
(#ý*(b)< 61 
where 4T)-I(x) is the inverse function of a standard normal cumulative density function, B is the 
number of bootstrap samples, and the numerator is the number of bootstrap replicates of the 
parameter of interest that are smaller than the parameter estimate in the original dataset. The 





61 (4 (. ) _6(i))2 
I Y2 
where n is the number of observations in the original dataset, 6(j) is the parameter estimate 




Figure 10.3 shows the Kaplan-Meier survival curves for time to first BCC in the intervention 
and control groups. There is little difference between the survival curves in the two groups. 
Using a log-rank test to test for equality of the survivor functions in the two groups gives ap 
value of 0.98, indicating no evidence of any difference in survivor functions in the two groups. 
The probability of surviving to ten years without a BCC is estimated to be 0.87 in the control 
group, and 0.86 in the intervention group. 
Because some subjects randon-dsed to the control group used sunscreen, and some subjects 
randon-tised to the intervention group did not use sunscreen every day, the survival curves are 
more similar than they would have been had all subjects in the intervention group used 
sunscreen every day and all subject in the control group never used sunscreen. A large amount 
of data is available in the Nambour Trial on the amount of sunscreen used by participants. 
These data are stratified by randomised group, and summarised in Table 10.5. Considering the 
data from all subjects simultaneously, responses to the first questionnaire appear to differ from 
subsequent responses. For example, 7% of participants indicated never using sunscreen in the 
first questionnaire on 31st August 1996. In the next questionnaire, this proportion increased to 
33%. This increase is accompanied by a decrease in the number of missing responses, and a 
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decrease in the number of people reporting using sunscreen for five days or more per week. 
Following the first questionnaire, there are no apparent discrepancies between questionnaire 
responses at any other times. The proportion of missing responses increases over time, as 
expected due to drop out from the study. The proportion of responses to the other categories in 
each questionnaire either remains fairly constant, or declines slightly. 
Figure 10.3: Kaplan-Meier survival curves for time to first basal cell carcinoma in the control and 









Time in years 
------ Control - Interventiod 
Considering reported sunscreen use in the intervention and control arms separately, there is a 
six-fold increase in the number of participants in the intervention group reporting never using 
sunscreen between the first and second questionnaires. This is accompanied by an 
approximately four-fold increase in the number of participants in the control group indicating 
no sunscreen use, although the absolute increase in the control group is greater than that in the 
intervention group. The decrease in the overall number of missing responses appears to be 
mainly due to a decrease in the number of missing responses in the control subjects. Missing 
responses fell by almost 50% in this group between the first and second questionnaires. The 
decrease in the number of subjects reporting sunscreen use every day is due to a decrease in the 
number of intervention subjects reporting this between the first and second questionnaires. In 
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10.3.2. Intention-to-treat analysis 
The usual method for estimating ITT acceleration factors would be to use a Weibull model. 
These are not used here as the analysis to estimate the efficacy of sunscreen will use a RPSFTM, 
and it makes more sense to compare estimated acceleration factors obtained using the same 
method. To obtain an ITT estimate of the acceleration parameter from a RPSFTM, the possibly 
counterfactual treatment-free failure times are calculated using Equation 8.2 where, for people 
in the control arm, Toi is the total analysis time and Tu is zero. Conversely, for people in the 
intervention arm, Tjj is the total analysis time and Toi is zero. 
Figure 10.4: Graph of the grid search for the intention-to-treat point estimate and 95% confidence 
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Acceleration parameter 
Figure 10.4 shows the results of the grid search to find the rff point estimate and 95% CI from 
the RPSFTM. The plotted line shows the value of the log-rank statistic at values of the 
acceleration parameter between -1 and 1. The horizontal dashed lines on the plot indicate the 
values at which the log-rank statistic equals 1.96,0 or -1.96. The point at which the plotted line 
crosses the value 1.96 defines the lower 95% confidence limit for the acceleration parameter, and 
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the point at which the plotted line crosses the value -1.96 defines the upper 95% confidence 
limit for the acceleration parameter. The point at which the plotted line crosses the value 0 
provides the point estimate of the acceleration parameter. The vertical dashed line indicates the 
point at which there is no effect of sunscreen use on time to first BCC. All values of the 
acceleration parameter to the right of this line indicate a harmful effect of sunscreen use on time 
to first BCC. Similarly, all values to the left of this vertical line indicate a beneficial effect of 
sunscreen use on time to first BCC. 
The ITT acceleration parameter obtained from the RPSFTM is 0.043 (-0.204-0.297) for the 
complete cases analysis, and 0.006 (-0.202-0.271) for the complete cohort analysis. The ITT 
hazard ratio, obtained using a Cox proportional hazards model, is 1.01 (0.76-1.35) for the 
complete cases analysis, and 1.00 (0.75-1.33) for the complete cohort analysis. The ITT p-value is 
0.921 for the complete cases analysis, and 0.983 for the complete cohort analysis. 
From these ITT results, and the properties of the RPSFrM, it is possible to predict what results 
will be obtained when analysing the effect of sunscreen use on time to first BCC. As the ITT 
estimate will be biased towards the null value as an estimate of treatment efficacy (as subjects in 
the intervention arm use more sunscreen than subjects in the control arm), allowing for 
sunscreen use will produce efficacy estimates that are further from the null value than the ITT 
estimate. In addition, as the RPSFrM preserves the p-value of the ITT analysis, the increase in 
the efficacy estimate will result in wider 95% CIs with 95% confidence limits that are further 
from the null value than the ITT 95% confidence limits. As the ITT p-values are large, small 
increases in the efficacy estimate will result in large increases in the width of the 95% CL 
10.3.3. Complete case analysis 
In this section, the effect of sunscreen use on time to first BCC is estimated, using data on 
people who did not drop out of the trial before 30th September 2002. 
Figure 10.5 shows the graphs for the grid searches for the point estimate and 95% Cls for the 
effect of sunscreen use on time to first basal cell carcinoma for the three different methods of 
allowing for missing sunscreen use information. Values of the acceleration parameter between 
-1 and 1 were searched for the last value carried forward and average post 1996 methods. For 
the average value method, the search was over values of the acceleration parameter between 4 
and 4, as upper and lower 95% confidence limits were not found in the original search range. 
The acceleration parameter point estimates and 95% CIs were derived from these graphs using 
the method described for the ITT RPSFrM analysis; the point estimate is defined as the value of 
the acceleration parameter where the log-rank statistic equals zero, and the 95% Cl is defined by 
the values of the acceleration parameter where the log-rank statistic equals 1.96 and -1.96. In 
contrast with the ITT analysis, in these analyses there may be multiple solutions for the point 
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estimate and 95% confidence limits. This occurs when the log rank statistic is equal to -1.96,0 
or 1.96 for several different values of the acceleration parameter. These multiple solutions are 
dealt with in the way described in Section 8.2.3.1. If the log-rank statistic crosses the required 
values (-1.96,0 or 1.96) at the points ao, al, ..., a., for even n, the estimate is taken to be 
1-0 
Figure 10.5: Graph of the grid searchfor the point estimate and 95% confidence intervalfor the effect of 
sunscreen use on time to first basal cell carcinoma from a rank preserving structural failure time model, 
using three methodsfor missing sunscreen use information. 
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Figure 10.6 shows a magnification of the multiple solutions for the upper 95% confidence limit 
when the average value method is used to allow for missing information on sunscreen use. The 
solutions occur at 1331,1.650,1.712,1.853,1.898,1.905 and 2.447. The upper 95% confidence 
limit for this analysis is therefore defined as 1.98. Multiple solutions also occur for the lower 
95% confidence limit for the analysis using the average value method, and for the point 
estimates for the acceleration parameter for all analyses. The same procedure is used for all 
multiple solutions occurring throughout this chapter. 
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Figure 10.6: Magnification of the multiple solutionsfor the upper 95% confidence limitfor the average 
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Acceleration parameter 
Mark and RobinS244 showed that, as compliance with the randomly allocated treatment 
worsens, the ability of the RPSFTM to distinguish the value of the true acceleration parameter 
from other values decreases. This is apparent in Figure 10.5 for the average value method. The 
grid search is non-monotonic, and at no value of the acceleration parameter does the log-rank 
statistic become greater than, and remain greater than, 1.96. The lower 95% confidence limit for 
this analysis is therefore defined to be -oo. This means that the data are consistent with 
sunscreen use being perfectly protective against BCC 
Table 10.6 shows the total amount of time using sunscreen and not using sunscreen in the 
intervention and control arms for each of the three methods for dealing with missing sunscreen 
use information. This table shows that the estimated sunscreen use in the control and 
intervention arms for the last value carried forward and average value from 1996 methods are 
different. When sunscreen use is estimated using the average value for the entire analysis time, 
there is very little difference between the estimated sunscreen use in the intervention and 
control groups. A comparison of the time using sunscreen between the randomised groups will 
then provide little information about the true value of the acceleration parameter, and leads to 
the problem of finding the lower 95% confidence limit seen in Figure 10.5. 
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Table 10.6: Summa? y of total time using, or not using sunscreen in the intervention and control armsfor 
the three different methodsfor missing data on sunscreen use. 
Intervention Control 
Time using sunscreen (years) 3,516 760 Last value Time not using sunscreen (years) 1,744 4,636 
Time using sunscreen (years) 3,476 768 Average value post 1996 Time not using sunscreen (years) 1,784 4,628 
Time using sunscreen (years) 2,013 1,397 Average value Time not using sunscreen (years) 3,247 3,999 
Table 10.7 shows the effect estimate, acceleration factor and hazard ratio from fitting a RPSFTM 
to those participants of the Nambour trial who did not drop out before the end of follow-up. 
The ITT estimate is shown, along with the estimates obtained when actual sunscreen use is 
considered using the three methods of allowing for missing information on sunscreen use. As 
predicted in Section 10.3. Z the point estimates allowing for sunscreen use are all further from 
the null value than the ITT estimate. For the last value carried forward analysis, the point 
estimate of ý is 2.1 times larger than the ITT point estimate. The hazard ratio also increases 
from 1.01 from the ITT analysis to 1.07 when sunscreen use is considered. For the average value 
post 1996 method, the point estimate of ý is 2.8 times larger than the ITT point estimate. The 
hazard ratio also increases from 1.01 from the ITT analysis to 1.09 when sunscreen use is 
considered. For the average value method for allowing for missing information on sunscreen 
use, the point estimate of ý is 6.4 times larger than the ITT point estimate. The hazard ratio 
also increases from 1.01 from the M analysis to 1.32 when sunscreen use is considered. 
Table 10.7. Effect estimate, acceleration factor and hazard ratio for the effect of sunscreen use on time to 
first basal cell carcinoma from a rank preserving structural failure time model, using three methods for 











(95% CI)a (95% CI)b 
HT 0.043 1.04 1.01 (-0.204-0.297) (0.82-1.35) (0.76-1.35) 
Last value carried forward 
0.091 1.10 1.07 
(-0.230-0.503) (0.79-1.65) (0.29-3.88) (0.75-1.74) 
Average value post 1996 
0.119 1.13 1.09 
(-0.234-0.515) (0.79-1.67) (0.20-6.04) (0.75-1.76) 
Average value 
0.277 1.32 1.32 
* (. 1.980) (0-7.24) (0.01-306.04) (0-5.49) 
Test-based 95% confidence interval, with the same p-value as the ITT estimate. 
b Bootstrapped 95% confidence interval, based on 1,000 bootstrap samples. 
* Based on 985 bootstrap samples. 
All 95% Cls for the analyses allowing for sunscreen use are wider than the 95% Cl for the ITT 
analysis. This was also predicted in Section 10.3.2. The test-based 95% Cls for the hazard ratios 
when sunscreen use is considered are very wide. Because the p-value for the ITT estimate is 
large (p=0.921), small increases in the hazard ratio result in a large increase in the width of the 
264 
Sunscreen use and BCC 
test-based 95% CL This is particularly evident when the average value method is used to allow 
for missing information on sunscreen use. The test-based 95% Cl for the hazard ratio provides 
almost no information in this situation. The bootstrapped 95% CI is generally narrower than 
the test-based 95% CI and may therefore be preferable to the test-based 95% Cl, as it is not 
influenced by large p-values. When deriving the bootstrapped 95% CI for the hazard ratio for 
the average value method, there were 15 bootstrapped datasets for which an estimate for the 
acceleration parameter could not be found. This bootstrapped 95% CI is therefore based on 
only 985 samples. The Cls wiU not be discussed further in this chapter. 
Table 10.8: The effects of recensoring in the complete cases dataset, using three methods for missing 
sunscreen use information. 
Analysis Control Intervention 
Last value Number of observations recensored 348 452 
carried forward Total time 5,468.48 5,595.40 
Total time lost 69.16 294.80 
Events lost 2 3 
Average value Number of observations recensored 348 453 
post 1996 Total time 5,493.11 5,699.71 
Total time lost 92.49 387.59 
Events lost 2 4 
Average value Number of observations recensored 353 428 
Total time 5,842.07 5,902.99 
Total time lost 414.30 581.41 
Events lost 7 7 
One of the main issues with analysis of this type is that recensoring is required to deal with 
informative censoring. This results in a loss of information, and the estimated acceleration 
parameters and 95% CIs displayed in Figure 10.5 and Table 10.7 may be due to recensoring 
rather than a true effect of sunscreen use on time to BCC. Table 10.8, therefore, shows the 
number of observations that are recensored for the analysis of sunscreen use, the total analysis 
time that would have been used had there been no recensoring, the analysis time lost due to 
recensorin& and the number of events lost due to recensoring for the three methods for 
allowing for missing information on sunscreen use. For the last value carried forward method 
800 (72.9%) observations were recensored. This, however, only resulted in the loss of 3.3% of 
the analysis time. Only five (2.6%) of the 189 first BCCs were lost due to recensoring. For the 
average value post 1996 method 801 (73.0%) observations were recensored. This, however, only 
resulted in the loss of 4.3% of the analysis time. Only six (3.2%) of the 189 first BCCs were lost 
due to recensoring. It would seem that the results presented in Table 10.7 and Figure 10.5 are 
unlikely to be greatly affected by recensoring for these two analysis methods. For the average 
value method, however, 781 (71.1%) of the observations were recensored. This resulted in the 
loss of 8.5% of the analysis time. Fourteen (7.4%) of the 189 first BCCs were lost due to 
recensoring. It would seem that the results presented in Table 10.7 and Figure 10.5 are more 
affected by recensoring than the results described for the other two methods for dealing with 
missing information on sunscreen use. 
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10.3.4. Complete cohort analysis 
III thi" the efted ot smiscreen use on time to first 13CC is estimated, using data from all 
1,021 particip, ints in the Nambour Trial. As the estimated acceleration parameters obtained iii 
these m, flYses are similar to those obtained in Section 10.3.3, the results will be presented more 
concisely. 
Figure 10.7: Graph o, t'llic grid search 
. 
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Figure 10.7 shows the graphs for the grid searches for the point estimate and 95'Y,, Cls for the 
Ofect of sunscreen use on time to first basal cell carcinorna for the three different methods of 
Alowing for inissing sunscreen use information. The acceleration parameter point estimates 
, 111d ')Y",, ('Is were derived from these graphs using the method described for the ITT RN, FTM 
. 111,11N. 'sis. i'llcre are multiple solutions for the point estimate of tile acceleration parameter for all 
three analyses. There are multiple solutions for the upper 95Y,, confidence limit for the average 
value post 1990 and the average V, 11LW 111alySCS. For the last value carried forward and the 
average value analyses, there are multiple solutions for the lower 95% confidence limit. These 
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multiple solutions are dealt with in the way described in Section 8.2.3.1 and Section 10.3.3. 
The inability of the RPSFTM to distinguish the value of the true acceleration parameter from 
other values is again apparent in Figure 10.7 for the average value method. The grid search is 
non-monotonic, and at no value of the acceleration parameter does the log rank statistic become 
greater than, and remain greater than, 1.96. The lower 95% confidence limit for this analysis is 
therefore defined to be -o-. Table 10.9 shows that there is very little difference between the 
estimated sunscreen use in the intervention and control groups for the average value method, 
which leads to the problem of finding the lower 95% confidence limit for this analysis. For the 
other two analyses, the estimated time using sunscreen is different between the intervention 
and control groups, and the same problems do not occur. 
Table 10.9: Summary of total time using, or not using sunscreen in the intervention and control armsfor 
the three different methodsfor missing data on sunscreen use. 
Intervention Control 
Last value 
Time using sunscreen (years) 4,559 875 
Time not using sunscreen (years) Z139 5,908 
Average value post 1996 
Time using sunscreen (years) 4,515 883 
Time not using sunscreen (years) Z182 5,899 
Average value 
Time using sunscreen (years) Z644 1,639 
Time not using sunscreen (years) 4,054 5,144 
Table 10.10 shows the effect estimate, acceleration factor and hazard ratio from fitting a 
RPSFTM to all participants of the Nambour trial. The ITT estimate is shown, along with the 
estimates obtained when actual sunscreen use is considered using the three methods of 
allowing for missing information on sunscreen use. For the last value carried forward analysis, 
the point estimate of ý is 12.2 times larger than the ITT point estimate. The hazard ratio also 
increases from 1.00 from the ITT analysis to 1.05 when sunscreen use is considered. For the 
average value post 1996 method, the point estimate of 0 is 12.7 times larger than the ITT point 
estimate. The hazard ratio also increases from 1.00 from the ITT analysis to 1.05 when 
sunscreen use is considered. Although the relative increases in the estimated acceleration 
factors are much greater for the complete cohort analysis than for the complete cases analysis, 
the estimated acceleration factors obtained from the two methods are similar. For the average 
value method for allowing for missing information on sunscreen use, the point estimate of is 
9.0 times larger than the ITT point estimate. The hazard ratio also increases from 1.00 from the 
ITT analysis to 1.07 when sunscreen use is considered. These are very different estimates from 
those obtained in the complete cases analyses, but it has already been seen that the model does 
not perform well when using the average sunscreen use over the entire analysis period, and 
therefore little should be inferred from the difference between the estimated acceleration 
parameters from the two analyses. 
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Table 10.10: Effect estimate, acceleration factor and hazard ratiofor the effect of sunscreen use on time to 
first basal cell carcinoma from a rank preseruing structural failure time model, using three methods for 
missime sunscreen use information. 
Effect estimate Acceleration 
factor Hazard ratio 
Analysis 
Estimate Estimate Estimate 
(95% Cl) (95% CI) (95% CI)a (95% CI)b 
ITT 0.006 1.01 1.00 (-0.202-0.271) (0.82-1.31) (0.75-1.33) 
Last value 0.073 1.08 1.05 
carried forward (-0.244-0.503) (0.78-1.65) (0-01-85.66) (0.77-1.82) 
Average value 0.076 1.08 1.05 
post 1996 (-0.245-0.510) (0.78-1.67) (0.01-124.49) (0.76-1.84) 
Average value 
0.054 1.06 1.07 
* (-oo-1.872) (0-6.50) (0.00-704.09) (0-4.26) 
a Test-based 95% confidence interval, with the same p-value as the ITT estimate. 
6 Bootstrapped 95% confidence interval, based on 1,000 bootstrap samples. 
* Based on 986 bootstrap samples 
Table 10.11 shows the number of observations that are recensored for the analysis of sunscreen 
use, the total analysis time that would have been used had there been no recensoring, the 
analysis time lost due to recensoring, and the number of events lost due to recensoring for the 
three methods for allowing for missing information on sunscreen use. For the last value carried 
forward method 1,138 (70.2%) observations were recensored. This, however, only resulted in 
the loss of 2.7% of the analysis time. Only three (1.6%) of the 189 first BCCs were lost due to 
recensoring. For the average value post 1996 method 1,139 (70.3%) observations were 
recensored. This, however, only resulted in the loss of 2.8% of the analysis time. Only three 
(1.6%) of the 189 first BCCs were lost due to recensoring. For the average value method 1,112 
(68.6%) observations were recensored. This, however, only resulted in the loss of 1.6% of the 
analysis time. Only two (1.1%) of the 189 first BCCs were lost due to recensoring. It would 
seem that the results presented in Table 10.10 and Figure 10.7 are unlikely to be greatly affected 
by recensoring for these analyses. 
Table 10-11: The effects of recensoring in the complete cohort, using three methodsfor missing sunscreen 
use information. 
Analysis Control Intervention 
Last value Number of observations recensored 419 719 
carried forward Total time 6,849.08 7,042.99 
Total time lost 63.55 313.06 
Events lost 2 1 
Average value Number of observations recensored 420 719 
post 1996 Total time 6,852.60 7,054.30 
Total time lost 66.71 323.50 
Events lost 2 1 
Average value Number of observations recensored 439 673 
Total time 6,873-78 6,844.47 
Total time lost 84.03 134.77 
Events lost 2 0 
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10.4. Discussion 
Summary of results 
For the analyses on both the complete cases and the complete cohort, there was no evidence for 
an effect of sunscreen on time to first BCC from the ITT analysis. The ITT point estimates were 
slightly greater than the null value, and therefore estimating the efficacy of sunscreen use on 
time to BCC using a RPSFTM produced point estimates that were further from the null than the 
ITT point estimate. As RPSFTMs respect the randomisation and preserve the ITT p-value, the 
increases in the point estimates were accompanied by an increase in the width of the 95% Cl 
when compared to the ITT 95% CL The additional amount of non-compliance created by using 
an average of the available information on sunscreen use, and applying this average to the 
whole follow-up period, meant that the model was unable to distinguish the true value of the 
acceleration parameter from any other values. 244 This resulted in infinite lower 95% confidence 
limits. 
Recensoring is required to avoid biased estimates from RPSFrMs due to informative censoring. 
This, however, results in loss of information and may affect effect estimates. For most of the 
analyses presented in this chapter, loss of information was small and it is unlikely that the effect 
estimates were greatly affected by this. For the analysis on the complete cases, using an average 
value of sunscreen use over the entire follow-up period to estimate the total time using 
sunscreen, 8.4% of the analysis time and 7.4% of the BCCs were lost due to recensoring. This 
may have influenced the results obtained from the RPSFrM, and account for the large 
difference between the rff estimate and the estimate obtained from the RPSFTM. 
10.4.2. Strengths and weaknesses 
The major strength of methods of analysing departures from randomised exposure in RCrs is 
that the efficacy of treatment can be estimated, rather than the effectiveness of the 
randomisation itself. This strength is, however, restricted by the data. If an ITT analysis 
provides no evidence of an effect of treatment on outcome, neither will a compliance analysis. 
In the analyses presented in this chapter, there was no evidence of a treatment effect for the rrr 
analyses, and the ITr point estimate was very close to the null value for both analyses presented 
here. The main use of a RPSFTM in this situation is to investigate the effect of departures from 
randomised exposure on the 95% Cl, and to find a range of parameter values that more truly 
reflects the efficacy of exposure. 
Data on use of sunscreen was provided by participant self-report. This is likely to be subject to 
some misclassification, and will therefore not be an accurate measurement of the amount of 
sunscreen used. The effects of exposure n-dsclassification on parameter estimates for standard 
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regression models have been well discussed (see Section 2.3.2), but similar investigations have 
not been carried out for RPSFrMs. It may be the case that exposure misclassification has little 
or no effect on parameter estimates obtained from RPSFTMs, a result that was demonstrated by 
Goetghebeur and Vansteelandt256 in the context of structural nested mean models. 
There was a large amount of missing information on sunscreen use in this dataset, due to both 
missing responses to the questionnaires, and the fact that information on sunscreen did not start 
to be collected until August 1996. Three methods were used to estimate the total time using 
sunscreen allowing for this missing data. In the first method, the most recently reported 
amount of sunscreen use was used. The second and third methods calculated an average of all 
available sunscreen use information, and applied this to the period between 31st August 1996 
and 30th September 2002, and for the entire follow-up time respectively. For the first two 
methods, participants randomised to the intervention arm were assumed to use sunscreen 
every day, while those randon-dsed to the control arm were assumed to never use sunscreen 
between the date of entry to the study and 31st August 1996. This is unlikely to have cwcurred 
in reality. Participants randomised to the control arm were told to use their usual amount of 
sunscreen. It is therefore likely that participants in the control arm were using sunscreen, at 
least for part of the time between their entry to the study and August 1996. The third method 
therefore seems the most plausible way to estimate the time using sunscreen, but the sin-dlarity 
between the amount of sunscreen used in the intervention and control arms meant that the 
model was unable to distinguish the true value of the acceleration parameter from other values. 
There is also likely to be some inaccuracy in the estimated amount of time using sunscreen 
obtained from this third method, as sunscreen use habits may have changed over the course of 
the trial, and the average of the reported sunscreen use after 1996 may not accurately reflect the 
amount of time that sunscreen was used in the first part of the trial. Due to the difficulty of 
accurately estimating the amount of time using sunscreen, it seems unlikely that the true effect 
of sunscreen use on time to BCC has been estimated. 
To use the self-reported sunscreen use in the analyses presented here, they were converted into 
proportions (as shown in Table 10.1). Different proportions could have been calculated for each 
category of sunscreen use. For example, using sunscreen one or two days per week was 
converted into a proportion equal to 1.5/7. This proportion could instead have been calculated 
as 1/7 or 2/7. Changing the way the proportion was calculated is unlikely to make a 
substantial difference to the results presented in this chapter. 
For the complete cohort analysis (presented in Section 103.4), drop out was assumed to be non- 
informative. If this assumption is not true the results presented in Section 103.4 will be biased, 
as censoring prior to the end of follow up will have been dealt with incorrectly. A different 
method is required to deal with informative censoring. 
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10.4.3. Future research 
Further research could be carried out on data from the Nambour Trial. A sensitivity analysis 
could be performed to investigate the impact of n-dsclassification of self-reported sunscreen use 
on the RPSFTM results presented in this chapter. Misclassification in repeated measures of 
polytomous variables could be investigated using an adaptation of the method proposed by 
Lash and Fink. 61 
The RPSFrM, proposed by Robins and TsiatiS, 237 has been extended to include time to repeated 
outcome events by Vandebosch, Goetghebeur and Van Damme2w and Matsui. 249 The Nambour 
Trial data contain information on all BCC occurrences during the trial. These methods for 
analysing compliance and time to repeated outcomes could be used. 
Data on other skin cancers, such as malignant melanoma and SCC, are available from the 
Nambour Trial. Similar analyses to those presented in this chapter could be carried out to 
investigate the effect of sunscreen use on these cancers. 
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This thesis has examined three aspects of causal modelling in epiden-dology; the effects of 
measurement error in continuous exposures and confounders on estimated exposure-outcome 
odds ratios (Part A), correcting exposure effect estimates for the effects of measurement error in 
continuous exposures and confounders (Part B), and estimating the efficacy of treatment in 
randomised trials in which there are departures from the randomly allocated treatment (Part C). 
Although these have been treated as distinct aspects within the topic of causal modelling, there 
are similar points to consider for all three topics, particularly in relation to the implications for 
study design and analysis (described below). These three topics are not, however, a 
comprehensive overview of all aspects of causal modelling in epidemiology. For example, 
estimating exposure effects in the presence of time-dependent confounding is one area that has 
not been considered. 
Some wider implications for study design and analysis have been highlighted in this thesis. 
Sensitivity analysis is not the best way to allow for measurement error in observational studies. 
The possibility of measurement error should be considered, for all variables, at the beginning of 
the study and steps should be taken to minimise it as far as possible. Studies should be 
designed to allow the use of methods that correct for measurement error (see Chapter 4), for 
example via internal or external validation of measurements, or via replicate measurements. 
Study design is also an important consideration for randomised trials in which there may be 
departures from the randon-dy allocated treatment. The design should then include assessment, 
as accurately as possible, of the amount of treatment received by each trial participant. 
In order to correct for measurement error, it is important to consider what is the causal 
exposure variable of interest. For example, in Chapter 7, the long-term average of the variables 
measured with error was considered to be the causal exposure. In this context, the error 
variance will include biological variation as well as any errors in measurement, and replicate 
measurements should be made at sufficiently large intervals to incorporate such variation. If 
the causal variable is the amount of exposure on a particular day, biological variation will not 
be included in the estimate of the measurement error variance, and replicate measurements 
should be made on the same day. Sin-dlar considerations apply to analyses of treatment efficacy 
in the presence of departures from randomly allocated treatment. In order to estimate the 
causal effect of treatment, the causal treatment (for example, the dose of drug consumed in a 
given time period) should be clearly defined, and the trial designed in such a way that the 
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Appendix 2 
Appendix 2. 
Additional graphs from the analyses in Chapter 7 
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Appendix 2 
Figure A2.1: Graphical representation of sensitivity analysis results for t1w effect of a unit increase in 
FEVi, a unit increase in log triglycerides, or a doubling of CRP on incident CHID, allowing for 
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Appendix 2 
Figure A2.2: Graphical representation of sensitivity analysis results for the effect of a unit increase in 
FEV,, a unit increase in log triglycerides, or a doubling of CRP on time to incident CHD, allowing for 
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Appendix 2 
Figure A2.3: Graphical representation of sensitivity analysis results for the effect of doubling CRP on 















Sensitivity analysis A 
----------- Sensitivity analysis B 
306 
Appendix 2 
Figure A2.4: Graphical representation of sensitivity analysis results for the effect of doubling CRP oil 
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Appendix 2 
Figure A2.5: Graphical representation of sensitivity analysis results for the effect of doubling CRP on 
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